<SEC-DOCUMENT>0000950103-21-002397.txt : 20210217
<SEC-HEADER>0000950103-21-002397.hdr.sgml : 20210217
<ACCEPTANCE-DATETIME>20210217160339
ACCESSION NUMBER:		0000950103-21-002397
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210217
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210217
DATE AS OF CHANGE:		20210217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
		CENTRAL INDEX KEY:			0001100682
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				061397316
		FISCAL YEAR END:			1226

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15943
		FILM NUMBER:		21644686

	BUSINESS ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		781-222-6000

	MAIL ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES INTERNATIONAL INC
		DATE OF NAME CHANGE:	20000605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19991208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dp146258_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:CRL="http://criver.com/20210217">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_CRL_criver.com_20210217 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20210217_20210217 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001100682 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityCentralIndexKey">0001100682</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="crl-20210217.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2021-02-17to2021-02-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001100682</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-17</xbrli:startDate>
        <xbrli:endDate>2021-02-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES &#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b>&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, DC 20549 </b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20210217__20210217_z15QqoQFJUHb"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>of the
Securities Exchange Act of 1934</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Date of
Report (Date of Earliest Event Reported): <span id="xdx_90A_edei--DocumentPeriodEndDate_c20210217__20210217_zhIwzhOJ3EZ1"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February 17, 2021</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20210217__20210217_z4SHMVFihBuh"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityRegistrantName">CHARLES RIVER LABORATORIES INTERNATIONAL,
INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified
in its charter) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 34%">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="width: 32%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20210217__20210217_zyEdyWirCQSg"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityFileNumber_c20210217__20210217_z2p9CMQyihZ7"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityFileNumber">001-15943</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20210217__20210217_zzcMBMQRkaZc"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityTaxIdentificationNumber">06-1397316</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of incorporation)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>File Number)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
<tr>
    <td colspan="3">&#160;</td>
    <td colspan="2">&#160;</td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20210217__20210217_zWudHoB6MuJd"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityAddressAddressLine1">251 Ballardvale
Street</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20210217__20210217_zXUxOZOif4Xb"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityAddressCityOrTown">Wilmington</ix:nonNumeric></span>,
<span id="xdx_907_edei--EntityAddressStateOrProvince_c20210217__20210217_zlnOoewi5fFh"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20210217__20210217_z3cAPjFvg5f7"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:EntityAddressPostalZipCode">01887</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">(Address
of Principal Executive Offices) (Zip Code)</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--CityAreaCode_c20210217__20210217_z5lv7U0Fje65"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:CityAreaCode">781</ix:nonNumeric></span>-<span id="xdx_90A_edei--LocalPhoneNumber_c20210217__20210217_zpqWUihIxRI"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:LocalPhoneNumber">222-6000</ix:nonNumeric></span>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">(Registrant&#8217;s
Telephone Number, including Area Code)</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span><b> </b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 34%; font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which registered</span></td></tr>
<tr>
    <td style="font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--Security12bTitle_c20210217__20210217_zIfxFAbsQxUj"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:Security12bTitle">Common
    stock, $0.01 per share</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--TradingSymbol_c20210217__20210217_zl1jI65OR9tc"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" name="dei:TradingSymbol">CRL</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--SecurityExchangeName_c20210217__20210217_zMeSTqgIlx57"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4%; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--WrittenCommunications_c20210217__20210217_zFKRyGRv0Wl3"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4%; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--SolicitingMaterial_c20210217__20210217_zH5TVB7hllE7"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4%; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20210217__20210217_zpthPG4Y6K5i"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4%; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20210217__20210217_zOKLJCEWx44j"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20210217__20210217_z1w5boXrwPia"><ix:nonNumeric contextRef="From2021-02-17to2021-02-17" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 17, 2021, Charles River Laboratories
International, Inc. (&#8220;<b>Charles River</b>&#8221;), Memphis Merger Sub, Inc. , a wholly-owned subsidiary of Charles River
(&#8220;<b>Merger Sub</b>&#8221;), Cognate BioServices, Inc. (&#8220;<b>Cognate</b>&#8221;) and Mercury Fund 2 Holdco LLC, solely
in its capacity as the initial representative of the Company Shareholders (as defined in the Merger Agreement) entered into an
Agreement and Plan of Merger (the &#8220;<b>Merger Agreement</b>&#8221;) pursuant to which and subject to the satisfaction or waiver
of the conditions set forth in the Merger Agreement, Merger Sub will be merged with and into Cognate, with Cognate surviving the
merger as a wholly-owned subsidiary of Charles River (the &#8220;<b>Merger</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection and concurrently with Charles
River&#8217;s entry into the Merger Agreement, (i) Charles River entered into support agreements (the &#8220;<b>Support Agreements</b>&#8221;)
with certain shareholders of Cognate pursuant to which such shareholders have agreed to vote their Cognate shares in favor of the
approval and adoption of the Merger Agreement, waive their statutory appraisal rights and agreed to certain other covenants and
(ii) Charles River entered into a rollover agreement (the &#8220;<b>Rollover Agreement</b>&#8221;) with certain holders of Cognate
options pursuant to which such holders have, among other things, agreed to exercise their options in accordance with the terms
specified in the Rollover Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><span style="text-decoration: underline">The Merger Agreement</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the terms of the Merger Agreement,
Charles River will acquire Cognate for approximately $875 million in cash, subject to certain customary adjustments. Consummation
of the Merger is subject to customary closing conditions, including among other things: (i) the adoption and approval of the Merger
Agreement by Cognate shareholders, (ii) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976 (the &#8220;<b>HSR Act</b>&#8221;), (iii) subject to the standards set forth in the Merger
Agreement, the accuracy of representations and warranties as of the closing and (iv) the absence of any developments that would
reasonably be expected to have a material adverse effect on Cognate. Closing is expected to occur in the first quarter of 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Charles River and Cognate each made customary
representations, warranties and covenants under the Merger Agreement. Cognate has agreed to certain covenants, including among
others, that it will use reasonable best efforts to conduct its business in the ordinary course and refrain from taking certain
actions until the consummation of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Merger Agreement may be terminated
under specified circumstances, including if the Merger is not consummated on or before May 17, 2021 (the &#8220;<b>Outside Date</b>&#8221;)
for any reason other than the nonperformance of the terminating party. If as of such date, the closing condition requiring the
expiration or termination of the waiting period under the HSR Act has not been satisfied and all other closing conditions (other
than conditions which by their nature are to be satisfied at Closing, but subject to such conditions being waived or capable of
being satisfied at Closing) to the Merger have been satisfied or waived, each of Charles River and Cognate shall have the right
upon written notice to extend the Outside Date until August 17, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the Merger
Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement,
which is filed as Exhibit 2.1 to this Current Report on Form 8-K and incorporated by reference herein. The representations, warranties
and covenants contained in the Merger Agreement have been made solely for the purposes of the Merger Agreement and as of specific
dates; were solely for the benefit of the parties to the Merger Agreement; are not intended as statements of fact to be relied
upon by stockholders of Charles River or other security holders, but rather as a way of allocating the risk between the parties
in the event the statements therein prove to be inaccurate; have been modified or qualified by certain confidential disclosures
that were made between the parties in connection with the negotiation of the Merger Agreement, which disclosures are not reflected
in the Merger Agreement itself; may no longer be true as of a given date; and may apply standards of materiality in a way that
is different from what may be viewed as material by stockholders of Charles River or other security holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><b><span style="text-decoration: underline">The Support Agreements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 17, 2021, concurrently
with and as an inducement for Charles River&#8217;s entry into the Merger Agreement, certain shareholders of Cognate as
indicated on the signature pages therein (collectively, the &#8220;<b>Cognate Shareholders</b>&#8221;), which together hold
in excess of 90% of the fully diluted capital stock of Cognate, entered into the Support Agreements. Pursuant to the Support
Agreements, each Cognate Shareholder agreed to: (i) vote all of its Cognate shares in favor of the approval and adoption of
the Merger Agreement, (ii) waive its statutory appraisal rights and (iii) agree to certain other covenants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each Cognate Shareholder has agreed that,
other than according to the terms of its respective Support Agreements, it will not (i) grant any proxies or enter into any voting
trust or other agreement or arrangement with respect to the voting of any Cognate stock, or (ii) subject to certain limited exceptions,
transfer, sell or otherwise dispose of any Cognate shares, in each case, during the term of the Support Agreement.
The Support Agreements will terminate if the Merger Agreement is terminated prior to the closing of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing description of the Support
Agreements does not purport to be complete and is qualified in its entirety by reference to the form of the Support Agreement,
which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 7.01 Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 17, 2021, Charles River issued
a press release announcing the transaction. A copy of the press release is attached hereto as Exhibit 99.1. The information being
furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of
the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference into any filing under the Securities Act
of 1933, except as expressly set forth by reference in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Exhibit</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1%; font-size: 12pt">&#160;</td>
    <td style="width: 9%; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Number</span></span></td>
    <td style="width: 90%; font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Title</span></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%"><a href="dp146258_ex0201.htm"><span style="font: 10pt Times New Roman, Times, Serif">2.1</span></a></td>
    <td style="width: 90%"><a href="dp146258_ex0201.htm"><span style="font-size: 10pt">Agreement and Plan of Merger, dated as
    of February 17, 2021, by and among Charles River Laboratories International, Inc., Memphis Merger Sub, Inc., Cognate BioServices,
    Inc. and Mercury Fund 2 Holdco LLC, solely in its capacity as the initial representative of the Company Shareholders.*</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1%; font-size: 12pt">&#160;</td>
    <td style="width: 9%; font-size: 12pt"><a href="dp146258_ex1001.htm"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></a></td>
    <td style="width: 90%; font-size: 12pt"><a href="dp146258_ex1001.htm">Form of <span style="font-size: 10pt">Support Agreement</span></a></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1%; font-size: 12pt">&#160;</td>
    <td style="width: 9%; font-size: 12pt"><a href="dp146258_ex9901.htm"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></a></td>
    <td style="width: 90%; font-size: 12pt"><a href="dp146258_ex9901.htm"><span style="font-size: 10pt">Press release, dated February
    17, 2021.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">101</span></td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Interactive Data Files pursuant to Rule 406 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (&#8220;Inline XBRL&#8221;)</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td style="font-size: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt">&#160;</td>
    <td style="font-size: 12pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Certain schedules and exhibits have been omitted pursuant to
Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule and/or exhibit to
the Securities and Exchange commission upon request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">Date: February 17, 2021</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Registrant)&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 6%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 43%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 8%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 6%"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 37%"><span style="font: 10pt Times New Roman, Times, Serif">/s/
    Bobbie L. King Jr.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Name: Bobbie L. King Jr.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Title: Assistant Secretary</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <!-- Field: /Page -->



<p style="margin: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoOVNijQ0WcIkPE1+oyKW7NSLupn+RfWjfEEAjJvSdXiJFY08pUyHBe5BkcsW4q7RFyLJHRXjE40s02gTBzvBnnWVvfrz8wpcBgYKbj2SXce2dnHBYJyHii5pNYgVSJknDYieirp2RLU6D1RlegbQEHpoYNes2v4cNRP8lS/eqTTsjOkE1AjeUgvyGWKoY9dfpBfHeQZamIRn1FYs3UNt+Y1nmqYVlhHbLcgP47+gDZ10kS -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>dp146258_ex0201.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 2.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>agreement
and plan of merger</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>BY
AND AMONG</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CHARLES
RIVER LABORATORIES INTERNATIONAL, INC.,</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>MEMPHIS
MERGER SUB, INC.,</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>cognate
bioservices, inc.</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>AND</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
SELLERS&rsquo; REPRESENTATIVE named HEREIN</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DATED
AS OF February 17, 2021</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Article 1 MERGER&#9;</B></FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; text-indent: 0in"><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; width: 34%; text-indent: 0in">1.1</TD>
    <TD STYLE="width: 33%; text-indent: 0in">Rollover and Merger</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.2</TD>
    <TD STYLE="text-indent: 0in">The Closing and the Effective Time</TD>
    <TD STYLE="text-align: right; text-indent: 0in">2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.3</TD>
    <TD STYLE="text-indent: 0in">Effect of the Merger</TD>
    <TD STYLE="text-align: right; text-indent: 0in">2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.4</TD>
    <TD STYLE="text-indent: 0in">Organizational Documents of the Surviving Company</TD>
    <TD STYLE="text-align: right; text-indent: 0in">2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.5</TD>
    <TD STYLE="text-indent: 0in">Directors and Officers of the Surviving Company</TD>
    <TD STYLE="text-align: right; text-indent: 0in">3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.6</TD>
    <TD STYLE="text-indent: 0in">Effect of the Merger on the Company Shares and Merger Sub Common Shares.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.7</TD>
    <TD STYLE="text-indent: 0in">Company Options.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.8</TD>
    <TD STYLE="text-indent: 0in">Appraisal Shares.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.9</TD>
    <TD STYLE="text-indent: 0in">Mechanism of Payment and Delivery of Certificates</TD>
    <TD STYLE="text-align: right; text-indent: 0in">4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.10</TD>
    <TD STYLE="text-indent: 0in">No Further Ownership Rights in the Company Shares</TD>
    <TD STYLE="text-align: right; text-indent: 0in">5</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.11</TD>
    <TD STYLE="text-indent: 0in">Payment of Indebtedness</TD>
    <TD STYLE="text-align: right; text-indent: 0in">5</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.12</TD>
    <TD STYLE="text-indent: 0in">Aggregate Closing Consideration Adjustment</TD>
    <TD STYLE="text-align: right; text-indent: 0in">6</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.13</TD>
    <TD STYLE="text-indent: 0in">Deliveries at the Closing</TD>
    <TD STYLE="text-align: right; text-indent: 0in">9</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">1.14</TD>
    <TD STYLE="text-indent: 0in">Withholding</TD>
    <TD STYLE="text-align: right; text-indent: 0in">9</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article 2 CONDITIONS TO CLOSING</B></FONT></TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">10</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 34%">2.1</TD>
    <TD STYLE="width: 33%; text-indent: 0in">Conditions to the Obligations of Each Party</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">10</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">2.2</TD>
    <TD STYLE="text-indent: 0in">Conditions to the Obligations of the Company</TD>
    <TD STYLE="text-align: right; text-indent: 0in">10</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">2.3</TD>
    <TD STYLE="text-indent: 0in">Conditions to the Obligations of Buyer and Merger Sub</TD>
    <TD STYLE="text-align: right; text-indent: 0in">11</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">2.4</TD>
    <TD STYLE="text-indent: 0in">Waiver of Conditions</TD>
    <TD STYLE="text-align: right; text-indent: 0in">11</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article 3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B></FONT></TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">11</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 34%">3.1</TD>
    <TD STYLE="width: 33%; text-indent: 0in">Organization and Power</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">11</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.2</TD>
    <TD STYLE="text-indent: 0in">Authorization; No Breach</TD>
    <TD STYLE="text-align: right; text-indent: 0in">12</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.3</TD>
    <TD STYLE="text-indent: 0in">Capitalization of the Company</TD>
    <TD STYLE="text-align: right; text-indent: 0in">12</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.4</TD>
    <TD STYLE="text-indent: 0in">Subsidiaries</TD>
    <TD STYLE="text-align: right; text-indent: 0in">13</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.5</TD>
    <TD STYLE="text-indent: 0in">Financial Statements; Undisclosed Liabilities</TD>
    <TD STYLE="text-align: right; text-indent: 0in">14</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.6</TD>
    <TD STYLE="text-indent: 0in">Absence of Certain Developments</TD>
    <TD STYLE="text-align: right; text-indent: 0in">14</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.7</TD>
    <TD STYLE="text-indent: 0in">Real Property; Personal Property</TD>
    <TD STYLE="text-align: right; text-indent: 0in">16</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.8</TD>
    <TD STYLE="text-indent: 0in">Tax Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">17</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.9</TD>
    <TD STYLE="text-indent: 0in">Company Material Contracts</TD>
    <TD STYLE="text-align: right; text-indent: 0in">18</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.10</TD>
    <TD STYLE="text-indent: 0in">Intellectual Property</TD>
    <TD STYLE="text-align: right; text-indent: 0in">20</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.11</TD>
    <TD STYLE="text-indent: 0in">Legal Proceedings</TD>
    <TD STYLE="text-align: right; text-indent: 0in">21</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.12</TD>
    <TD STYLE="text-indent: 0in">Brokerage</TD>
    <TD STYLE="text-align: right; text-indent: 0in">21</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.13</TD>
    <TD STYLE="text-indent: 0in">Company Employee Benefit Plans</TD>
    <TD STYLE="text-align: right; text-indent: 0in">21</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.14</TD>
    <TD STYLE="text-indent: 0in">Compliance with Applicable Laws</TD>
    <TD STYLE="text-align: right; text-indent: 0in">23</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.15</TD>
    <TD STYLE="text-indent: 0in">Certain Business Practices.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">23</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.16</TD>
    <TD STYLE="text-indent: 0in">Environmental</TD>
    <TD STYLE="text-align: right; text-indent: 0in">24</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.17</TD>
    <TD STYLE="text-indent: 0in">Employees and Labor Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">24</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.18</TD>
    <TD STYLE="text-indent: 0in">Regulatory Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.19</TD>
    <TD STYLE="text-indent: 0in">Affiliate Transactions</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.20</TD>
    <TD STYLE="text-indent: 0in">Insurance</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">i</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 33%">3.21</TD>
    <TD STYLE="width: 34%; text-indent: 0in">Customers and Suppliers</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">26</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">3.22</TD>
    <TD STYLE="text-indent: 0in">EXCLUSIVITY OF REPRESENTATIONS AND WARRANTIES</TD>
    <TD STYLE="text-align: right; text-indent: 0in">26</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article 4 REPRESENTATIONS AND WARRANTIES OF BUYER
    AND MERGER SUB</B></FONT></TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">26</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 33%">4.1</TD>
    <TD STYLE="width: 34%; text-indent: 0in">Organization; Ownership of Merger Sub; No Prior Activities</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">26</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.2</TD>
    <TD STYLE="text-indent: 0in">Authorization; No Breach</TD>
    <TD STYLE="text-align: right; text-indent: 0in">27</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.3</TD>
    <TD STYLE="text-indent: 0in">Legal Proceedings</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.4</TD>
    <TD STYLE="text-indent: 0in">Investigation</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.5</TD>
    <TD STYLE="text-indent: 0in">Financing</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.6</TD>
    <TD STYLE="text-indent: 0in">Brokerage</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.7</TD>
    <TD STYLE="text-indent: 0in">Investment Intent; Restricted Securities</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.8</TD>
    <TD STYLE="text-indent: 0in">Solvency</TD>
    <TD STYLE="text-align: right; text-indent: 0in">29</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">4.9</TD>
    <TD STYLE="text-indent: 0in">EXCLUSIVITY OF REPRESENTATIONS AND WARRANTIES</TD>
    <TD STYLE="text-align: right; text-indent: 0in">29</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article 5 COVENANTS AND AGREEMENTS</B></FONT></TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">29</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 34%">5.1</TD>
    <TD STYLE="width: 33%; text-indent: 0in">Operation of the Business</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">29</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.2</TD>
    <TD STYLE="text-indent: 0in">Access</TD>
    <TD STYLE="text-align: right; text-indent: 0in">30</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.3</TD>
    <TD STYLE="text-indent: 0in">Termination of Related Party Agreements</TD>
    <TD STYLE="text-align: right; text-indent: 0in">31</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.4</TD>
    <TD STYLE="text-indent: 0in">Exclusivity</TD>
    <TD STYLE="text-align: right; text-indent: 0in">31</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.5</TD>
    <TD STYLE="text-indent: 0in">Press Release and Announcements</TD>
    <TD STYLE="text-align: right; text-indent: 0in">31</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.6</TD>
    <TD STYLE="text-indent: 0in">Confidentiality</TD>
    <TD STYLE="text-align: right; text-indent: 0in">31</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.7</TD>
    <TD STYLE="text-indent: 0in">Reasonable Best Efforts</TD>
    <TD STYLE="text-align: right; text-indent: 0in">32</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.8</TD>
    <TD STYLE="text-indent: 0in">Regulatory Approvals</TD>
    <TD STYLE="text-align: right; text-indent: 0in">32</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.9</TD>
    <TD STYLE="text-indent: 0in">Consents</TD>
    <TD STYLE="text-align: right; text-indent: 0in">34</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.10</TD>
    <TD STYLE="text-indent: 0in">Director and Officer Liability and Indemnification</TD>
    <TD STYLE="text-align: right; text-indent: 0in">34</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.11</TD>
    <TD STYLE="text-indent: 0in">Expenses; Transfer Taxes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">35</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.12</TD>
    <TD STYLE="text-indent: 0in">Post-Closing Record Retention and Access</TD>
    <TD STYLE="text-align: right; text-indent: 0in">36</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.13</TD>
    <TD STYLE="text-indent: 0in">Tax Matters; Tax Returns</TD>
    <TD STYLE="text-align: right; text-indent: 0in">36</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.14</TD>
    <TD STYLE="text-indent: 0in">Resignations</TD>
    <TD STYLE="text-align: right; text-indent: 0in">38</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.15</TD>
    <TD STYLE="text-indent: 0in">Section 280G Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">38</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.16</TD>
    <TD STYLE="text-indent: 0in">Investigation; No Other Representations; Non-Reliance</TD>
    <TD STYLE="text-align: right; text-indent: 0in">39</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">5.17</TD>
    <TD STYLE="text-indent: 0in">Employee Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">40</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article 6 TERMINATION</B></FONT></TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">40</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 34%">6.1</TD>
    <TD STYLE="width: 33%; text-indent: 0in">Termination</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">40</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">6.2</TD>
    <TD STYLE="text-indent: 0in">Effect of Termination</TD>
    <TD STYLE="text-align: right; text-indent: 0in">41</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>Article 7 MISCELLANEOUS&#9;</B></FONT></TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">42</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 34%">7.1</TD>
    <TD STYLE="width: 33%; text-indent: 0in">No Survival of Representations and Warranties and Certain Covenants</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">42</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.2</TD>
    <TD STYLE="text-indent: 0in">Sellers&rsquo; Representative</TD>
    <TD STYLE="text-align: right; text-indent: 0in">43</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.3</TD>
    <TD STYLE="text-indent: 0in">Amendment and Waiver</TD>
    <TD STYLE="text-align: right; text-indent: 0in">46</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.4</TD>
    <TD STYLE="text-indent: 0in">Notices</TD>
    <TD STYLE="text-align: right; text-indent: 0in">46</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.5</TD>
    <TD STYLE="text-indent: 0in">Assignment</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.6</TD>
    <TD STYLE="text-indent: 0in">Severability</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.7</TD>
    <TD STYLE="text-indent: 0in">No Strict Construction</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.8</TD>
    <TD STYLE="text-indent: 0in">Captions</TD>
    <TD STYLE="text-align: right; text-indent: 0in">48</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">ii</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in; width: 34%">7.9</TD>
    <TD STYLE="width: 33%; text-indent: 0in">Complete Agreement</TD>
    <TD STYLE="width: 33%; text-align: right; text-indent: 0in">48</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.10</TD>
    <TD STYLE="text-indent: 0in">Interpretation</TD>
    <TD STYLE="text-align: right; text-indent: 0in">48</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.11</TD>
    <TD STYLE="text-indent: 0in">Disclosure Schedules</TD>
    <TD STYLE="text-align: right; text-indent: 0in">48</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.12</TD>
    <TD STYLE="text-indent: 0in">Counterparts</TD>
    <TD STYLE="text-align: right; text-indent: 0in">49</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.13</TD>
    <TD STYLE="text-indent: 0in">Governing Law</TD>
    <TD STYLE="text-align: right; text-indent: 0in">49</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.14</TD>
    <TD STYLE="text-indent: 0in">CONSENT TO JURISDICTION</TD>
    <TD STYLE="text-align: right; text-indent: 0in">49</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.15</TD>
    <TD STYLE="text-indent: 0in">WAIVER OF JURY TRIAL</TD>
    <TD STYLE="text-align: right; text-indent: 0in">50</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.16</TD>
    <TD STYLE="text-indent: 0in">Prevailing Party</TD>
    <TD STYLE="text-align: right; text-indent: 0in">50</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.17</TD>
    <TD STYLE="text-indent: 0in">Third-Party Beneficiaries and Obligations</TD>
    <TD STYLE="text-align: right; text-indent: 0in">50</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.18</TD>
    <TD STYLE="text-indent: 0in">Specific Performance</TD>
    <TD STYLE="text-align: right; text-indent: 0in">51</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.19</TD>
    <TD STYLE="text-indent: 0in">No Partnership Created</TD>
    <TD STYLE="text-align: right; text-indent: 0in">51</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.20</TD>
    <TD STYLE="text-indent: 0in">Deliveries</TD>
    <TD STYLE="text-align: right; text-indent: 0in">51</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.21</TD>
    <TD STYLE="text-indent: 0in">Non-Recourse</TD>
    <TD STYLE="text-align: right; text-indent: 0in">51</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.22</TD>
    <TD STYLE="text-indent: 0in">Recitals</TD>
    <TD STYLE="text-align: right; text-indent: 0in">52</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-indent: 0in">7.23</TD>
    <TD STYLE="text-indent: 0in">Time of Essence</TD>
    <TD STYLE="text-align: right; text-indent: 0in">52</TD></TR>
</TABLE>
<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 33%"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Article 8 DEFINITIONS&#9;</B></FONT></TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; width: 33%"><FONT STYLE="font-size: 10pt">52</FONT></TD></TR>
</TABLE>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">iii</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><U>LIST OF
EXHIBITS</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Exhibit(s)</U></FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit
        A</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit
        B</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P></TD>
    <TD><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Form of Company Shareholder
        Approval</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Form of Certificate of
        Merger</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit C</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of Buyer and Merger Sub Closing Certificate</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit D</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of Company Closing Certificate</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit E</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of Escrow Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit F</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form of Paying Agent Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exhibit G</FONT></TD>
    <TD><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Accounting
        Principles</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><U>Schedules</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; text-align: justify"><FONT STYLE="font-size: 10pt">Schedule I</FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-size: 10pt">Disclosure Schedules</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Schedule II</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Net Working Capital Schedule</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Schedule III</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Permitted Liens Schedule</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Schedule IV</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Specified Trademarks</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Schedule V</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Company Knowledge Persons</FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">iv</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><U>AGREEMENT
AND PLAN OF MERGER</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">THIS
AGREEMENT AND PLAN OF MERGER (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of February 17, 2021, by and
among (i) Charles River Laboratories International, Inc., a Delaware corporation (&ldquo;<U>Buyer</U>&rdquo;), (ii) Memphis Merger
Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Buyer (&ldquo;<U>Merger Sub</U>&rdquo;), (iii) Cognate BioServices,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and (iv) Mercury Fund 2 Holdco LLC, solely in its capacity as
the initial representative of the Company Shareholders (as defined below) (the &ldquo;<U>Sellers&rsquo; Representative</U>&rdquo;).
Each of the above referenced parties is sometimes referred to in this Agreement individually as a &ldquo;<U>Party</U>&rdquo; and
collectively as the &ldquo;<U>Parties</U>.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
on the terms and subject to the conditions of this Agreement and the applicable provisions of the General Corporation Law of the
State of Delaware (the &ldquo;<U>DGCL</U>&rdquo;), Buyer, Merger Sub and the Company are hereby adopting a plan of merger that
provides (i)&nbsp;for the merger of Merger Sub with and into the Company, with the Company being the surviving entity (the &ldquo;<U>Surviving
Company</U>&rdquo;) and (ii)&nbsp;that each issued and outstanding Company Share will be converted into the right to receive a
portion of the Aggregate Closing Consideration on the terms and subject to the conditions set forth in this Agreement;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
the Board of Directors of the Company has (i) determined that this Agreement and the transactions contemplated hereby are fair
to and in the best interests of the Company&rsquo;s Shareholders, (ii) approved, adopted and declared advisable this Agreement
and the transactions contemplated hereby, (iii) directed that the approval and adoption of this Agreement (including the Merger)
be submitted to the Company&rsquo;s Shareholders (entitled to vote thereon) for their approval by written consent, and (iv) recommended
the approval and adoption of this Agreement (including the Merger) by the Company&rsquo;s Shareholders;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
the Board of Directors of Buyer has approved, adopted and declared advisable this Agreement and the transactions contemplated
hereby;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
the Board of Directors of Merger Sub has (i) determined that this Agreement and the transactions contemplated hereby are fair
to and in the best interests of the sole stockholder of Merger Sub, (ii) approved, adopted and declared advisable this Agreement
and the transactions contemplated hereby, (iii) directed that the approval and adoption of this Agreement (including the Merger)
be submitted to the sole stockholder of Merger Sub for its approval by written consent and (iv) recommended the approval and adoption
of this Agreement (including the Merger) by the sole stockholder of Merger Sub;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
promptly following the execution and delivery of this Agreement, the Company will obtain the approval of this Agreement by the
Company Shareholders (entitled to vote thereon) holding at least 85% of the Company Shares pursuant to a written consent in the
form attached as <U>Exhibit A</U> hereto (the &ldquo;<U>Company Shareholder Approval</U>&rdquo;) and deliver a copy of the Company
Shareholder Approval to Buyer;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
concurrently with the execution and delivery of this Agreement, and as an inducement and condition to Buyer&rsquo;s willingness
to enter into this Agreement, each holder of Company Options (each, a &ldquo;<U>Rollover Holder</U>&rdquo;) has entered into a
Rollover and Support Agreement (each, a &ldquo;<U>Rollover Agreement</U>&rdquo;) pursuant to which, effective as of immediately
prior to the Closing, the Rollover Options held by each such Rollover Holder will be treated in accordance with <U>Section &lrm;1.7</U>,
on the terms and subject to the conditions set forth in the Rollover Agreements (the &ldquo;<U>Rollover</U>&rdquo;); and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">WHEREAS,
concurrently with the execution and delivery of this Agreement, and as an inducement and condition to Buyer&rsquo;s willingness
to enter into this Agreement, certain of the Company&rsquo;s Shareholders have entered into Support Agreements (each, a &ldquo;<U>Support
Agreement</U>&rdquo;) agreeing to certain matters with respect to the transactions contemplated hereby;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">NOW,
THEREFORE, in consideration of the premises and the mutual promises contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
1 </FONT><FONT STYLE="font-size: 10pt"><U><BR>
<BR>
MERGER</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Rollover
and Merger</U>. Immediately prior to the Closing, Buyer and the Rollover Holders shall consummate the Rollover in accordance with
the Rollover Agreements. Immediately following the Rollover, at the Effective Time and on the terms and subject to the conditions
of this Agreement and the applicable provisions of the DGCL, Merger Sub will merge with and into the Company, the separate corporate
existence of Merger Sub will cease and the Company will continue as the Surviving Company (the &ldquo;<U>Merger</U>&rdquo;). </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-decoration: none; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>The
Closing and the Effective Time</U>. The closing of the transactions contemplated by this Agreement (the &ldquo;<U>Closing</U>&rdquo;)
will take place remotely via the electronic exchange of documents and signatures on the second Business Day following the satisfaction
or waiver of the conditions set forth in &lrm;<U>Article 2</U> (other than those conditions that by their terms or nature are
to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted by applicable Law, waiver of such
conditions by the Party or Parties entitled to the benefit thereof at the Closing), or at such other place, on such other date
or at such other time as is mutually agreeable to Buyer and the Sellers&rsquo; Representative. The date of the Closing is referred
to in this Agreement as the &ldquo;<U>Closing Date</U>.&rdquo; All matters to be calculated as of the Closing Date pursuant to
this Agreement will be calculated as of the Adjustment Calculation Time unless otherwise specified in this Agreement. On the Closing
Date, on the terms and subject to the conditions of this Agreement and the applicable provisions of the DGCL, the Parties will
cause the Merger to be consummated by the Company&rsquo;s filing&nbsp;of the Certificate of Merger (the &ldquo;<U>Certificate
of Merger</U>&rdquo;) in substantially the form&nbsp;of Exhibit&nbsp;B hereto with the Secretary of State of the State of Delaware
as required by, and executed in accordance with, the applicable provisions of the DGCL (the time of such filing with the Secretary
of State of the State of Delaware, or such later time as may be agreed upon in writing by Buyer and the Sellers&rsquo; Representative
and specified in the Certificate of Merger, is referred to herein as the &ldquo;Effective Time&rdquo;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Effect
of the Merger</U>. At the Effective Time, the effect of the Merger will be as provided in the applicable provisions of the DGCL.
Without limiting the generality of the foregoing, and subject thereto, at the Effective Time by virtue of the Merger and without
any action on the part of Merger Sub or the Company, all properties, rights, privileges, powers and franchises of the Company
and Merger Sub will vest in the Surviving Company, and all debts, liabilities and duties of the Company and Merger Sub will become
the debts, liabilities and duties of the Surviving Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organizational
Documents of the Surviving Company</U>. At the Effective Time, by virtue of the Merger and without any action on the part of Merger
Sub or the Company, (a) the certificate of incorporation of Merger Sub, as in effect immediately prior to the Effective Time,
shall become the certificate of incorporation of the Surviving Company and shall be the certificate of incorporation of the Surviving
Company until thereafter amended as provided therein and under the DGCL, except that the name of the Company reflected therein
shall be &ldquo;Cognate BioServices, Inc.&rdquo;, and (b) the bylaws of Merger </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Sub,
as in effect immediately prior to the Effective Time, shall become the bylaws of the Surviving Company and shall be the bylaws
of the Surviving Company until thereafter amended as provided therein, in the certificate of incorporation of the Surviving Company
and under the DGCL, except that the name of the Surviving Company reflected therein shall be &ldquo;Cognate BioServices, Inc.&rdquo;.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;</U></FONT><U><FONT STYLE="font-size: 10pt">Directors
and Officers of the Surviving Company</FONT></U><FONT STYLE="font-size: 10pt">. From and after the Effective Time, until their
respective successors are duly elected or appointed and qualified in accordance with applicable Law, (i) the directors of Merger
Sub immediately prior to the Effective Time shall be the directors of the Surviving Company (and all directors of the Company
immediately prior to the Effective Time shall be removed as of the Effective Time) and (ii) the officers of Merger Sub immediately
prior to the Effective Time shall be the officers of the Surviving Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Effect
of the Merger on the Company Shares and Merger Sub Common Shares</U>. At the Effective Time, by virtue of the Merger and without
any action on the part of Merger Sub, the Company or the Company Shareholders, and subject to <U>Section &lrm;1.7</U> with respect
to Company Options and <U>Section &lrm;1.8</U> with respect to Appraisal Shares, each Company Share issued and outstanding immediately
prior to the Effective Time (excluding any Company Shares held as treasury stock or held or owned by the Company or any Subsidiary
of the Company immediately prior to the Effective Time, which Company Shares shall be canceled without any payment being made
in respect thereof), on the terms and subject to the conditions set forth in this Agreement, will be converted automatically into
the right to receive a portion of the Aggregate Closing Consideration and such amounts payable following the Closing pursuant
to this Agreement in respect of such Company Shares as follows: (i) at the Effective Time, the portion of the Estimated Aggregate
Closing Consideration allocable to such Company Share (which, for the avoidance of doubt, may vary depending upon the class of
such Company Share) as set forth in the Distribution Schedule and (ii)&nbsp;following the Effective Time, any Additional Consideration
that becomes payable, if any, as set forth on the Distribution Schedule. All such Company Shares, when converted pursuant to this
<U>Section &lrm;1.6</U>, will no longer be outstanding, and each former holder thereof will cease to have any rights with respect
thereto, except the right to receive the portion of the Aggregate Closing Consideration set forth in this <U>Section &lrm;1.6
</U>and any amounts payable following the Closing pursuant to this Agreement in respect of such Company Shares. Notwithstanding
anything to the contrary in this Agreement or in any Related Agreement, in no event shall Buyer be obligated to pay to the Company
Equityholders at the Closing in respect to their Company Securities, or shall the Company Equityholders be entitled to receive
at the Closing in respect of their Company Securities at the Closing, in the aggregate, an amount in excess of the Aggregate Closing
Consideration. At the Effective Time, by virtue of the Merger and without any action on the part of Merger Sub, the Company or
Buyer, the common shares in Merger Sub issued and outstanding immediately prior to the Effective Time will be converted into and
exchanged for an equivalent number of common shares in the Surviving Company. Each certificate of Merger Sub evidencing ownership
of any such common shares, if any, will automatically be deemed to be evidence of ownership of such interests of the Surviving
Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Company
Options</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">As
of immediately prior to the Effective Time, each Company Option that is outstanding and unvested shall be deemed to have vested
in full as of such time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">As
of immediately prior to the Effective Time, each Rollover Option shall be exercised and no longer be outstanding and shall
cease to exist on or after the Effective Time, without any payment being made in respect thereof, except (i) as contemplated
by the applicable Rollover Agreement and (ii) following the Effective Time, any Additional Consideration that becomes
payable, if any, as set forth on the Distribution Schedule.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Effective
as of the Effective Time, each Company Option that is not a Rollover Option shall, upon the terms and subject to the conditions
of this Agreement and as applicable, the Rollover Agreement, automatically be exercised into Company Shares and the holder thereof
shall have the right to receive an amount in cash, without interest equal to (i) at the Effective Time, the portion of the Estimated
Aggregate Closing Consideration allocable to such Company Options as set forth in the Distribution Schedule (all such amounts
in the aggregate, &ldquo;<U>Closing Option Amount</U>&rdquo;) and (ii) following the Effective Time, any Additional Consideration
that becomes payable, if any, as set forth on the Distribution Schedule. All such Company Options, when exercised pursuant to
this <U>Section <B>&lrm;</B>1.7(c)</U>, will no longer be outstanding, and each former holder thereof will cease to have any rights
with respect thereto, except the right to receive the portion of the Aggregate Closing Consideration set forth in this <U>Section
<B>&lrm;</B>1.7(c)</U> and any amounts payable following the Closing pursuant to this Agreement in respect of such Company Options.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Appraisal
Shares</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Notwithstanding
anything in this Agreement to the contrary, any Company Shares that are outstanding immediately prior to the Effective Time and
that are held by any Person who is entitled to demand and has properly demanded appraisal of such shares in connection with the
Merger pursuant to, and who complies in all respects with, Section 262 of the DGCL (&ldquo;<U>Section 262</U>&rdquo; and such
shares, &ldquo;<U>Appraisal Shares</U>&rdquo;) shall not be converted into the right to receive the consideration contemplated
to be payable in respect thereof by this <B><U>&lrm;</U></B><U>Article 1</U>, and instead, such holder shall be entitled to payment
of the fair value of such shares in accordance with Section 262. At the Effective Time, all Appraisal Shares shall automatically
be canceled and shall cease to exist and the holders of such Appraisal Shares shall cease to have any rights with respect thereto,
except the right to receive the fair value of such Appraisal Shares in accordance with Section 262, and a holder of Appraisal
Shares shall not be entitled to exercise any of the voting rights or other rights of a stockholder of the Surviving Company. Notwithstanding
the foregoing, if any holder of Appraisal Shares shall, as of the Effective Time, fail to perfect or otherwise shall waive, withdraw
or lose the right to appraisal under Section 262 or a court of competent jurisdiction shall determine that such holder is not
entitled to the relief provided by Section 262, then such Appraisal Shares shall be deemed to have been converted as of the Effective
Time into, and to have become exchangeable solely for the right to receive, the consideration contemplated to be payable in respect
thereof by this <B>&lrm;</B>Article 1, and the right of such holder to be paid the fair value of such holder&rsquo;s Appraisal
Shares under Section 262 shall cease.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company shall provide prompt notice to Buyer of any demand for appraisal of any Company Shares, withdrawals of such demands and
any other instruments served pursuant to Section 262, in each case, received by the Company in writing. Buyer shall have the right
and opportunity to participate in all negotiations and Proceedings with respect to any demand or threatened demand for appraisal
of any Company Shares in connection with the Merger, including those that take place prior to the Effective Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary herein, any portion of the Estimated Aggregate Closing Consideration deposited with the Paying Agent
pursuant hereto in respect of any Appraisal Shares shall be returned to the Surviving Corporation (or one of its designated Affiliates)
upon its written demand, which demand may be made by the Surviving Corporation at any time after the date that is 365 days after
the Effective Time, and no Company Shareholder (other than the Company Shareholder holding such Appraisal Shares) shall be entitled
to any portion of such Estimated Aggregate Closing Consideration.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Mechanism
of Payment and Delivery of Certificates</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Following
the date hereof, the Company will deliver to each Company Shareholder a Letter of Transmittal in customary form reasonably acceptable
to each of Buyer and the Sellers&rsquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Representative
(a &ldquo;<U>Letter of Transmittal</U>&rdquo;). At the Effective Time, Buyer will deliver, by wire transfer of immediately available
funds to the Paying Agent, cash in an amount equal to the portion of the Estimated Aggregate Closing Consideration payable to
the Company Shareholders in accordance with <U>Section <B>&lrm;</B>1.6</U> (less the Purchase Price Adjustment Escrow Deposit
Amount). To the extent that, no later than two Business Days prior to the Closing Date, any Company Shareholder delivers such
Letter of Transmittal, duly executed and completed in accordance with the instructions thereto, to the Company, the Paying Agent
will pay to such Company Shareholder at the Closing the portion of the Estimated Aggregate Closing Consideration payable to such
Company Shareholder in accordance with <U>Section <B>&lrm;</B>1.6</U> (less a portion of the Purchase Price Adjustment Escrow
Deposit Amount attributable to such Company Shares as set forth on the Distribution Schedule), which amounts will be paid by the
Paying Agent in cash by wire transfer of immediately available funds to the account designated by such Company Shareholder in
such Company Shareholder&rsquo;s Letter of Transmittal and in accordance with the Paying Agent Agreement; <I>provided,</I> that,
for the avoidance of doubt, Rollover Holders will not receive any portion of the Estimated Aggregate Closing Consideration with
respect to any Rollover Options.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Following
the Closing, upon delivery by a Company Shareholder that did not receive its allocable portion of the Estimated Aggregate Closing
Consideration at the Closing pursuant to <U>Section&nbsp;<B>&lrm;</B>1.9(a)</U> to the Paying Agent of a Letter of Transmittal,
duly executed and completed in accordance with the instructions thereto, the Paying Agent will pay to such Company Shareholder,
within five Business Days after such delivery, cash in an amount equal to the portion of the Estimated Aggregate Closing Consideration
payable to such Company Shareholder in accordance with <U>Section <B>&lrm;</B>1.6</U>, which amounts will be paid by the Paying
Agent in cash by wire transfer of immediately available funds to the account designated by such Company Shareholder in such Company
Shareholder&rsquo;s Letter of Transmittal and in accordance with the Paying Agent Agreement<I>; provided,</I> that, for the avoidance
of doubt, Rollover Holders will not receive any portion of the Estimated Aggregate Closing Consideration with respect to any Rollover
Options. No interest or dividends will be paid or accrued on the consideration payable to any Company Shareholder hereunder. Until
surrendered in accordance with the provisions of this <U>Section&nbsp;<B>&lrm;</B>1.9(b)</U>, the Company Shares will represent,
for all purposes, only the right to receive an amount in cash equal to the portion of the Aggregate Closing Consideration payable
in respect thereof pursuant to <U>Section <B>&lrm;</B>1.6</U> and the Additional Consideration, without any interest or dividends
thereon.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">None
of Buyer, Merger Sub, the Company, the Paying Agent or the Surviving Company will be liable to any Person in respect of any cash
or property delivered to a public official required by any applicable abandoned property, escheat or similar Law.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Further Ownership Rights in the Company Shares</U>. The Aggregate Closing Consideration and any amounts that become payable following
the Closing in respect of the Company Shares in accordance with the terms of this Agreement will be deemed to be full satisfaction
of all rights pertaining to such Company Shares and, as of and following the Effective Time, there will be no further registration
of transfers on the records of the Surviving Company of Company Shares that were outstanding immediately prior to the Effective
Time.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Payment
of Indebtedness</U>. It is contemplated by the Parties that, at the Closing, all Indebtedness set forth on Schedule&nbsp;&lrm;1.11
(&ldquo;<U>Closing Repaid Indebtedness</U>&rdquo;) will be fully repaid and such repayment will be funded by Buyer. In order to
facilitate such repayment, on or prior to the Closing, the Company will use reasonable best efforts to obtain payoff letters for
all such Closing Repaid Indebtedness, which payoff letters will acknowledge (a) the aggregate principal amount and all accrued
but unpaid interest constituting such Indebtedness as of the Closing Date and (b) that, upon payment of such aggregate amounts
on the Closing Date, the Company Entities shall have paid in full all amounts arising under or owing or payable thereunder and
in connection therewith, and that all Liens related to such Closing Repaid Indebtedness shall be released.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Aggregate
Closing Consideration Adjustment</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">At
least three Business Days prior to the Closing, the Company will prepare and deliver (or cause to be delivered) to Buyer (i) a
statement (the &ldquo;<U>Estimated Closing Statement</U>&rdquo;) setting forth the Company&rsquo;s good faith estimates of, and
reasonable supporting documentation for, the Closing Cash (the &ldquo;<U>Estimated Closing Cash</U>&rdquo;), the Closing Net Working
Capital Surplus (if any) (the &ldquo;<U>Estimated Closing Net Working Capital Surplus</U>&rdquo;), the Closing Net Working Capital
Deficit (if any) (the &ldquo;<U>Estimated Closing Net Working Capital Deficit</U>&rdquo;), the Closing Indebtedness (the &ldquo;<U>Estimated
Closing Indebtedness</U>&rdquo;), the Unpaid Sellers&rsquo; Transaction Expenses (the &ldquo;<U>Estimated Unpaid Sellers&rsquo;
Transaction Expenses</U>&rdquo;) and the Aggregate Closing Consideration resulting therefrom (the &ldquo;<U>Estimated Aggregate
Closing Consideration</U>&rdquo;) and (ii)&nbsp;the Distribution Schedule. The Estimated Closing Statement will, with respect
to the Estimated Closing Cash, the Estimated Closing Net Working Capital Surplus (if any), the Estimated Closing Net Working Capital
Deficit (if any), the Estimated Closing Indebtedness and the Estimated Unpaid Sellers&rsquo; Transaction Expenses, be prepared
in accordance with the definitions in this Agreement. Buyer will be afforded the opportunity to review and comment on the Estimated
Closing Statement and the Distribution Schedule, and the Company shall consider such comments in good faith.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, (i) the Parties acknowledge and agree that the preparation of the Distribution Schedule
and the allocation set forth therein are the sole responsibility of the Company Shareholders and (ii) in no event shall Buyer,
Merger Sub and their respective Affiliates (including, following the Effective Time, the Company Entities), have any liability
to any Person (including each of the Company Equityholders) for any inaccuracy or miscalculations in the Distribution Schedule.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Within
90 days following the Closing Date, Buyer will prepare and deliver to the Sellers&rsquo; Representative&nbsp;a statement (the
&ldquo;<U>Closing Statement</U>&rdquo;) setting forth Buyer&rsquo;s good faith calculation of the Closing Cash, the Closing Net
Working Capital Surplus (if any), the Closing Net Working Capital Deficit (if any), the Closing Indebtedness, the Unpaid Sellers&rsquo;
Transaction Expenses and the Aggregate Closing Consideration resulting therefrom. The Closing Statement will, with respect to
the Closing Cash, the Closing Net Working Capital Surplus (if any), the Closing Net Working Capital Deficit (if any), the Closing
Indebtedness and the Unpaid Sellers&rsquo; Transaction Expenses, be prepared in accordance with the definitions in this Agreement.
Following the Sellers&rsquo; Representative&rsquo;s receipt of the Closing Statement and until the Closing Statement and the resulting
Aggregate Closing Consideration are finally determined, Buyer will, and will cause the Company Entities and their Representatives
to, (i) assist the Sellers&rsquo; Representative and its Representatives in the review of the Closing Statement by providing the
Sellers&rsquo; Representative and its Representatives with reasonable access at reasonable times and upon reasonable notice to
the books and records (including work papers, schedules, memoranda and other documents) of the Company Entities for purposes of
their review of the Closing Statement and (ii) reasonably cooperate with the Sellers&rsquo; Representative and its Representatives
in connection with such review, including providing reasonable access at reasonable times and upon reasonable notice to all other
information necessary or useful in connection with the review of the Closing Statement as may be reasonably requested by the Sellers&rsquo;
Representative and its Representatives and reasonable access at reasonable times and upon reasonable notice to all relevant personnel
involved in the preparation of the Closing Statement, including all such Company personnel responsible for accounting and finance
and the Company&rsquo;s outside accountants and advisors (subject to the execution of customary access letters if requested).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Closing Statement and the Closing Cash, the Closing Net Working Capital Surplus (if any), the Closing Net Working Capital Deficit
(if any), the Closing Indebtedness, the Unpaid Sellers&rsquo; Transaction Expenses and the Aggregate Closing Consideration set
forth thereon will become final and binding on the Parties 45 days following the Sellers&rsquo; Representative&rsquo;s receipt
thereof unless the Sellers&rsquo; Representative delivers written notice of its disagreement (a &ldquo;<U>Notice of Disagreement</U>&rdquo;)
to Buyer prior to</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">such
date; <I>provided</I>, that, the Closing Statement and the Closing Cash, the Closing Net Working Capital Surplus (if any), the
Closing Net Working Capital Deficit (if any), the Closing Indebtedness and the Unpaid Sellers&rsquo; Transaction Expenses and
the Aggregate Closing Consideration resulting therefrom will become final and binding on the Parties upon the Sellers&rsquo; Representative&rsquo;s
delivery, prior to the expiration of such 45-day period, of written notice to Buyer of its acceptance of the Closing Statement
and the Closing Cash, the Closing Net Working Capital Surplus (if any), the Closing Net Working Capital Deficit (if any), the
Closing Indebtedness and the Unpaid Sellers&rsquo; Transaction Expenses and the Aggregate Closing Consideration set forth thereon.
Any Notice of Disagreement will specify in reasonable detail the nature and amount of any disagreement so asserted.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
a Notice of Disagreement is delivered by the Sellers&rsquo; Representative, then the Closing Statement (as revised in accordance
with this <U>Section&nbsp;<B>&lrm;</B>1.12(e)</U>), and the Closing Cash, the Closing Net Working Capital Surplus (if any), the
Closing Net Working Capital Deficit (if any), the Closing Indebtedness and the Unpaid Sellers&rsquo; Transaction Expenses and
the Aggregate Closing Consideration set forth thereon will become final and binding on the Parties on the earlier of (i)&nbsp;the
date on which all matters specified in the Notice of Disagreement are finally resolved in writing by the Sellers&rsquo; Representative
and Buyer and (ii) the date on which all matters specified in the Notice of Disagreement not resolved by the Sellers&rsquo; Representative
and Buyer are finally resolved in writing by a nationally recognized accounting, consulting or valuation firm jointly selected
and engaged by the Sellers&rsquo; Representative and Buyer (such firm, the &ldquo;<U>Arbiter</U>&rdquo;). The Closing Statement
will be revised to the extent necessary to reflect any mutually agreed resolution by the Sellers&rsquo; Representative and Buyer
and/or final resolution made by the Arbiter in accordance with this <U>Section&nbsp;<B>&lrm;</B>1.12(e)</U>. During the 30-day
period immediately following the delivery of a Notice of Disagreement, or such longer period as the Sellers&rsquo; Representative
and Buyer may agree in writing, the Sellers&rsquo; Representative and Buyer will seek in good faith to resolve in writing any
differences they may have with respect to any matter specified in the Notice of Disagreement. At the end of such 30-day period
or such agreed-upon longer period, the Sellers&rsquo; Representative and Buyer will submit to the Arbiter for review and resolution
of any and all matters (but only such matters) that remain in dispute and that were included in the Notice of Disagreement. Buyer
and the Sellers&rsquo; Representative will instruct the Arbiter to, and the Arbiter will, make a final determination (acting as
an expert and not as an arbitrator) of the items included in the Closing Statement (only to the extent such amounts remain in
dispute) in writing and in accordance with the guidelines and procedures set forth in this Agreement. Buyer and the Sellers&rsquo;
Representative will reasonably cooperate with the Arbiter during the term of its engagement. Buyer and the Sellers&rsquo; Representative
will instruct the Arbiter not to, and the Arbiter will not, assign a value to any item in dispute greater than the greatest value
for such item assigned by Buyer, on the one hand, or the Sellers&rsquo; Representative, on the other hand, or less than the smallest
value for such item assigned by Buyer, on the one hand, or the Sellers&rsquo; Representative, on the other hand. Buyer and the
Sellers&rsquo; Representative will also instruct the Arbiter to, and the Arbiter will, make its determination based solely on
presentations by Buyer and the Sellers&rsquo; Representative that are in accordance with the guidelines and procedures set forth
in this Agreement (<I>i.e.</I>, not on the basis of an independent review). The Closing Statement and the Closing Cash, the Closing
Net Working Capital Surplus (if any), the Closing Net Working Capital Deficit (if any), the Closing Indebtedness and the Unpaid
Sellers&rsquo; Transaction Expenses and the Aggregate Closing Consideration set forth thereon will become final and binding on
the Parties on the date the Arbiter delivers its final resolution in writing to Buyer and the Sellers&rsquo; Representative (which
final resolution will be requested by the Parties to be delivered not more than 30 days (or such longer period as may be agreed
in writing) following submission of such disputed matters), and such resolution by the Arbiter will not, absent manifest error,
be subject to court review or otherwise appealable. The fees and expenses of the Arbiter pursuant to this <U>Section&nbsp;<B>&lrm;</B>1.12(e)
</U>will be allocated between Buyer, on the one hand, and the Sellers&rsquo; Representative, on the other hand, based on the percentage
that the portion of the contested amount not awarded to the Buyer Parties or Seller Parties, as applicable, bears to the amount
actually contested by such Persons.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
the Estimated Aggregate Closing Consideration is less than the Aggregate Closing Consideration as finally determined pursuant
to this <U>Section&nbsp;<B>&lrm;</B>1.12</U> (such shortfall, the &ldquo;<U>Adjustment Amount</U>&rdquo;), then Buyer will, within
three Business Days after the Closing Statement becomes final and binding on the Parties pursuant to this <U>Section&nbsp;<B>&lrm;</B>1.12</U>,
make payment of the Adjustment Amount in cash by wire transfer in immediately available funds to (i) the Paying Agent for further
distribution to the Company Shareholders, and (ii) to the Surviving Company for further distribution to the former holders of
Company Options, in each case, with such amounts, being distributable in accordance with the Distribution Schedule. Furthermore,
if the Estimated Aggregate Closing Consideration is less than or equal to the Aggregate Closing Consideration as finally determined
pursuant to this <U>Section&nbsp;<B>&lrm;</B>1.12</U>, Buyer and the Sellers&rsquo; Representative will promptly deliver joint
written instructions to the Escrow Agent to cause the Escrow Agent to make payment of the Purchase Price Adjustment Escrow Funds
from the Purchase Price Adjustment Escrow Account, within three Business Days after the Closing Statement becomes final and binding
on the Parties pursuant to this <U>Section&nbsp;<B>&lrm;</B>1.12</U>, (A) to the Paying Agent for further distribution to the
Company Shareholders and (B)&nbsp;to the Surviving Company for further distribution to the former holders of Company Options,
in each case, with such amounts, being distributable in accordance with the Distribution Schedule.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
the Estimated Aggregate Closing Consideration is greater than the Aggregate Closing Consideration as finally determined pursuant
to this <U>Section&nbsp;<B>&lrm;</B>1.12</U> (such excess, the &ldquo;<U>Excess Amount</U>&rdquo;), then Buyer and the Sellers&rsquo;
Representative will deliver joint written instructions to the Escrow Agent to cause the Escrow Agent to make payment, within three
Business Days after the Closing Statement becomes final and binding on the Parties pursuant to this <U>Section&nbsp;<B>&lrm;</B>1.12</U>,
to Buyer, in cash by wire transfer in immediately available funds of the Excess Amount from the Purchase Price Adjustment Escrow
Funds in the Purchase Price Adjustment Escrow Account. In the event that the Excess Amount is less than the Purchase Price Adjustment
Escrow Funds (such shortfall, the &ldquo;<U>Remaining Purchase Price Adjustment Escrow Funds</U>&rdquo;), Buyer and the Sellers&rsquo;
Representative will simultaneously with delivery of the instructions described in the immediately foregoing sentence deliver joint
written instructions to the Escrow Agent to cause the Escrow Agent to pay the Remaining Purchase Price Adjustment Escrow Funds
from the Purchase Price Adjustment Escrow Account in cash by wire transfer in immediately available funds (or other alternative
delivery arrangement mutually agreed by the Sellers&rsquo; Representative and Buyer in writing) (i)&nbsp;to the Paying Agent for
further distribution to the Company Shareholders and (ii)&nbsp;to the Surviving Company for further distribution to the former
holders of Company Options, in each case, with such amounts, being distributable in accordance with the Distribution Schedule.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
and Merger Sub each agree that (i)&nbsp;the payment of the Excess Amount (if any) from the Purchase Price Adjustment Escrow Funds
in the Purchase Price Adjustment Escrow Account in accordance with the Escrow Agreement will be the sole and exclusive remedy
and source of recovery against the Seller Parties for payment of the Excess Amount (if any) and (ii) the purchase price adjustment
set forth in this <U>Section&nbsp;<B>&lrm;</B>1.12</U>, and the dispute resolution provisions set forth in this <U>Section&nbsp;<B>&lrm;</B>1.12</U>,
will be the sole and exclusive remedies as between the Parties for the matters addressed by this <U>Section&nbsp;<B>&lrm;</B>1.12</U>.
The Company and the Sellers&rsquo; Representative each agree that the Adjustment Amount shall not exceed an amount equal to the
Purchase Price Adjustment Escrow Funds.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Parties agree that any payment pursuant to this <U>Section&nbsp;<B>&lrm;</B>1.12</U> will be treated as an adjustment to the Aggregate
Closing Consideration for U.S. federal, state, local and non-U.S. Tax purposes, except as otherwise required by applicable Law.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Parties agree that the purpose of preparing the Closing Statement and calculating the Aggregate Closing Consideration and the
components thereof is solely to assess the accuracy of the amounts set forth in the Estimated Closing Statement, and such processes
are not intended to permit the introduction of different accounting methods, policies, principles, practices, procedures, reserves</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">classifications
or estimation methodologies for the purpose of calculating the Aggregate Closing Consideration than those described in the Accounting
Principles.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Deliveries
at the Closing. At the Closing</U>, the Parties, as applicable, will deliver, or cause to be delivered, each of the following:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will deliver to the Paying Agent, by wire transfer of immediately available funds to an account designated in writing by the Paying
Agent, cash in an amount equal to (i) the Estimated Aggregate Closing Consideration, <I>minus </I>(ii) the Purchase Price Adjustment
Escrow Deposit Amount in accordance with <U>Section <B>&lrm;</B>1.6</U>, <I>minus</I> (iii)&nbsp;the Closing Option Amount;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will deliver to the Company, by wire transfer of immediately available funds to an account designated in writing by the Company
for further distribution to the recipients thereof as provided in the Estimated Closing Statement, cash in an amount equal to
(i) the Closing Option Amount, <I>plus</I> (ii) the aggregate amount of Transaction Payments as set forth in the Estimated Closing
Statement as Indebtedness;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will deliver to the Escrow Agent, by wire transfer of immediately available funds to an account designated in writing by the Escrow
Agent, out of funds that otherwise would have been paid as Estimated Aggregate Closing Consideration, cash in an amount equal
to the Purchase Price Adjustment Escrow Deposit Amount, for deposit into an escrow account (the &ldquo;<U>Purchase Price Adjustment
Escrow Account</U>&rdquo;) established pursuant to the terms of the Escrow Agreement;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will deliver to the Sellers&rsquo; Representative, by wire transfer of immediately available funds to an account designated in
writing by the Sellers&rsquo; Representative, cash in an amount equal to the Sellers&rsquo; Representative Expense Fund in accordance
with <U>Section&nbsp;<B>&lrm;</B>7.2(e)</U>;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will repay, or cause to be repaid, on behalf of the Company Entities, the Closing Repaid Indebtedness outstanding as of the Closing
Date in accordance with <U>Section <B>&lrm;</B>1.11</U>, including all amounts due and owing pursuant to the Credit Facility;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will pay, or cause to be paid, all Estimated Unpaid Sellers&rsquo; Transaction Expenses; and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">(i)&nbsp;each
Company Shareholder will deliver to Buyer a duly executed IRS Form W-9 or (ii) the Company will deliver to Buyer a duly executed
affidavit dated as of the Closing Date in accordance with Treasury Regulation Sections&nbsp;1.897-2(h) and 1.1445-2(c) stating
that the Company is not and has not been a &ldquo;United States real property holding corporation&rdquo; within the meaning of
Section&nbsp;897(c)(2) of the Code, together with a draft notice prepared in accordance with Treasury Regulation Section&nbsp;1.897-2(h)(2),
which Buyer shall be entitled to file (together with copies of such affidavit) with the IRS in accordance with such Treasury Regulation
(notwithstanding anything else to the contrary, in the event that this <U>Section <B>&lrm;</B>1.13(f)</U> is not satisfied at
or prior to Closing, Buyer may not delay Closing and Buyer&rsquo;s sole remedy shall be to deduct and withhold any amounts required
by applicable Tax Law to be deducted and withheld as a result of not receiving any such form or certificate).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">1.14&#9;</FONT><FONT STYLE="font-size: 10pt"><U>Withholding</U>.
Buyer, its Affiliates, the Escrow Agent, the Paying Agent, and the Company Entities shall be entitled to deduct and withhold from
any consideration otherwise payable pursuant to this Agreement such amounts as each is required to deduct and withhold with respect
to the making of such payment under any applicable provision of federal, state, local or foreign Tax Law. If any amount is so
deducted and withheld, such deducted and withheld amounts shall (a) be timely remitted by to the appropriate Taxing Authority
in accordance with applicable Tax Law, and (b) to the extent so remitted to</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">the
appropriate Taxing Authority, be treated for all purposes of this Agreement as having been paid to the Person otherwise entitled
to such payment. Other than with respect to deductions and withholdings attributable to (x) the failure of the Company Shareholders
or the Company to deliver the forms or certificate described in <U>Section <B>&lrm;</B>1.13(f)</U>, or (y) compensatory payments
to current and former employees of the Company, Buyer shall give written notice, not less than three Business Days prior to Closing,
to the Sellers&rsquo; Representative of any applicable withholding requirement of which Buyer has knowledge. Buyer, its Affiliates,
the Escrow Agent and the Paying Agent shall fully cooperate with the Sellers&rsquo; Representative prior to Closing to reduce
or eliminate any such withholding in a manner consistent with applicable Law.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
2 </FONT><FONT STYLE="font-size: 10pt"><U><BR>
<BR>
CONDITIONS TO CLOSING</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to the Obligations of Each Party</U>.  The respective obligations of each Party to consummate the transactions contemplated by
this Agreement to take place at the Closing is subject to the satisfaction or, to the extent permitted by applicable Law, waiver
by each of the Parties of the following conditions on or before the Closing Date:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Antitrust</U>.
Any applicable waiting period (and any extensions thereof) under the HSR Act relating to the transactions contemplated by this
Agreement (or under any applicable timing agreements, understandings or commitments entered into with or made to a Governmental
Authority to extend any waiting period or not close the transactions contemplated hereby) will have expired or been terminated
(the &ldquo;<U>HSR Clearance</U>&rdquo;).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Restraint</U>. No injunction, judgement, ruling or order by a court or Governmental Authority or applicable Law will be in effect
or pending that enjoins, restrains, prevents or prohibits the consummation of the Closing or makes the consummation of the Closing
illegal.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;</U></FONT><U><FONT STYLE="font-size: 10pt">Conditions
to the Obligations of the Company</FONT></U><FONT STYLE="font-size: 10pt">.  The obligation of the Company to consummate the transactions
contemplated by this Agreement to take place at the Closing is subject to the satisfaction or, to the extent permitted by applicable
Law, waiver of the following conditions on or before the Closing Date:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
and Warranties</U>. The representations and warranties set forth in <B><U>&lrm;</U></B><U>Article 4</U> will be true and correct
at and as of the Closing Date as if made anew as of such date (except to the extent any such representation or warranty expressly
relates to an earlier date (in which case solely as of such earlier date)), except for any failure of such representations and
warranties to be true and correct that would not, individually or in the aggregate, have or reasonably be expected to have a material
adverse effect on Buyer&rsquo;s or Merger Sub&rsquo;s ability to consummate the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Performance
of Covenants</U>. Buyer and Merger Sub will have performed in all material respects all of the covenants and agreements required
to be performed by them under this Agreement at or prior to the Closing.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certificate</U>.
Buyer will have delivered to the Sellers&rsquo; Representative a certificate from an officer of each of Buyer and Merger Sub in
the form set forth as <U>Exhibit C</U>, dated as of the Closing Date, stating that the conditions specified in <U>Section&nbsp;<B>&lrm;</B>2.2(a)
</U>and <U>Section&nbsp;<B>&lrm;</B>2.2(b)</U> have been satisfied.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Any condition
specified in this <U>Section&nbsp;&lrm;2.2</U> may be waived in a writing executed by the Sellers&rsquo; Representative on behalf
of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;</U></FONT><U><FONT STYLE="font-size: 10pt">Conditions
to the Obligations of Buyer and Merger Sub</FONT></U><FONT STYLE="font-size: 10pt">.  The obligation of Buyer and Merger Sub to
consummate the transactions contemplated by this Agreement to take place at the Closing is subject to the satisfaction or, to
the extent permitted by applicable Law, waiver of the following conditions on or before the Closing Date:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
and Warranties</U>. (i) The Fundamental Representation set forth in the first sentence of <U>Section&nbsp;<B>&lrm;</B>3.3(a)</U>
shall be true and correct in all respects as of the Closing Date as if made anew as of such date, except for <I>de minimis</I>
errors, (ii) each of the other Fundamental Representations will be true and correct in all material respects as of the Closing
Date as if made anew as of such date (except to the extent any such Fundamental Representation expressly relates to an earlier
date (in which case such Fundamental Representation shall be true and correct in all material respects as of such earlier date)),
and (iii) each of the representations and warranties of the Company set forth in <B><U>&lrm;</U></B><U>Article 3</U> (other than
the Fundamental Representations) (disregarding all materiality and Company Material Adverse Effect qualifications contained therein,
except for those representation in <U>Section <B>&lrm;</B>3.6(a)</U>) will be true and correct as of the Closing Date as if made
anew as of such date (except to the extent any such representation or warranty expressly relates to an earlier date (in which
case such representations or warranty shall be true and correct as of such earlier date)), except for any failure of any such
representation or warranty referred to in this <U>clause&nbsp;(iii)</U> to be true and correct that has not had, and would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Performance
of Covenants</U>. The Company will have performed in all material respects all of the covenants and agreements required to be
performed by it under this Agreement at or prior to the Closing; <U>provided</U>, <U>that</U>, the failure to obtain any third-party
consent or waiver under <U>Section <B>&lrm;</B>5.9</U> will not, in and of itself, be deemed a breach hereunder and the obtainment
of any such consents or waivers will not be a condition to Closing unless otherwise provided in this <B>&lrm;</B><U>Article </U>2.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certificate</U>.
The Company will have delivered to Buyer a certificate from an officer of the Company in the form set forth as <U>Exhibit D</U>,
dated as of the Closing Date, stating that the conditions specified in <U>Section&nbsp;<B>&lrm;</B>2.3(a)</U>, <U>Section&nbsp;<B>&lrm;</B>2.3(b)
</U>and <U>Section <B>&lrm;</B>2.3(d)</U> have been satisfied.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Material Adverse Effect</U>. Since the date of this Agreement, no Company Material Adverse Effect will have occurred.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Any condition
specified in this <U>Section&nbsp;&lrm;2.3</U> may be waived in a writing executed by Buyer on behalf of Buyer and Merger Sub.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Waiver
of Conditions</U>. If the Closing occurs, all conditions to the Closing which have not been fully satisfied as of the Closing
will be deemed to have been satisfied or waived by the Parties.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
3 </FONT><FONT STYLE="font-size: 10pt; text-decoration: none"><BR>
<BR>
</FONT><FONT STYLE="font-size: 10pt"><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">The
Company hereby represents and warrants to Buyer and Merger Sub as follows, except as set forth on the Schedules delivered to Buyer
pursuant to the terms of this Agreement:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organization
and Power</U>.  The Company is a corporation validly existing and in good standing under the Laws of the State of Delaware and
is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which the failure to so be
in good standing or qualify would reasonably be expected to have, individually or in the aggregate with all such other failures,
a Company Material Adverse Effect. The Company Entities have all requisite organizational power and authority </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">necessary
to own and operate their properties and to carry on their businesses as now conducted except for any such power and authority
which the failure to have would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Authorization;
No Breach</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">This
Agreement has been duly executed and delivered by the Company and constitutes a valid and binding obligation of the Company, enforceable
in accordance with its terms, and each other Related Agreement to which any Company Entity is a party, when executed and delivered
by such Company Entity, will constitute a valid and binding obligation of such Company Entity, enforceable in accordance with
its terms, in each case, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other
Laws affecting creditors&rsquo; rights generally and as limited by the availability of specific performance and the application
of equitable principles. The Company Shareholder Approval is the only approval or consent of the Company Entities or the Company
Shareholders necessary in connection with the execution and delivery of, or the performance by the Company of its obligations
under, this Agreement and the other Related Agreements to which it is or will be a party, or the consummation of the transactions
contemplated hereby or thereby, and there are no other votes, approvals, consents or other proceedings of the equityholders of
any of the Company Entities (other than those that have been obtained prior to the execution of this Agreement) required in connection
therewith. The Company Shareholder Approval constitutes a valid, irrevocable and effective adoption of this Agreement and the
Related Agreements in compliance with applicable Law and the Company&rsquo;s Organizational Documents.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Assuming
receipt of and subject to the consents set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.2(b)</U> and the HSR Clearance (and assuming
the accuracy of the representations and warranties of Buyer in <U>Section <B>&lrm;</B>4.2(b)</U>), except as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.2(b)</U>,
the execution, delivery and performance of this Agreement and the Related Agreements by the Company Entities do not and will not
(with or without the giving of notice or the lapse of time, or both) (i) result in any material breach of any of the provisions
of, (ii)&nbsp;constitute a material default under, (iii) give any third party the right to terminate, cancel, accelerate or materially
modify any right or obligation of any Company Entity under, (iv) result in the creation of any lien, security interest, charge
or encumbrance on any of the units, shares of capital stock or other equity interests or any material assets of any Company Entity
pursuant to the provisions of or (v)&nbsp;require any authorization, consent, approval, exemption or other action by, or notice
to, any Governmental Authority, in each case, except as has been obtained or as contemplated by this Agreement, under (A) the
Organizational Documents of any Company Entity, (B) any Contract, (C) any judgment, order or decree to which any Company Entity
is subject or (D) any Law to which any Company Entity is subject, except, in the case of each of the foregoing clauses (B), (C)
and (D), where it would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Capitalization
of the Company</U>. </P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
authorized, issued and outstanding equity interests of the Company are as set forth on <U>Schedule&nbsp;<B>&lrm;</B>3.3(a)</U>.
The equity interests of the Company that are issued and outstanding have been duly authorized and are validly issued, and are
owned of record, collectively, by the Company Equityholders free and clear of all Liens, other than Permitted Liens, and were
issued in compliance in all material respects with all applicable securities Laws and the Company&rsquo;s Organizational Documents
free and clear of all pre-emptive rights and other similar rights to acquire or purchase. Except as set forth on <U>Schedule&nbsp;<B>&lrm;</B>3.3(a)</U>,
(a) there are no outstanding (i) equity securities or phantom or other equity interests (including options, warrants, equity-linked
awards, calls or rights of first refusal) of the Company, (ii)&nbsp;securities of the Company convertible into or exchangeable
for or embodying any right to acquire equity shares or other equity securities of the Company or (iii) options or other rights
to acquire from the Company</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">any
equity securities or phantom or other equity interests (including any options, warrants, equity linked awards, calls or rights
of first refusal) of the Company (the items in clauses (i), (ii) and (iii) being referred to collectively as the &ldquo;<U>Company
Securities</U>&rdquo;) and (b) there are no outstanding obligations of the Company, actual or contingent, to issue or deliver,
or repurchase, redeem or otherwise acquire, any Company Securities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth on the <U>Schedule&nbsp;<B>&lrm;</B>3.3(b)</U>, there are no agreements to which the Company is a party with respect
to the voting or transfer of any Company Securities. To the Knowledge of the Company, there are no agreements to which the Company
is not a party with respect to the voting of any Company Securities, any grant to any holder thereof (individually or with others)
of approval rights over any action or inaction of the Company or that restrict the transfer of any Company Securities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule
<B>&lrm;</B>3.3(c)</U> contains a true and complete list of all outstanding Company Securities that represent equity or equity-based
compensation provided to a current or former Service Provider, including with respect to each such award, as applicable, the holder,
number of Company Securities applicable to such award, date of grant, exercise price, and strike price or participation threshold.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
allocations of the Estimated Aggregate Closing Consideration and any Additional Consideration set forth in the Distribution Schedule
will, as of the Closing, comply with the requirements of applicable Law in all material respects and the Company&rsquo;s Organizational
Documents.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Subsidiaries</U>.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule&nbsp;<B>&lrm;</B>3.4(a)
</U>sets forth (i) the name of each Subsidiary of the Company, (ii) the jurisdiction of its incorporation or organization and
(iii) the direct owner of the outstanding capital stock or other equity interests of such Subsidiary and the percentage of the
outstanding capital stock or other equity interests of such Subsidiary owned by the Company or any of its Subsidiaries. Except
as set forth on <U>Schedule&nbsp;<B>&lrm;</B>3.4(a)</U>, the Company does not have any Subsidiaries and no Company Entity owns
or controls, directly or indirectly, any capital stock, equity interests, voting securities or other ownership interest in any
Person or is, directly or indirectly, a participant in any joint venture, partnership or similar arrangement. No Company Entity
has any obligation to make any Investment (whether by loan, capital contribution, purchase of securities or otherwise, and including
any additional Investments) in any Person (other than any of its Subsidiaries). Each of the Company&rsquo;s Subsidiaries is duly
organized, validly existing and (where applicable) in good standing under the Laws of the jurisdiction of its incorporation or
organization, as applicable, possesses all requisite power and authority to own and operate its properties, to carry on its businesses
as now being conducted and is qualified to do business in each jurisdiction in which the ownership of its properties or the conduct
of its business requires it by Law to be so qualified, except in such jurisdictions where the failure to be so qualified and in
good standing, individually or in the aggregate with all such other failures, would not reasonably be expected to have, a Company
Material Adverse Effect. All of the outstanding capital stock or other equity interests of each of the Company&rsquo;s Subsidiaries
is duly authorized, validly issued and fully paid, and owned by the Company or another Subsidiary of the Company free and clear
of any Liens, other than Permitted Liens. There are no authorized or outstanding options, warrants, purchase rights, subscription
rights, conversion rights or other Contracts that require any Subsidiary of the Company to issue, sell or otherwise cause to become
outstanding any of its equity interests. No Subsidiary of the Company is subject to any obligation (contingent or otherwise) to
repurchase, redeem or otherwise acquire or retire any of its equity interests. There are no statutory or contractual preemptive
rights, rights of first refusal or similar restrictions with respect to the equity interests of any Subsidiary of the Company.
There are no agreements or understandings among any Persons with respect to the voting or transfer of the equity interests of
any Subsidiary of the Company to which the Company is a party.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">True
and complete copies of the Company Entities&rsquo; Organizational Documents have been made available to Buyer and reflect all
amendments and modifications made thereto at any time prior to the date of this Agreement. No Company Entity is in material breach
of any of its Organizational Documents.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Financial
Statements; Undisclosed Liabilities</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule
<B>&lrm;</B>3.5(a)</U> sets forth the true, complete and correct copies of the following financial statements: (a) the audited
consolidated balance sheet of the Company as of each of December 31, 2018 and December 31, 2019 and the related audited consolidated
statements of operations and comprehensive loss, changes in shareholders&rsquo; equity and cash flows of the Company for the fiscal
years then ended (and footnotes thereto), and (b) the unaudited consolidated balance sheet of the Company Entities as of December
31, 2020 (the &ldquo;<U>Latest Balance Sheet</U>&rdquo;) and the related unaudited consolidated statements of income, stockholders&rsquo;
equity and cash flows of the Company Entities for the 12-month period then ended. Except as set forth in <U>Schedule <B>&lrm;</B>3.5(a)</U>,
the foregoing financial statements (including the notes thereto, if any) have been prepared from and are consistent with the books
and records of the Company Entities and present fairly, in all material respects, the consolidated financial position of the Company
Entities as of the dates referred to for such financial statements and the consolidated results of their operations and their
cash flows for the periods referred to therein, and have been prepared in accordance with GAAP, consistently applied throughout
the periods covered thereby (except as may be indicated in the notes thereto and subject, in the case of the unaudited financial
statements, to the lack of footnote disclosures (none of which, if presented, would materially differ from those in the audited
financial statements of the Company) and, in the case of the Latest Balance Sheet, to normal and recurring year-end adjustments,
the effect of which would not, individually or in the aggregate, be material to the Company Entities, taken as a whole).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule <B>&lrm;</B>3.5(b)</U>, the Company Entities do not have any material liabilities or obligations (whether
matured or unmatured, fixed or contingent or otherwise) (collectively, &ldquo;<U>Liabilities</U>&rdquo;), and, to the Knowledge
of the Company, there is no existing condition that would reasonably be expected to result in such a material Liability, except
(i) Liabilities specifically reflected on and adequately reserved against in the Latest Balance Sheet or specifically disclosed
in the notes thereto, (ii) Liabilities in respect of trade or business obligations that have arisen since the date of the Latest
Balance Sheet in the ordinary course of business or under executory contracts entered into in the ordinary course of business
(other than as a result of any breach or default thereunder) and (iii) Liabilities disclosed on another section of the Schedules.
Except as shall be taken into account in the Closing Statement (as finally determined in accordance with <U>Section&nbsp;<B>&lrm;</B>1.12)</U>,
there is no Indebtedness or Unpaid Sellers&rsquo; Transaction Expenses of the Company Entities as of the Adjustment Calculation
Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Absence
of Certain Developments</U>. Except as set forth in Schedule&nbsp;&lrm;3.6, as otherwise contemplated by this Agreement or as
necessary or advisable in accordance with any COVID-19 Measures binding upon or applicable to the Company Entities or otherwise
in response to health and safety considerations related to COVID-19, since the date of the Latest Balance Sheet, none of the Company
Entities has:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">suffered
a Company Material Adverse Effect;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">issued
or sold any of its capital stock or other equity interests, securities convertible into its capital stock or other equity interests
or warrants, options or other rights to purchase its capital stock or other equity interests, except for transactions between
or among Company Entities;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">declared,
set aside or made any material payment or material distribution of cash or other property to any of the Company&rsquo;s equityholders
with respect to such equityholder&rsquo;s equity interests or otherwise, or purchased, redeemed or otherwise acquired any equity
interests of the Company;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">split,
combined or reclassified any Company Securities;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">mortgaged
or pledged any material portion of its properties or assets or subjected any material portion of its properties or assets to any
Lien, except for Permitted Liens;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">acquired
any business, property, securities, interests or assets, in each case, for a purchase price in excess of $1,000,000 or otherwise
outside of the ordinary course of business;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">sold,
assigned, leased, licensed or otherwise transferred any material portion of its tangible assets, except for inventory or obsolete
or worn assets in the ordinary course of business;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">sold,
assigned, transferred, licensed, abandoned or otherwise disposed of, failed to take any action necessary to maintain, enforce
or protect, or created or incurred any Lien (other than Permitted Liens) on, any material Company Owned Intellectual Property
or material Company Intellectual Property exclusively licensed to the Company, except in the ordinary course of business;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">(A)
made or granted or increased any material bonus or any material compensation or benefit to any Key Employee, (B) materially amended
or terminated any material Employee Benefit Plan, (C) granted any equity or equity-based or other incentive award to, or discretionarily
accelerated the vesting or payment of any such awards held by, any Key Employee, (D) granted or increased any severance, retention
or termination pay to, or entered into or amended any retention, termination, employment, consulting, change in control or severance
agreement with, any Key Employee, (E) hired any Key Employees or (F) terminated the employment of any Key Employees other than
for cause, except, with respect to (A)-(F), in each case, (x) in the ordinary course of business or (y)&nbsp;as required by applicable
Law;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">changed
any annual accounting period, adopted or changed any method of accounting or accounting practices, estimation techniques, assumptions,
policies or principles theretofore adopted or followed, except, in each case, as required by GAAP or applicable Law;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">made
any material election relating to Taxes, changed any material election relating to Taxes already made, adopted or changed any
material method of Tax accounting, settled or compromised any material Tax liability, entered into any closing agreement within
the meaning of Section 7121 of the Code (or any corresponding or similar provision of state, local or foreign Tax Law) with respect
to any material Tax liability, filed any amended material Tax Return, consented to any extension or waiver of the statute of limitations
regarding any material amount of Taxes (other than in the ordinary course of business), settled or consented to any claim or assessment
relating to any material amount of Taxes, or sought any relief under, or taken any action in respect of, any provision of the
CARES Act, related to Taxes (including the deferral of any payments in respect of payroll Taxes under Section 2302 thereof);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">amended
or modified its Organizational Documents;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">commenced
or settled or offered or proposed to settle any material legal Proceeding or any legal Proceeding that relates to the transactions
contemplated by this Agreement;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">committed
to make any capital expenditure outside the ordinary course of business in excess of $500,000;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">(i)
created, incurred, assumed, suffered to exist or otherwise became liable with respect to any material Indebtedness, other than
short-term Indebtedness incurred in the ordinary course of business (including with respect to letters of credit) or borrowings
under the Credit Facility and Indebtedness which is repaid in full at or prior to the Closing or (ii) made any loans or advances
to, or guarantees for the benefit of, any Persons except in the ordinary course of business;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">entered
into, amended or modified in any material respect or terminated any Company Material Contract (or contract that would have been
a Company Material Contract had such contract not been terminated) or any waiver, release or assignment of any material rights,
claims or benefits of any Company Entity under any such Company Material Contract (other than any expiration of any Company Material
Contract in accordance with its terms);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">changed
in any material respect the manner in which the Company Entities extend discounts, rebates or credits to their customers;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">suffered
any material damage or destruction or other casualty loss with respect to any material asset or property owned, leased, or otherwise
used by the Company Entities, whether or not covered by insurance; or</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">agreed
to do any of the foregoing.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Real
Property; Personal Property</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule
<B>&lrm;</B>3.7(a)</U> sets forth a true and complete list of all Owned Real Property. With respect to each parcel of Owned Real
Property:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">A
Company Entity owns good and marketable title to such parcel of Owned Real Property, free and clear of all Liens, other than (A)&nbsp;real
estate Taxes and installments of special assessments not yet delinquent, (B)&nbsp;utility easements, public roads, highways and
rights-of-way, in each case that do not materially interfere with the present or contemplated use or occupancy of such Owned Real
Property, (C)&nbsp;other encumbrances and exceptions set forth on <U>Schedule <B><I>&lrm;</I></B>3.7(a)</U> and (D)&nbsp;Permitted
Liens.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">There
are no leases, subleases, licenses, concessions or other agreements entered into by or otherwise granting to any party or parties
the right of use or occupancy of any portion of the Owned Real Property, other than those constituting Permitted Liens.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Other
than the right of Buyer pursuant to this Agreement, there are no outstanding options or rights of first refusal to purchase such
Owned Real Property, any portion thereof or interest therein granted by or otherwise.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
plants, buildings and structure on each parcel of Owned Real Property and Leased Real Property are in reasonable operating condition
(ordinary wear and tear excepted).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000"><U>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT><U><FONT STYLE="font-size: 10pt">Schedule&nbsp;<B>&lrm;</B>3.7(b)
</FONT></U><FONT STYLE="font-size: 10pt">sets forth a true and complete list of all Material Leases and the address of each parcel
of Leased Real Property. The Company has made available to Buyer a true, correct and complete copy of each such Material Lease
(including all amendments, extensions, renewals, guaranties and other agreements with respect thereto). No Company Entity has
received written notice of any material default under any of the Material Leases that has not been cured or waived. Except as
set forth in Schedule&nbsp;<B>&lrm;</B>3.7(b), with respect to each of the Material Leases, (i) such Material Lease is legal,
valid, binding and enforceable against the Company, and to the Knowledge of the Company, against the other parties thereto, and
in full force and effect, (ii) such Material Lease is free and clear of all Liens other than Permitted</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Liens
and (iii) neither the Company Entities nor, to the Knowledge of the Company, any other party to the Material Lease is in breach
or default under such Material Lease, and no event has occurred or circumstance exists that, with the delivery of notice, the
passage of time or both, would constitute such a breach or default under such Material Lease, except to the extent such breach
or default would not reasonably be expected to result in a Company Material Adverse Effect. To the Knowledge of the Company, no
event has occurred that would allow any other party to a Material Lease to terminate or accelerate performance under or otherwise
modify (including upon the giving of notice or the passage of time) any such Material Lease.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
(i) as set forth in <U>Schedule <B>&lrm;</B>3.7(c)</U>, (ii)&nbsp;as set forth on the Latest Balance Sheet and (iii) for Permitted
Liens, one of the Company Entities owns, free and clear of all Liens, or has a contract, license or lease to use, all of the tangible
personal property and other tangible assets shown on the Latest Balance Sheet and not disposed of in the ordinary course of business
thereafter, acquired thereafter or located on its premises, in each case that is material to the business or operations of the
Company Entities taken as a whole. Except as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.7(c)</U>, such tangible personal property
and tangible assets in the aggregate are in reasonable operating condition (ordinary wear and tear excepted). Such tangible personal
property and tangible assets, together with the Owned Real Property and the Leased Real Property, constitute all the property,
assets and rights used in and are sufficient for the conduct of the business of the Company Entities as presently conducted and
as currently contemplated to be conducted, except, in each case, as would not reasonably be expected to have, individually or
in the aggregate, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Tax
Matters.</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule <B>&lrm;</B>3.8(a)</U>, (i) each Company Entity has timely filed all material Tax Returns that it
was required to file prior to the date hereof (except those under valid extensions) and all such Tax Returns were correct and
complete in all material respects; (ii) all material Taxes due and payable by any Company Entity prior to the date hereof have
been paid by such Company Entity (except those Taxes that are being contested in good faith and with respect to which reserves
have been provided for in accordance with GAAP) and all material Taxes of the Company Entities for any Pre-Closing Tax Period
will either be paid prior to the Closing or taken into account in the calculation of Net Working Capital or Indebtedness, as applicable;
(iii) no deficiency or proposed adjustment that has not been paid or otherwise resolved for any material amount of Tax has been
asserted or assessed by any Taxing Authority in writing against any Company Entity as of the date hereof; (iv) no Company Entity
has consented in writing to extend the time in which any material Tax may be assessed or collected by any Taxing Authority after
the date hereof (other than pursuant to extensions of time to file Tax Returns obtained in the ordinary course of business); (v)
as of the date hereof, there are no ongoing or pending Tax audits, claims, examinations, actions, litigations, suits, or other
proceedings by any Taxing Authority against any Company Entity and there are no written requests for written rulings or determinations
in respect of any Tax or Tax asset pending between any Company Entity and any Taxing Authority; (vi) in the last six years, no
written claim has been made by a Taxing Authority in a jurisdiction where any Company Entity does not file Tax Returns that such
Company Entity is or may be subject to Tax by that jurisdiction; (vii) there are no Liens (other than Permitted Liens) for material
Taxes on any of the assets of the Company Entities; (viii) the Company Entities have withheld and paid all material Taxes required
to have been withheld and paid prior to the date hereof in connection with any amounts paid or owing to any employee, independent
contractor, creditor, stockholder or other third party; (ix)&nbsp;no Company Entity has been a party to any &ldquo;listed transaction,&rdquo;
as defined in Section&nbsp;6707A(c)(2) of the Code and Treasury Regulation Section&nbsp;1.6011-4(b)(2); (x) each Company Entity
is and has since its formation been treated as either a corporation or disregarded entity for U.S. federal income Tax purposes;
(xi) within the past two years, no Company Entity has been a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled corporation&rdquo;
in a distribution intended to qualify under Section 355 of the Code (or any other similar provision of state, local, or non-U.S.
Tax Law); (xii) no Company Entity has sought any relief under, or taken any action in respect of, any provision of the</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">CARES
Act, related to Taxes (including the deferral of any payments in respect of payroll Taxes under Section 2302 thereof); and (xiii)
no Company Entity will be required to make, after the Closing, any installment payment under Section 965(h) of the Code.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule <B>&lrm;</B>3.8(b)</U>, no Company Entity (i) has been a member of an Affiliated Group filing a consolidated
federal income Tax Return (other than a group the common parent of which is a Company Entity) or (ii) has any liability for the
Taxes of any Person (other than a Company Entity) under Treasury Regulation Section 1.1502-6 (or any similar provision of state
or local Tax Law), as transferee or successor or by Contract (other than a Contract the primary purpose of which is not the sharing
or allocation of, or indemnification for, Taxes).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">No
Company Entity will be required to include any material adjustment in taxable income for any Post-Closing Tax Period (i) under
Section 481(c) of the Code (or any similar provision of the Tax laws of any jurisdiction) as a result of a change in method of
accounting for a Pre-Closing Tax Period, (ii) as a result of any closing agreement entered into prior to the Closing, (iii) as
a result of any installment sale made prior to the Closing, (iv) as a result of the application of the look-back method (as defined
in Section 460(b) of the Code) to a long-term contract entered into prior to the Closing, or (v) as a result of any prepaid amounts
received or deferred revenue accrued prior to the Closing.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Company
Material Contracts</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule&nbsp;<B>&lrm;</B>3.9(a)
</U>sets forth a list as of the date hereof of each of the following types of Contracts to which any of the Company Entities is
a party:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement (A) for the employment or engagement of any Key Employee or (B) providing for any change in control bonus, transaction
bonus and similar compensation or benefit;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement that is a collective bargaining agreement with any labor organization that represents employees of any Company Entity;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement containing a covenant that materially limits (or purports to limit) the freedom of any Company Entity or any of its
Affiliates (including, following the Closing, Buyer and its Affiliates) to compete in any line of business or with any Person
or in any area or which imposes exclusivity requirements (including &ldquo;requirements&rdquo; obligations) on any Company Entity
or any of its Affiliates (including, following the Closing, Buyer and its Affiliates);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement that (A) imposes or contains any (1) &ldquo;most favored nation&rdquo;, &ldquo;most favored customer&rdquo; or similar
obligations or (2) &ldquo;right of first refusal&rdquo; or &ldquo;right of first offer&rdquo; or similar provision or (B) provides
for any Person to be the exclusive provider to any Company Entity of any material product or service;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
lease or other agreement pursuant to which any Company Entity is a lessor (excluding any leases of equipment under agreements
with customers) or a lessee of any tangible personal property, or holds or operates any tangible personal property owned by another
Person, except for any leases of personal property under which the aggregate annual rent or lease payments do not exceed $100,000;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
Contract pursuant to which any Company Entity (A) obtains any right to use, or covenant not to be sued under, any third party
Intellectual Property that is material to the Company Entities (excluding license agreements requiring an annual payment of less
than $250,000 and agreements</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">for
commercial or &ldquo;off-the-shelf&rdquo; or open source software or services) or (B) grants any right to use, or covenant not
to be sued under, any Intellectual Property that is material to the Company Entities (excluding non-exclusive licenses granted
by any of the Company Entities in the ordinary course of business), and, in each case of (A) and (B), excluding (1) Contracts
granting ancillary or incidental rights to Intellectual Property, (2) non-disclosure agreements, employment agreements, and independent
contractor agreements entered into in the ordinary course of business, and (3) customer Contracts entered into in the ordinary
course of business;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement or contract under which any Company Entity has (A) borrowed any money or issued any note, indenture or other similar
evidence of Indebtedness or guaranteed such Indebtedness of others (other than intercompany indebtedness or endorsements for the
purpose of collection), in each case having an outstanding principal amount in excess of $500,000, (B) granted Liens over the
assets of any Company Entity (other than Permitted Liens) or (C) granted any loan or made any other extension of credit (other
than accounts receivable payments in the ordinary course of business);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
contract or group of related contracts (A) with a Top Customer, or (B) for the delivery by the Company Entities of products or
services to customers under which the aggregate annualized revenue of the Company Entities&rsquo; from such contracts or group
of related contracts is reasonably expected to be in excess of $1,000,000</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
Contract or group of related Contracts (other than purchase orders entered into in the ordinary course of business) (A) with a
Top Supplier or (B) for the purchase, lease or license of materials, supplies, goods, services, software, equipment or other assets
under which the aggregate annualized payment of the Company Entities&rsquo; from such contracts or group of related contracts
is reasonably expected to be in excess of $400,000;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
(A) joint venture or similar arrangements with third parties, (B) stockholders, investors rights, registration rights or similar
Contracts or (C) Contract with any Governmental Authority (other than, in the case of clause (C), any such Contracts entered into
the ordinary course of business with customers of the Company Entities);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement for the acquisition of any Person or any business unit thereof or the disposition of any material assets of the Company
Entities (other than sales of inventory in the ordinary course of business), in each case, involving payments in excess of $1,000,000,
other than agreements in which the applicable acquisition or disposition has been consummated and there are no obligations of
any Company Entity ongoing;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
material Contract providing for the uncapped indemnification with respect to any infringement, misappropriation or other violation
of Intellectual Property of any Person by any Company Entity, excluding (A) indemnifications provided in Contracts entered into
in the ordinary course of business and (B) contracts under which liability which cannot be limited or excluded by law; and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt; color: #010000">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
agreement requiring capital expenditures after the date of this Agreement in an amount in excess of $1,000,000 in any calendar
year.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.9(b)</U>, each Contract disclosed (or required to be disclosed) on <U>Schedule&nbsp;<B>&lrm;</B>3.9(a)
</U>and, as of the Closing, any other Contract in existence that would have been required to be disclosed on <U>Schedule&nbsp;<B>&lrm;</B>3.9(a)
</U>if in existence on the date hereof (each, a &ldquo;<U>Company Material Contract</U>&rdquo;) (a) is in full force and effect
(subject to expiring in accordance with its terms) and (b) represents the legal, valid and binding obligations of and are enforceable
against the Company Entity party thereto and, to the Knowledge of the Company, represent the legal, valid and binding obligations
of and are</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">enforceable
against the other parties thereto, in accordance with their respective terms, subject in each case to applicable bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors&rsquo; rights generally and as limited
by the availability of specific performance and the application of equitable principles. Except as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.9(b)</U>,
(i)&nbsp;none of the Company Entities is in material breach of or material default under any Company Material Contract, (ii) none
of the Company Entities has received any written notice of material breach of or material default under any Company Material Contract
and (iii) to the Knowledge of the Company, no event has occurred that would reasonably be expected to result in a material breach
of, a material default under any Company Material Contract (in each case, with or without notice or lapse of time or both). The
Company Entities have made available to Buyer a true, correct and complete copy of each of the written Company Material Contracts,
together with all amendments, extensions, guarantees and other binding supplements thereto as of the date hereof. Since the date
of the Latest Balance Sheet, none of the Company Entities has received any written notice of an intention to terminate or, in
the case of a Company Material Contract related to an ongoing relationship with the other party thereto, determination not to
renew or extend on substantially similar terms, any Company Material Contract by any of the parties to any Company Material Contract.
With respect to any Company Material Contract that, by its terms, would automatically renew or extend absent notice or other action
by a party thereto, no such party has given any such notice or taken any such action.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Intellectual
Property</U>. <U>Schedule 3.10(A)</U> sets forth a true and complete list of the registered trademarks, registered service marks,
internet domain names, registered copyrights, and applications for any of the foregoing owned as of the date hereof by the Company
and its Subsidiaries and all such issued and registered Intellectual Property is subsisting and in full force and effect, and,
to the Knowledge of the Company, valid and enforceable. <U>Schedule 3.10(B)</U> sets forth a true and complete list of the patents
and patent applications owned as of the date hereof by the Company and/or its Subsidiaries and, to the Knowledge of the Company,
all such patents and patent applications are solely owned by the Company or its Subsidiaries or jointly owned by the Company and/or
its Subsidiaries on the one hand and a third party on the other hand. Except as set forth in <U>Schedule 3.10</U>:</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P></U>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">(i)
the Company Entities solely and exclusively own and possess good title to all material Intellectual Property owned or purported
to be owned by any of the Company Entities, including the Intellectual Property set forth in <U>Schedule <B>&lrm;</B>3.10</U>,
and hold all of their right, title and interest in and to all material Company Intellectual Property free and clear of all Liens
(other than Permitted Liens) and (ii) no material Intellectual Property exclusively licensed to or owned (or purported to be exclusively
licensed to or owned) by any of the Company Entities has been adjudged invalid or unenforceable in whole or part;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">the
Company Entities own or have a valid and enforceable license or other sufficient right to use to all Intellectual Property necessary
for, or used or held for use in, the conduct of the business of the Company Entities in all material respects;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">since
the Lookback Date, neither the Company nor any of its Subsidiaries has received any written notices from any third party with
respect to infringement, misappropriation, or other violation of any third party Intellectual Property by any Company Entity;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">no
Company Entity has since the Lookback Date infringed, induced or contributed to the infringement of, misappropriated, or otherwise
violated or is currently infringing, inducing or contributing to the infringement of, misappropriating, or otherwise violating
the Intellectual Property of any third party;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">there
is no, and, since the Lookback Date, has been no, Proceeding pending or, to the Knowledge of the Company, threatened, against
any Company Entity (i) alleging that the any Company Entity has infringed, misappropriated or otherwise violated any Intellectual
Property of any third party or</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">(ii)
challenging the validity, enforceability, scope, ownership or inventorship of, or any Company Entity&rsquo;s rights in, any Company
Intellectual Property;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">to
the Knowledge of the Company, no third party is currently infringing, misappropriating, or otherwise violating any Intellectual
Property owned or controlled by any of the Company Entities, in each case except as would not reasonably be expected to be, individually
or in the aggregate, material to the Company Entities, taken as a whole;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">except
as would not reasonably be expected to be, individually or in the aggregate, material to the Company Entities, taken as a whole,
(i)&nbsp;the Company Entities take reasonable steps designed to maintain the confidentiality of all Company Intellectual Property
in the possession of the Company Entities, or that has been disclosed or otherwise made available to any of the Company Entities,
the value of which to the Company Entities is contingent upon maintaining the confidentiality thereof, and, to the Knowledge of
the Company, there has been no unauthorized disclosure of any such confidential Company Intellectual Property, (ii)&nbsp;the consummation
of the transactions contemplated by this Agreement will not alter, encumber, impair or extinguish any Company Intellectual Property
and (iii)&nbsp; there exist no restrictions on the disclosure, use, license or transfer of any Company Intellectual Property owned
or purported to be owned by any of the Company Entities; and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">except
as would not reasonably be expected to be, individually or in the aggregate, material to the Company Entities, taken as a whole,
(i) the Company Entities have, since the Lookback Date, complied with all applicable Laws, contractual obligations and internal
and external policies relating to privacy, data protection or the collection, storage, use or other processing of personal information
in the course of their respective operations, (ii) no Proceedings have been asserted or, to the Knowledge of the Company, threatened
against any Company Entity since the Lookback Date alleging a violation of any of the foregoing, (iii)&nbsp;the IT Assets operate
and perform in a manner that permits the Company Entities to conduct their respective businesses as currently conducted, and the
Company Entities take commercially reasonable steps designed to protect the security, integrity and continuous operation of the
same and (iv)&nbsp;to the Knowledge of the Company, there has been no security breach or intrusion of any IT Assets (or any information
or transactions stored or contained therein or transmitted thereby) since the Lookback Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>.  Except as set forth in <U>Schedule&nbsp;&lrm;3.11</U>, there are, and since the Lookback Date there have been,
no material Proceedings (x) pending or, to the Knowledge of the Company, threatened against any Company Entity or (y) pending
or threatened by any Company Entity against any Person, in each case at law or in equity, or before or by any Governmental Authority
or arbitrator that, if determined or resolved adversely in accordance with the plaintiff&rsquo;s demands, would reasonably be
expected to be, individually or in the aggregate, material to the Company Entities, taken as a whole. Except as set forth on Schedule&nbsp;&lrm;3.11,
as of the date hereof, no Company Entity nor any of their respective assets or properties is subject to any material writ, judgment,
consent, stipulation, award, order or decree of any court or other Governmental Authority. </FONT></P></U>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Brokerage</U>.
 Except for fees and expenses payable to Morgan Stanley &amp; Co. LLC, a copy of whose engagement agreement related to the Merger
has been provided to Buyer (with customary redactions), there are no claims for brokerage commissions, finder&rsquo;s fees or
similar compensation in connection with the transactions contemplated by this Agreement based on any arrangement or agreement
made by or on behalf of any Company Entity or by which any Company Entity is bound for which Buyer or any of its Affiliates (including,
following the Closing, the Company Entities) would have any liability. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></U>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Company
Employee Benefit Plans</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule&nbsp;<B>&lrm;</B>3.13(a)
</U>sets forth a list of each material Employee Benefit Plan as of the date hereof. With respect to each Employee Benefit Plan
(other than an International Plan), the Company has made available to Buyer, copies of, as applicable, the plan document and any
material amendments thereto and the most recently filed annual return/report (Form 5500) and, with respect to each material International
Plan, the Company has made available to Buyer a summary of the material terms thereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Employee Benefit Plan has been maintained and administered in all material respects in accordance with its terms and complies
in form and in operation in all material respects with the applicable requirements of ERISA, the Code and other applicable Laws.
Other than routine claims for benefits, there is no material Proceeding pending or, to the Knowledge of the Company, threatened
against an Employee Benefit Plan by any participant or beneficiary in such Employee Benefit Plan or any Governmental Authority.
Since the Lookback Date, there has been no action, suit, proceeding or claim (other than routine claims for benefits) pending
against, or to the Company&rsquo;s knowledge, threatened against, any Employee Benefit Plan before any Governmental Authority,
which, if determined or resolved adversely to the Company and its Subsidiaries, would reasonably be expected to have a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Employee Benefit Plan that is intended to meet the requirements of a &ldquo;qualified plan&rdquo; under Section&nbsp;401(a) of
the Code has received a favorable determination letter or is in the form of a prototype or volume submitter plan that has received
a favorable opinion letter from the Internal Revenue Service.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">None
of the Company Entities contributes to, has any obligation to contribute to or has any liability with respect to any Title&nbsp;IV
Plan or any Multiemployer Plan. No Employee Benefit Plan is a &ldquo;multiple employer plan&rdquo; (as described in Section 413(c)
of the Code) or a defined benefit plan. Neither the Company nor any of its Subsidiaries sponsors, maintains or contributes to
any Employee Benefit Plan that provides for post-employment or post-retirement health or medical or life insurance benefits for
retired, former or current Service Providers, except as required to avoid excise tax under Section 4980B of the Code.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.13(e)</U>, (i)&nbsp;no Employee Benefit Plan would, by its terms, provide any material
payment or benefit or accelerate the time of any material payment or vesting of any material compensation or benefits to any current
or former Service Provider as a result of the transactions contemplated by this Agreement, (ii)&nbsp;nothing shall limit or restrict
the right of any Company Entity or, after the Closing, Buyer, to merge, amend or terminate any Employee Benefit Plan, and (iii)&nbsp;the
consummation of the transactions contemplated by this Agreement (either alone or together with any other event) shall not result
in the payment of any amount that would not be deductible under Section 280G of the Code.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Employee Benefit Plan, and any award thereunder, that is or forms part of a &ldquo;nonqualified deferred compensation plan&rdquo;
(within the meaning of Section 409A or 457A of the Code) has been timely amended (if applicable) to comply and has been operated
and administered in all material respects in compliance with, and all Company Entities have complied in practice and operation
with, all applicable requirements of Sections 409A and 457A of the Code, and no amounts currently deferred or to be deferred under
any such plan would be not determinable when otherwise includible in income under Section 457A of the Code. Except as set forth
on <U>Schedule&nbsp;<B>&lrm;</B>3.13(f)</U>, no Company Entity has any obligation to gross-up, indemnify or otherwise reimburse
any current or former Service Provider for any Taxes incurred by such Service Provider, including under Section 409A, 457A or
4999 of the Code.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
International Plan (i) has been maintained in all material respects in compliance with its terms and Applicable Law, (ii) if intended
to qualify for special tax treatment, meets in all material respects all the requirements for such treatment, and (iii) if required
by Applicable Law to be</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">funded,
book-reserved or secured by an insurance policy, is funded, book-reserved or secured by an insurance policy, as applicable, to
the extent required by Applicable Law and based on reasonable actuarial assumptions in accordance with applicable accounting principles.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Compliance
with Applicable Laws.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.14<B>&lrm;</B>(a)</U>, none of the Company Entities is in material violation of,
and since the Lookback Date, each of the Company Entities has complied in all material respects with, all material Laws of any
Governmental Authority applicable to the Company Entities. Except as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.14<B>&lrm;</B>(a)</U>,
since the Lookback Date, no Company Entity has received any written communication from a Governmental Authority that alleges that
any Company Entity is not in compliance in all material respects with any material Laws, except with respect to matters that have
been settled or resolved. There is no Order that is or would reasonably be expected to be, individually or in the aggregate, material
to the Company Entities, taken as whole.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Company Entity owns or possesses all right, title and interest in and to each of its respective Permits issued or granted by any
Governmental Authority that are material to the conduct of the business of the Company Entities (the &ldquo;<U>Material Permits</U>&rdquo;)
and has complied and is in compliance in all material respects with all such Material Permits, and no written or, to the knowledge
of the Company, oral notices have been received by any Company Entity since the Lookback Date alleging the failure to hold any
of the foregoing. The appropriate Company Entity has accurately filed all reports and paid all fees, assessments, and contributions
required by the Material Permits and applicable Laws, except such reports, fees, assessment and contributions the failure of which
to file or pay, as applicable, would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect. Each Company Entity has obtained all required registrations and other certifications required for the conduct
and operation of such Company Entity&rsquo;s business in the jurisdictions in which such Company Entity operates. No written notice
of violation or notice of forfeiture seeking to revoke, reconsider the grant of, cancel, suspend, modify or declare any of the
Material Permits held by any Company Entity invalid has been received by the applicable Company Entity since the Lookback Date,
is pending or, to the Knowledge of the Company, has been threatened before any Governmental Authority.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Company Entity has complied in all material respects with respect to any applicable &ldquo;escheat,&rdquo; &ldquo;abandoned property,&rdquo;
&ldquo;unclaimed property,&rdquo; or other similar Laws.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certain
Business Practices</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Since
the Lookback Date, no Company Entity nor any director, officer or employee of any Company Entity or, to the Knowledge of the Company,
any other Person acting for or on behalf of any Company Entity, has, in relation to any Company Entity, violated any Anti-Corruption
Law in any material respect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Company Entity has maintained and currently maintains accurate books and records and maintains policies and procedures reasonably
designed to ensure compliance in all material respects with Anti-Corruption Laws. There have been no false or fictitious entries
made in the books and records of a Company Entity relating to any secret or unrecorded fund or any unlawful payment, gift or other
thing of value, and no Company Entity has established or maintained a secret or unrecorded fund.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">No
Company Entity, nor, to the Knowledge of the Company, any of their respective directors, officers or employees, or, to the Knowledge
of the Company, any other Person acting for or on behalf of any Company Entity, is a non-U.S. Government Official.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Since
the Lookback Date, no Company Entity nor any director, officer or employee of any Company Entity or, to the Knowledge of the Company,
any other Person acting for or on behalf of any Company Entity: (i) is named as a &ldquo;specially designated national&rdquo;
on the most current list published by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;),
(ii) has been or is currently subject to any sanctions administered by OFAC, the U.S. Department of State, the United Nations
Security Council or the European Union, or (iii) has engaged or is currently engaging in any business or other dealings with,
in, involving or relating to (A) any country subject to a comprehensive embargo under the sanctions administered by OFAC, the
U.S. Department of State, the United Nations Security Council or the European Union or (B) any Person subject to sanctions administered
by OFAC, the U.S. Department of State, the United Nations Security Council or the European Union, in either case of (A) or (B),
in material violation of any applicable sanctions.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Company Entity has, since the Lookback Date, conducted its import, export and reexport transactions in accordance in all material
respects with all applicable import, export and reexport Laws administered by U.S. Customs and Border Protection, the Export Administration
Regulations and the statutes, Executive Orders and regulations administered by OFAC.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Environmental</U>.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.16</U>, each Company Entity is and, since the Lookback Date, has been in compliance
in all material respects with all Environmental Laws, which compliance includes obtaining, maintaining, renewing and materially
complying with all Permits (including any Permits related to the use, storage, handling or transportation of radioactive materials)
required by Environmental Laws (&ldquo;<U>Environmental Permits</U>&rdquo;).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">No
Company Entity has, since the Lookback Date, received any written notice, demand, request for information, citation, summons or
complaint regarding any violation of, or any liability under, any Environmental Law or Environmental Permit, except where such
violation or liability would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">No
Hazardous Material has been released at, on, under, to, in or from (i) any property or facility now or previously owned, leased
or operated by, or (ii) any property or facility to which any Hazardous Material has been transported for disposal, recycling
or treatment by or on behalf of, in each case any Company Entity (or any of their respective predecessors), except as would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company has made available to Buyer copies of any material environmental investigation, study, audit, test, review, analysis or
other report in the possession or control of the Company Entities that relates to any Company Entity (or any of their respective
predecessors) or any property or facility now or previously owned, leased or operated by any Company Entity (or any of their respective
predecessors).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;</U></FONT><U><FONT STYLE="font-size: 10pt">Employees
and Labor Matters</FONT></U><FONT STYLE="font-size: 10pt">. </P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">As
of the date hereof, except as set forth in <U>Schedule <B>&lrm;&lrm;</B>3.17(a)</U>, to the Knowledge of the Company, no Key Employee
has indicated in writing that he or she intends to resign or retire as a result of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule <B>&lrm;</B>3.17(b)</U>, none of the Company Entities are party to or bound by any collective bargaining
agreement or collective bargaining relationship with any labor organization, and since the Lookback Date, no labor organization
or group of employees has filed any</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">representation
petition or made any written demand for recognition of a collective bargaining representative with respect to any Company Entity.
To the Knowledge of the Company, as of the date hereof, no union organizing or decertification activities are underway or threatened
with respect to the employees of any of the Company Entities, and no such activities have occurred from the Lookback Date through
the date hereof. As of the date hereof, there are no strikes, walkouts, work stoppages or slowdowns, lockouts, picketing or other
material labor disputes pending against the Company Entities or, to the Knowledge of the Company, threatened, and no such disputes
have occurred since the Lookback Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
as set forth in <U>Schedule&nbsp;<B>&lrm;</B>3.17(c)</U>, since the Lookback Date, each of the Company Entities has complied with
all applicable Laws relating to the employment of labor, including provisions thereof relating to wages, hours, equal opportunity,
fair labor standards, nondiscrimination, workers compensation, collective bargaining and the withholding and payment of social
security and other payroll Taxes, except where any such noncompliance would not reasonably be expected to have, individually or
in the aggregate, a Company Material Adverse Effect. Since the Lookback Date, none of the Company Entities has implemented any
plant closing or layoff of employees that triggered notice or other obligations under the WARN Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Regulatory
Matters</U>. Except for those matters that would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect: (i) the Company Entities are, and since the Lookback Date have been, in compliance with all applicable
Regulatory Laws and Healthcare Laws; (ii) each of the Company Entities holds and is in compliance with, and since the Lookback
Date has held and been in compliance with, all Permits required under Regulatory Laws for the operation of its respective business;
(iii) there is, and since the Lookback Date there has been, no Proceeding arising under Regulatory Laws or Healthcare Laws that
is pending or, to the Knowledge of the Company, threatened against any of the Company Entities; (iv) none of the Company Entities
has received any written notice of, or is subject to, any order, settlement, judgment, injunction, decree, corporate integrity
agreement, deferred prosecution agreement, Form-483, warning letter, recall or import alert, in each case involving uncompleted,
outstanding or unresolved liabilities or corrective or remedial obligations relating to or arising under Regulatory Laws or Healthcare
Laws; (v) none of the Company Entities is, and since the Lookback Date none of the Company Entities has been, excluded from participating
in any Governmental Health Program or debarred under any Regulatory Laws; (vi) all products manufactured or otherwise produced,
distributed or sold, or services rendered, by or on behalf of the Company Entities have been manufactured and produced in accordance
with applicable Regulatory Laws; (vii) none of the Company Entities has made an untrue statement of material fact or fraudulent
statement to the FDA or any other similar Governmental Authority and (viii) there have been no product recalls (whether voluntary
of involuntary) since the Lookback Date.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Affiliate
Transactions</U>. <U>Schedule&nbsp;&lrm;3.19 </U>sets forth a complete list as of the date hereof of all material agreements between
any Company Entity, on the one hand, and any Related Party (other than a Company Entity), on the other hand, other than (x) employment
agreements, equity or incentive equity documents and Organizational Documents, (y) loans and other extensions of credit for travel,
business or relocation expenses or other employment-related purposes, in each case, in the ordinary course of business and (z)
the Employee Benefit Plans.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">I<U>nsurance</U>.
<U>Schedule&nbsp;&lrm;3.20 </U>sets forth each material insurance policy maintained as of the date hereof with respect to the
properties, assets, businesses, directors and officers of the Company Entities. All of the insurance policies set forth or required
to be set forth in Schedule&nbsp;&lrm;3.20 (the &ldquo;Insurance Policies&rdquo;) are, as of the date hereof, in full force and
effect. No Company Entity is in material default with respect to its obligations under any such insurance policies, and there
has not been any lapse in coverage under any Insurance Policy. There are no claims <U>related</U> to the <U>business</U> of the
Company Entities pending under any </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
</U>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Insurance
Policy as to which coverage has been denied or disputed or in respect of which there is an outstanding reservation of rights (other
than ordinary course reservations of rights).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Customers
and Suppliers</U><FONT STYLE="text-transform: uppercase">.</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule
<B>&lrm;</B>3.21(a)</U> sets forth (i) a list of the top ten&nbsp;(10) customers of the Company Entities (on a consolidated basis
determined by volume of sales to such customers) (each a &ldquo;<U>Top Customer</U>&rdquo;) and (ii) a list of the top ten (10)
suppliers of the Company Entities (on a consolidated basis determined by volume of purchases from such suppliers) (each a &ldquo;<U>Top
Supplier</U>&rdquo;), in each case for the fiscal years ended December 31, 2019 and December 31, 2020. Since January 1, 2021,
neither the Company nor any of its Subsidiaries has received any written notice from any Top Customer or Top Supplier to the effect
that any such Top Customer or Top Supplier will stop, or materially decrease the rate of, buying or supplying materials, products
or services from or to the Company Entities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Schedule
<B>&lrm;</B>3.21(b)</U> sets forth, in all material respects, a true and accurate list, as of the date hereof, of all (i) backlog
amounts and (ii) deposit amounts relating to customers of the Company Entities, together with reasonably detailed information
regarding the specific customers and studies to which such backlog or deposit amounts relate.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>EXCLUSIVITY
OF REPRESENTATIONS AND WARRANTIES</U>. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS <B>&lrm;</B><U>Article 3</U>, THE COMPANY
EXPRESSLY DISCLAIMS ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE, EXPRESS OR IMPLIED, AS TO THE CONDITION, VALUE OR
QUALITY OF ITS BUSINESSES OR ASSETS, AND THE COMPANY SPECIFICALLY DISCLAIMS ANY REPRESENTATION OR WARRANTY OF MERCHANTABILITY,
USAGE, SUITABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE WITH RESPECT TO ITS ASSETS, THE WORKMANSHIP THEREOF, AND THE ABSENCE
OF ANY DEFECTS THEREIN, WHETHER LATENT OR PATENT, IT BEING UNDERSTOOD THAT SUCH SUBJECT ASSETS ARE BEING ACQUIRED &ldquo;AS IS,
WHERE IS&rdquo; ON THE CLOSING DATE, AND IN THEIR PRESENT CONDITION, AND BUYER AND MERGER SUB HAVE RELIED SOLELY ON THEIR OWN
EXAMINATION AND INVESTIGATION THEREOF. FURTHER, EXCEPT AS EXPRESSLY SET FORTH IN THIS <FONT STYLE="text-transform: uppercase">&lrm;<U>Article
</U></FONT><U>3</U> THE COMPANY HEREBY EXPRESSLY DISCLAIMS ANY OTHER REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE, LEGAL
OR CONTRACTUAL, EXPRESS OR IMPLIED, NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE BUYER, MERGER SUB OR ANY OF THEIR RESPECTIVE
OFFICERS, DIRECTORS, MANAGERS, EMPLOYEES, AGENTS OR REPRESENTATIVES OF ANY DOCUMENTATION OR OTHER INFORMATION (INCLUDING ANY FINANCIAL
PROJECTIONS OR OTHER SUPPLEMENTAL DATA). NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, BUYER ACKNOWLEDGES AND AGREES
THAT NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, ARE MADE WITH RESPECT TO (I) ANY OF THE SPECIFIED
TRADEMARKS OR (II) ANY OF THE PATENTS OR PATENT APPLICATIONS INCLUDED IN THE COMPANY INTELLECTUAL PROPERTY, OTHER THAN THE REPRESENTATIONS
AND WARRANTIES MADE IN THE SECOND SENTENCE OF SECTION 3.10.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
4</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><U><BR>
</U><BR>
<U>REPRESENTATIONS AND WARRANTIES OF BUYER AND MERGER SUB</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">Each
of Buyer and Merger Sub represents and warrants to the Company as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organization;
Ownership of Merger Sub; No Prior Activities</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
and Merger Sub are each a Delaware corporation duly organized, validly existing and in good standing under the Laws of Delaware
and are qualified to do business as a foreign corporation and are in good standing in each jurisdiction in which the failure to
so be in good standing or qualify would reasonably be expected to, individually or in the aggregate with all other such failures,
have a material adverse effect on Buyer&rsquo;s or Merger Sub&rsquo;s ability to perform each of their respective obligations
under this Agreement, the Related Agreements or consummate the transactions contemplated hereby or thereby.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
owns, directly or indirectly, 100% of the issued and outstanding shares of capital stock of Merger Sub. Buyer has all requisite
corporate power and authority necessary to own and operate its properties and to carry on its business as now conducted and to
enter into this Agreement and consummate the transactions contemplated hereby and thereby. The copies of the Organizational Documents
of Merger Sub that have been made available to the Company reflect all amendments made thereto at any time prior to the date of
this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Merger
Sub was formed solely for the purpose of engaging in the transactions contemplated by this Agreement and the Related Agreements
to which it is or will be a party. Except for obligations or liabilities incurred in connection with its formation and the transactions
contemplated by this Agreement, Merger Sub has not and will not have (i) prior to the Closing engaged in any other business activities
or (ii) incurred, directly or indirectly, through any Subsidiary or Affiliate, any obligation or liability or engaged in any business
activity of any type or kind whatsoever or entered into any Contract with any Person.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Authorization;
No Breach</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
and Merger Sub each have all requisite organizational power and authority to execute and deliver this Agreement and the Related
Agreements to which such Person is or will be a party, to perform their respective obligations hereunder and thereunder and to
consummate the transactions contemplated hereby and thereby. The execution and delivery of, and performance by, Buyer and Merger
Sub of this Agreement has been, and with respect to any Related Agreements to which such Person will be a party, will be prior
to the Closing, authorized by all required action on the part of such Person and its directors, shareholders, managers and members,
as applicable. This Agreement and the Related Agreements to which each of Buyer and Merger Sub is or will be a party have been
or will be, at or prior to the Closing, duly executed and delivered by such Person and, subject to the due authorization, execution
and delivery of this Agreement and the Related Agreements to which such Person is or will be a party by the other parties hereto
and thereto, constitute, or when executed and delivered will constitute, valid and binding agreements of such Person, enforceable
against such Person in accordance with their respective terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and other Laws affecting creditors&rsquo; rights generally and as limited by the availability of specific
performance and the application of equitable principles.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Assuming
receipt of and subject to the HSR Clearance (and assuming the accuracy of the representations and warranties in <U>Section <B>&lrm;</B>3.2(b)</U>),
except as set forth in <U>Schedule&nbsp;<B>&lrm;</B>4.2(b)</U>, the execution, delivery and performance of this Agreement and
the Related Agreements to which Buyer or Merger Sub is or will be a party by Buyer and Merger Sub, as applicable, do not and will
not (with or without the giving of notice or the lapse of time, or both) (i) result in any material breach of any of the provisions
of, (ii) constitute a material default under, (iii) give any third party the right to terminate, cancel, accelerate or modify
any right or obligation of Buyer, Merger Sub or any of Buyer&rsquo;s other Subsidiaries under, (iv) result in the creation of
any lien, security interest, charge or encumbrance on any of the shares of capital stock or other equity interests or any material
assets of Buyer, Merger Sub or any of Buyer&rsquo;s other Subsidiaries pursuant to the provisions of or (v)&nbsp;require any authorization,
consent, approval, exemption or other action</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">by,
or notice to, any Governmental Authority, in each case, except as has been obtained or as contemplated by this Agreement, under
(w) the Organizational Documents of Buyer, Merger Sub or any of Buyer&rsquo;s other Subsidiaries, (x) any material Contract to
which any of Buyer, Merger Sub or any of Buyer&rsquo;s other Subsidiaries is a party or by which any of their assets are bound,
(y) any judgment, order or decree to which Buyer, Merger Sub or any of Buyer&rsquo;s other Subsidiaries is subject or (z) any
Law to which any of Buyer, Merger Sub or any of Buyer&rsquo;s other Subsidiaries is subject, except, in the case of each of the
foregoing clauses&nbsp;(x), (y) and (z), where it would not, individually or in the aggregate, have a material adverse effect
on Buyer&rsquo;s or Merger Sub&rsquo;s ability to perform each of their respective obligations under this Agreement, the Related
Agreements or consummate the transactions contemplated hereby or thereby.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. As of the date hereof, there are no Proceedings pending or, to the Knowledge of Buyer, threatened against Buyer
or Merger Sub at law or in equity, or before or by any Governmental Authority, except for any such Proceedings that have not had
and would not reasonably be expected to, individually or in the aggregate, have a material adverse effect on Buyer&rsquo;s or
Merger Sub&rsquo;s ability to perform each of their respective obligations under this Agreement, the Related Agreements or consummate
the transactions contemplated hereby or thereby.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investigation</U>.
Buyer acknowledges that Buyer is conducting its own investigation and analysis, and is relying solely on the express representations
and warranties set forth in <B><U>&lrm;</U></B><U>Article 3</U> (and is not relying on any other representations, warranties or
information) in entering into the transactions contemplated by this Agreement. Buyer is capable of evaluating the merits and risks
of the transactions contemplated by this Agreement and is able to bear the substantial economic risk of such investment for an
indefinite period of time. Buyer has been afforded to its satisfaction access to the books and records, facilities and personnel
of the Company Entities for purposes of conducting a due diligence investigation, has received all information requested by it
and its Representatives from the Company Entities and has conducted to its satisfaction a due diligence investigation of the Company
Entities.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Financing</U>.
Buyer has the financial capability and all sufficient cash on hand necessary to consummate the transactions contemplated by this
Agreement on the terms and subject to the conditions set forth herein (including the ability to (i) fund the entire Aggregate
Closing Consideration and (ii) pay in full all Closing Repaid Indebtedness and all other fees, costs and expenses payable by Buyer
and its Affiliates on the Closing Date in connection with the consummation of the transactions contemplated by this Agreement),
and will have such financial capability as of the Closing Date. Buyer hereby agrees that it is not a condition or contingency
to Closing or to any of its or Merger Sub&rsquo;s obligations under this Agreement that Buyer or Merger Sub obtains financing
or funding for the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Brokerage</U>.
None of the Company Entities have any liability or obligation to pay brokerage commissions, finder&rsquo;s fees or similar compensation
in connection with the transactions contemplated by this Agreement based on any arrangement or agreement made by Buyer or on behalf
of Buyer.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investment
Intent; Restricted Securities</U>. Pursuant to the transactions contemplated hereby, Buyer is acquiring the Company Shares solely
for Buyer&rsquo;s own account, for investment purposes only and not with a view to, or with any present intention of, reselling
or otherwise distributing the Company Shares or dividing its participation therein with others. Buyer understands and acknowledges
that (a)&nbsp;none of the Company Shares have been registered or qualified under the Securities Act or under any securities Laws
of any state of the United States or any other jurisdiction and were issued in reliance on specific exemptions thereunder, (b)
the Company Shares constitute &ldquo;restricted securities&rdquo; as defined in Rule 144 under the Securities Act, (c) none of
the Company Shares are traded or tradable on any securities exchange or over the counter, and (d) none of the Company Shares may
be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless a registration statement under the
Securities Act with respect</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">to
such Company Shares, as applicable, and qualification in accordance with any applicable state securities Laws becomes effective
or unless such registration and qualification is inapplicable, or an exemption therefrom is available. Buyer will not sell, transfer,
offer for sale, pledge, hypothecate or otherwise dispose of any of the Company Shares acquired hereunder or any interest therein
in any manner that may cause the Company Shareholders to be in violation of the Securities Act or any applicable state securities
Laws. Buyer is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of the Securities Act. Buyer acknowledges that it
is informed as to the risks of the transactions contemplated by this Agreement and of ownership of the Company Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Solvency</U>.
Immediately after giving effect to the Merger and assuming (i) the accuracy of the representations and warranties of the Company
set forth in Article 3 and (ii) the satisfaction of the conditions to Closing set forth in &lrm;Article 2, each of Buyer and the
Surviving Company and its Subsidiaries shall (a) be able to pay their respective debts as they become due; (b) own property which
has a fair saleable value greater than the amounts required to pay their respective debts as and when they become due (including
a reasonable estimate of the amount of all contingent liabilities); and (c) have adequate capital to carry on their respective
businesses. No transfer of property is being made and no obligation is being incurred in connection with the transactions contemplated
hereby with the intent to hinder, delay or defraud either present or future creditors of Buyer, Merger Sub or the Company or its
Subsidiaries.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>EXCLUSIVITY
OF REPRESENTATIONS AND WARRANTIES</U>. THE REPRESENTATIONS AND WARRANTIES MADE BY BUYER AND MERGER SUB IN THIS &lrm;Article 4
ARE IN LIEU OF AND ARE EXCLUSIVE OF ALL OTHER REPRESENTATIONS AND WARRANTIES, INCLUDING ANY IMPLIED WARRANTIES. EXCEPT AS EXPRESSLY
SET FORTH IN THIS &lrm;Article 4, EACH OF BUYER AND MERGER SUB HEREBY DISCLAIMS ANY OTHER REPRESENTATIONS OR WARRANTIES OF ANY
KIND OR NATURE, LEGAL OR CONTRACTUAL, EXPRESS OR IMPLIED.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
5 </FONT><FONT STYLE="font-size: 10pt"><U><BR>
</U><BR></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><U>COVENANTS
AND AGREEMENTS</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Operation
of the Business</U>. </P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">During
the period from the date of this Agreement until the earlier of the Closing and the termination of this Agreement in accordance
with <U>Section <B>&lrm;</B>6.1</U> (the &ldquo;<U>Interim Period</U>&rdquo;), except (i) as set forth on <U>Schedule <B>&lrm;</B>5.1</U>,
(ii) as otherwise set forth in this Agreement (including the Disclosure Schedules), (iii) consented to in writing by Buyer (which
consent will not be unreasonably withheld, conditioned or delayed), (iv) as required by any applicable Law or any Contract to
which a Company Entity is a party as of the date hereof or (v) to the extent the Company determines, in its reasonable discretion
and after engaging in good faith discussions with Buyer, may be necessary or advisable in accordance with COVID-19 Measures binding
upon or applicable to the Company Entities or otherwise in response to health and safety considerations related to COVID-19, the
Company will (A) use reasonable best efforts to conduct its business and the business of the other Company Entities in all material
respects in the ordinary course of business consistent with past practice and (B) use its reasonable best efforts, with respect
to itself and the other Company Entities, to manage working capital (including the timing of collection of accounts receivable
and payment of accounts payable) in the ordinary course of business consistent with past practice; <I>provided</I>, that the Company
Entities may use available cash to pay any Sellers&rsquo; Transaction Expenses or Indebtedness prior to the Closing, for distributions
or dividends or for any other purpose. Without limiting the foregoing, during the Interim Period, except (i) as otherwise provided
for in this Agreement (including the Disclosure Schedules), (ii) as consented to by Buyer in writing (which consent will not be
unreasonably withheld, conditioned or delayed), (iii) in the ordinary course of business of the</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Company
Entities consistent with past practice, (iv) as required by any applicable Law or any Contract to which a Company Entity is a
party as of the date hereof or (v) to the extent the Company determines, in its reasonable discretion and after engaging in good
faith discussions with Buyer, may be necessary or advisable in accordance with COVID-19 Measures binding upon or applicable to
the Company Entities or otherwise in response to health and safety considerations related to COVID-19, the Company will not, and
will not permit any of the other Company Entities to, intentionally take any action that, if taken after the date of the Latest
Balance Sheet, would be required to be disclosed on the Disclosure Schedules pursuant to <U>Section <B>&lrm;</B>3.6(b)</U> through
<U>Section <B>&lrm;</B>3.6(s)</U>; <I>provided, </I>that, for purposes of the foregoing, each reference to &ldquo;Key Employee&rdquo;
in <U>Section <B>&lrm;</B>3.6(i)</U> shall be deemed to be replaced by &ldquo;Service Provider&rdquo;.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Nothing
in this <U>Section <B>&lrm;</B>5.1</U> is intended to result in any of the Company Entities ceding control to Buyer of any of
the Company Entities&rsquo; basic ordinary course of business and commercial decisions prior to the Closing Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Access</U>.
During the Interim Period, the Company will grant to Buyer and its authorized Representatives reasonable access, during normal
business hours and upon reasonable notice in a manner so as not to interfere with the normal business operations of the Company
Entities, to books and records of the Company Entities that are in the possession or under the control of the Company Entities,
in each case to the extent reasonably necessary to enable Buyer to complete the transactions contemplated by this Agreement; <I>provided
</I>that (i) such access occurs in such a manner as the Company reasonably determines to be appropriate to protect the confidentiality
of the transactions contemplated by this Agreement, and (ii) nothing in this Agreement will require any Company Entity to provide
access to, or to disclose any information to, Buyer, Merger Sub or any of their respective Representatives if such access or disclosure
would (based on the Company&rsquo;s good faith determination) be reasonably likely to (A) result in the loss or waiver of any
legal privilege or breach any duty of confidentiality owed to any Person, (B) be in violation of any applicable Laws (including
Antitrust Laws) or the provisions of any Contract to which any Company Entity is a party, or (C) result in access to any material
manufacturing standard operating procedures or protocols that are maintained as trade secrets that would cause competitive harm
to the Company if the transactions contemplated by this Agreement are not consummated (<I>provided</I>, that, in each case, the
Company will, and will cause its Subsidiaries to, use reasonable best efforts to make appropriate substitute disclosure arrangements
under circumstances in which such restrictions apply (including redacting such information (w) as necessary to comply with applicable
Laws and contractual arrangements in effect on or after the date hereof, (x) as necessary to address reasonable legal privilege
and (y) as necessary to protect competitively sensitive information covered by clause (C) above). Other than as expressly provided
in the preceding sentence, Buyer and Merger Sub are not authorized to and will not (and will cause their Representatives and Affiliates
not to) contact any officer, director, employee, manager, customer, supplier, distributor, lessee, lessor, lender or other material
business relation of any of the Company Entities prior to the Closing without the prior written consent of the Company (<I>provided</I>,
that the foregoing restriction shall not prohibit any contacts or communications with (1) such Persons in the ordinary course
of business unrelated to the Company Entities or the transactions contemplated by this Agreement, <I>provided, further</I>, that
no reference to this Agreement or the transactions contemplated hereby are made, or (2) (A) the Company's Chief Executive Officer
and Chief Financial Officer and (B) following consultation by Buyer in good faith with the Company&rsquo;s Chief Executive Officer
or Chief Financial Officer, any other employees of the Company, in each case, on a reasonable basis for purposes of integration
planning). Buyer and Merger Sub will, and will cause their respective Representatives to, abide by the terms of the Confidentiality
Agreement with respect to such access and any information furnished pursuant to this <U>Section &lrm;5.2</U>. For the avoidance
of doubt, in no event will the access provided for in this <U>Section&nbsp;&lrm;5.2</U> or any other obligation of the Company
Entities hereunder include any right of Buyer or any of its Affiliates or Representatives to conduct any invasive sampling or
analysis of environmental media, including of the nature commonly referred to as a &ldquo;Phase II Environmental Investigation&rdquo;
or any soil or groundwater testing.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Termination
of Related Party Agreements</U>. Except for (a) any ordinary course agreements incident to the employment by any Company Entity
of any Company Shareholder and (b) those arrangements set forth on <U>Schedule 5.3</U>, at or prior to the Closing (with
such termination, payment, settlement or discharge effective as of Adjustment Calculation Time), the Company shall, and shall
cause the other Company Entities to, (i) pay, settle or discharge all account balances owed from any Company Entity to any Related
Party of such Company Entity (other than any intercompany balances between the Company Entities) and (ii) terminate all Contracts
between or among any Company Entity, on the one hand, and any Related Party of such Company Entity (other than intercompany agreements
between the Company Entities, as applicable), on the other hand (including any Contract set forth on <U>Schedule&nbsp;&lrm;3.19</U>),
in each case without any continuing liability or obligation of any of the Company Entities thereunder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Exclusivity</U>.
 During the Interim Period, each of the Company Entities, on behalf of themselves and each of their respective controlled Affiliates,
agrees that they (a) will not, and will use reasonable best efforts to cause their respective Representatives not to, solicit,
initiate or knowingly encourage any proposal or offer from any Person (other than Buyer and its Affiliates and Representatives)
for the acquisition of all or any material portion of the equity interests or all or any material portion of the assets of the
Company Entities and (b) will, and will use reasonable best efforts to cause their respective Representatives to, immediately
cease and cause to be terminated any existing discussions or negotiations with any Person (other than Buyer and its Affiliates
and Representatives) conducted heretofore with respect to the acquisition of all or any material portion of the equity interests
or all or any material portion of the assets of the Company Entities.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></P></U>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Press
Release and Announcements</U>. The Parties agree that, during the Interim Period, no public release or announcement related to
the transactions contemplated by this Agreement will be issued or made by or on behalf of Buyer, on the one hand, without the
prior consent of the Sellers&rsquo; Representative, or by or on behalf of any Company Entity or any of the Company Shareholders,
on the other hand, without the prior consent of Buyer, in each case not to be unreasonably withheld, delayed or conditioned, except
that each of the Parties may make announcements to the extent such Party reasonably determines in good faith that such announcement
is required by applicable Law or regulation (or by obligations pursuant to any listing agreement with any national securities
exchange or stock market, in which case the Party making such release or announcement will, to the extent practicable and permitted
under applicable Law or regulation, allow the other Parties reasonable time to comment on such release or announcement in advance
of such issuance). Notwithstanding the foregoing, with respect to any information that has been publicly disclosed or announced
in accordance with the terms of this <U>Section 5.5</U>, following such public disclosure or announcement, such information
may be included by any Party in any subsequent public disclosure or announcement. Buyer, the Sellers&rsquo; Representative and
the Company will each cooperate in good faith to prepare a press release to be issued on the Closing Date, the contents of which
will be mutually agreed upon by Buyer, the Sellers&rsquo; Representative and the Company. The Parties further acknowledge and
agree that the Company Shareholders may disclose such terms and the existence of this Agreement and the transactions contemplated
by this Agreement to their Affiliates in order that such Persons may provide information of the kind customarily provided with
respect to their investments about the subject matter of this Agreement and the transactions contemplated by this Agreement to
their respective limited partners and prospective limited partners in connection with their fundraising, marketing, informational
and reporting activities, in each case so long as such recipients are obligated to keep such information confidential.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Confidentiality</U>.
The information provided pursuant to this Agreement will be used solely for the purpose of effecting the transactions contemplated
by this Agreement and will be governed by all the terms and conditions of the Confidentiality Agreement. Each of Buyer and Merger
Sub acknowledges that all information provided to it and to any of its Affiliates or Representatives by or on behalf of the Company
or any of its Affiliates or Representatives (including pursuant to <U>Section &lrm;5.2</U>) is subject to the </FONT></P></U>




<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
</U>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">terms
of the Confidentiality Agreement, the terms of which are hereby incorporated into this Agreement by reference; <I>provided</I>
that if there is any contradiction between the terms of this Agreement and the terms of the Confidentiality Agreement, then the
terms of this Agreement will control and govern to the extent of such contradiction.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Reasonable
Best Efforts</U>. Subject to the terms of this Agreement (including the limitations set forth in Section 5.8 and this Section
&lrm;5.7), each of the Parties will use its reasonable best efforts to cause its conditions to Closing to be satisfied and the
Closing to occur as promptly as practicable and no Party will take any action designed to prevent, impede or delay the Closing;
<I>provided </I>that, notwithstanding the foregoing or anything else contained herein, the Company Entities will not be required
to (a) expend any money to remedy any breach of any representation or warranty hereunder, (b) commence any litigation or arbitration
proceeding, (c) waive or surrender any right or modify any agreement (including any Material Contract), (d) offer or grant any
accommodation or concession (financial or otherwise) to any third party, (e) make any payment to third parties, (f) obtain any
consent required for the consummation of the transactions contemplated hereby, (g) waive or forego any right, remedy or condition
hereby or (h) provide financing to Buyer or Merger Sub for the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Approvals</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyer
and the Company will each file or cause to be filed, promptly (but in any event by no later than February 18, 2021) after the
date of this Agreement, any notifications or the like required to be filed under the HSR Act and all other applicable Antitrust
Laws with respect to the transactions contemplated by this Agreement. With respect to filings under the HSR Act,</FONT> each of
the Company, <FONT STYLE="font-size: 10pt">Buyer and Merger Sub will seek early termination of the waiting period under the HSR
Act. Buyer, Merger Sub and the Company will respond to any requests for additional information made by any agencies as soon as
advisable and use reasonable best efforts to take all other actions necessary and advisable (and not omit or fail to take any
action necessary and advisable) to cause the waiting periods (and any extensions thereof) or other requirements under the HSR
Act and all other applicable Antitrust Laws to terminate or expire no later than necessary to ensure that the Closing will occur
no later than the Outside Date (assuming all other conditions to Buyer&rsquo;s and Merger Sub&rsquo;s obligation to close have
been satisfied or will be satisfied at the Closing), including (subject to the Sellers&rsquo; Representative&rsquo;s rights under
<U>Section <B>&lrm;</B>6.1</U>) resisting in good faith, at Buyer&rsquo;s cost and expense (including the institution or defense
of legal Proceedings), any assertion that the transactions contemplated by this Agreement constitute a violation of any Antitrust
Laws, all to the end of expediting consummation of the transactions contemplated by this Agreement and ensuring that the Closing
will occur no later than the Outside Date. The &ldquo;reasonable best efforts&rdquo; of Buyer will include Buyer entering into
and performing one or more agreements to hold separate and divest or license such businesses, products and assets of the Company
Entities and/or of Buyer and/or its Affiliates, and to take all such other actions as may be necessary to obtain the agreement
or consent of any Governmental Authority to the transactions contemplated by this Agreement, in each case, on such terms as may
be required by such Governmental Authority and at such time as may be necessary to ensure that the Closing will occur no later
than the Outside Date, so long as such action is conditioned upon the occurrence of the Closing. Buyer and Merger Sub shall not,
and shall not permit any of their Affiliates to, acquire or agree to acquire by merging or consolidating with, or by purchasing
a portion of the assets of or equity in, or by any other manner, any business of any Person or other business organization or
division thereof, or otherwise acquire or agree to acquire any assets or equity interests, in each case, that would reasonably
be expected to impose any material delay in the obtaining of, or materially increase the risk of not obtaining, approval from,
or avoiding an Proceeding by, any Governmental Authority under Antitrust Laws necessary to consummate the transactions contemplated
by this Agreement or the expiration or termination of any applicable waiting period. The &ldquo;reasonable best efforts&rdquo;
of the Company will include the Company, at the written request of Buyer, agreeing to take any action (at Buyer&rsquo;s expense)
as may be</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">necessary
to obtain the agreement or consent of any Governmental Authority to the transactions contemplated by this Agreement, so long as,
such action is conditioned upon the occurrence of the Closing.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Subject
to the limitations set forth in <U>Section <B>&lrm;</B>5.7</U>, during the Interim Period, Buyer and the Company will each, at
their respective cost and expense, use reasonable best efforts to make all filings and obtain all consents, approvals or authorizations
required to be obtained, if any, in order to ensure the transfer or continued effectiveness of all Environmental Permits and related
financial assurances on the Closing Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">During
the Interim Period, Buyer will at its sole cost: (i) use reasonable best efforts to determine which additional filings are required
to be made by Buyer prior to the Closing Date and which consents, approvals, permits or authorizations are required to be obtained
prior to the Closing Date from Governmental Authorities in connection with the execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby (the &ldquo;<U>Regulatory Approvals</U>&rdquo;), (ii) make all such filings
and seek all such Regulatory Approvals as promptly as practicable and (iii) use reasonable best efforts to take, or cause to be
taken, all other actions and do, or cause to be done, all other things necessary or appropriate to consummate the transactions
contemplated by this Agreement. The Company agrees to use reasonable best efforts to (and will cause the Company Entities to use
reasonable best efforts to) promptly respond to any requests for information, inquiries or undertakings or commitments sought
by the Governmental Authorities from the Company Entities in connection with the Regulatory Approvals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Without
limiting the generality of the foregoing, each of Buyer and Merger Sub, on the one hand, and the Company, on the other hand, will,
unless prohibited by applicable Law or by the applicable Governmental Authority, and to the extent reasonably practicable, (i)
not participate in or attend any meeting, or engage in any material conversation, with any Governmental Authority in respect of
the transactions contemplated by this Agreement without the other party, (ii) give the other party reasonable prior notice of
any such meeting or conversation, (iii) in the event one party is prohibited by applicable Law or by the applicable Governmental
Authority from participating in or attending any such meeting or engaging in any such conversation, keep such party apprised with
respect thereto, (iv) cooperate in the filing of any substantive memoranda, white papers, filings, correspondence or other written
communications explaining or defending this Agreement or any of the transactions contemplated by this Agreement, articulating
any regulatory or competitive argument or responding to requests or objections made by any Governmental Authority and allow the
other party a reasonable opportunity to provide comments on such filing, submission or communication prior to submission and (v)
furnish the other party with copies of all substantive filings, submissions, correspondence and communications (and memoranda
setting forth the substance thereof) between it and its affiliates and their respective Representatives, on the one hand, and
any Governmental Authority or members of any Governmental Authorities&rsquo; staff, on the other hand, with respect to this Agreement
and the transactions contemplated hereby, <I>provided however,</I> that materials may be provided on an outside-counsel only basis
as necessary to comply with contractual arrangements or applicable Laws and as necessary to address reasonable attorney-client
or other privilege or confidentiality concerns. Further, each of Buyer and the Company shall notify the other promptly upon the
receipt of: (A) any communication from any official of any Governmental Authority in connection with any filing made pursuant
to this Agreement; (B) knowledge of the commencement or threat of commencement of any Proceeding by or before any Governmental
Authority with respect to the transactions contemplated by this Agreement (and shall keep the other party informed as to the status
of any such Proceeding or threat); and (C) any request by any official of any Governmental Authority for any amendment or supplement
to any filing made pursuant to this Agreement or any information required to comply with any legal requirements applicable to
the transactions contemplated by the Agreement. Notwithstanding the foregoing or anything in this Agreement to the contrary, Buyer
shall, following consultation with the Company and after giving due and good faith consideration to its views and Buyer&rsquo;s
obligation to use its reasonable best efforts to consummate the transactions contemplated by this Agreement, (A) direct and control
all aspects of the</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Parties&rsquo;
efforts to gain regulatory clearance before any Governmental Authority with respect to the transactions contemplated hereby pursuant
to any Antitrust Law, including any timing agreements, understandings or commitments entered into with or made to any Governmental
Authority, and (B) take the lead in communicating with regulators and control the overall development of the positions to be taken
and the regulatory actions to be requested in any filing or submission with a Governmental Authority in connection with the transactions
contemplated hereby and in connection with any investigation or other inquiry or litigation by or before, or any negotiations
with, a Governmental Authority with respect thereto.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Consents</U>.
Prior to the Effective Time, at the written request of Buyer, the Company shall use its reasonable best efforts (and the Company
shall cause the other Company Entities to use their respective reasonable best efforts) to obtain any consents or waivers (including
under any Contracts) from, or provide notice to, any Person (excluding a Governmental Authority) that is necessary for the execution
and delivery of this Agreement or with respect to the transactions contemplated hereby, in each case, to the extent set forth
on Schedule &lrm;5.9; <I>provided</I> that in connection with obtaining any such third-party consent or waiver, no Company Entity
will be required to make any payment to such Person (and, without the written consent of Buyer, no Company Entity shall) agree
to make any payment to such Person, grant any accommodations or accept any amendment, conditions or obligations.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Director
and Officer Liability and Indemnification</U>. </P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Without
limiting any additional rights that any Person may have under any other agreement, from the Closing Date through the sixth anniversary
of the date on which the Closing Date occurs, Buyer will indemnify and hold harmless each present (as of immediately prior to
the Closing) and former officer, director, manager, employee, fiduciary or agent of any of the Company Entities, in each case,
acting in the capacity as a director or officer of any of the Company Entities (the &ldquo;<U>D&amp;O Indemnified Parties</U>&rdquo;)
to the same extent such persons are currently indemnified by the applicable Company Entity pursuant to such Company Entity&rsquo;s
Organizational Documents against all claims, losses, liabilities, damages, judgments, inquiries, fines and reasonable fees, costs
and expenses, including attorneys&rsquo; fees and disbursements, incurred in connection with any Proceeding arising out of or
relating to (i) the fact that the D&amp;O Indemnified Party is or was an officer or director of a Company Entity, or otherwise
acting in the capacity as a director or officer of a Company Entity, or (ii) matters existing or occurring on or prior to the
Closing Date (including this Agreement and the transactions and actions contemplated by this Agreement) related to such person&rsquo;s
conduct as an officer or director of a Company Entity, or otherwise acting in the capacity as a director or officer of a Company
Entity, whether asserted or claimed prior to, on or after the Closing Date, to the fullest extent permitted under applicable Law.
In the event of any such Proceeding, (w) each D&amp;O Indemnified Party will be entitled to advancement of reasonable expenses
incurred in the defense of any Proceeding or investigation from Buyer or the Company within ten Business Days of receipt by Buyer
from the D&amp;O Indemnified Party of a request therefor, so long as such request is accompanied by an undertaking to repay such
advances to the extent required by applicable Law, (x) neither Buyer, the Company, nor any of their respective Affiliates, will
settle, compromise or consent to the entry of any judgment in any Proceeding or threatened Proceeding (in either case in which
indemnification could be sought by such D&amp;O Indemnified Party hereunder) unless such settlement, compromise or consent (I)(A)
includes an unconditional and full release of such D&amp;O Indemnified Party from all liability arising out of such Proceeding,
(B) does not involve any finding or admission of violation of Law or admission of any wrongdoing or violation of any other Person&rsquo;s
rights and does not include a statement or admission of fault, culpability or failure to act on the part of the D&amp;O Indemnified
Party and (C) does not subject the D&amp;O Indemnified Party to any injunctive relief or other equitable remedy, or (II) or such
D&amp;O Indemnified Party otherwise consents, (y)&nbsp;the D&amp;O Indemnified Party shall not without the prior consent of Buyer
or the Surviving Company, settle, compromise or consent to the entry of any judgment in any Proceeding or threatened Proceeding
(in either case in which indemnification is being sought by such D&amp;O Indemnified</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Party
hereunder) and (z) the D&amp;O Indemnified Parties, Buyer, the Company Entities, and their respective Affiliates will cooperate
in the defense of any such matter.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">None
of the D&amp;O Indemnified Parties, Buyer, the Company, or any of their respective Affiliates, will settle, compromise or consent
to the entry of any judgment in any Proceeding or threatened Proceeding without approval of the applicable director and officer
insurance provider to the extent such indemnification obligation is covered in the &ldquo;tail&rdquo; insurance policies referred
to in <U>Section <B>&lrm;</B>5.10(d)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">From
and after the Closing through the sixth anniversary of the Closing Date, Buyer will not, and will not permit any of the Company
Entities to, amend, repeal or modify in a manner adverse to the beneficiary thereof any provision in the Surviving Company&rsquo;s
or any other Company Entities&rsquo; Organizational Documents or any indemnification or similar agreements relating to the exculpation
or indemnification of former officers, managers, directors, employees, fiduciaries or agents of the Company Entities in effect
immediately prior to the Closing, it being the intent of the Parties that the officers, managers, directors, employees, fiduciaries
and agents of the Company Entities prior to the Closing will, following the Closing, continue to be entitled to such exculpation
and indemnification to the fullest extent permitted under applicable Law. Buyer will pay all reasonable expenses, including reasonable
attorneys&rsquo; fees that may be incurred by any D&amp;O Indemnified Party in enforcing the covenants set forth in this <U>Section
<B>&lrm;</B>5.10</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">In
conjunction with the Closing, the Company (at Buyer&rsquo;s expense) will obtain, maintain and fully pay for irrevocable &ldquo;tail&rdquo;
insurance policies covering all Persons who were officers or directors of any of the Company Entities, or managers, employees,
fiduciaries or agents acting in the capacity as a director or officer of a Company Entity, in each case, at or prior to the Closing
with a claims period of at least six (6) years from the Closing Date from an insurance carrier with the same or better credit
rating as the Company Entities&rsquo; current insurance carrier with respect to directors&rsquo; and officers&rsquo; liability
insurance in an amount and scope at least as favorable as the Company Entities&rsquo; existing policies with respect to matters
existing or occurring at or prior to the Closing Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">In
the event that Buyer, any Company Entity or any of their respective successors or assigns, at any time from the Closing Date through
the six (6) year anniversary of the Closing Date, (i) consolidates with or merges into any other Person and will not be the continuing
or surviving corporation or entity in such consolidation or merger or (ii) transfers all or substantially all of its properties
or assets to any Person, then, and in either such case, Buyer will make proper provision so that the successors and assigns of
Buyer or the applicable Company Entities, as the case may be, expressly assume the obligations set forth in this <U>Section <B>&lrm;</B>5.10</U>.
Notwithstanding anything in this Agreement or elsewhere to the contrary, the provisions of this <U>Section <B>&lrm;</B>5.10</U>
will survive the consummation of the Closing indefinitely.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
obligations of Buyer and its Subsidiaries (including the Company Entities) under this <U>Section <B>&lrm;</B>5.10</U> will not
be terminated or modified in such a manner as to adversely affect any D&amp;O Indemnified Party without the prior written consent
of such affected Person. Each D&amp;O Indemnified Party is an express third party beneficiary of this <U>Section <B>&lrm;</B>5.10</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses;
Transfer Taxes</U>. Each Party will be solely responsible for payment of any fees and expenses incurred by or on behalf of it
or its Affiliates in connection with the transactions contemplated by this Agreement or otherwise required by applicable Law;
<I>provided</I>, that (i) any fees or expenses of any Company Entity incurred by or at the written direction of Buyer or any of
its Affiliates will not constitute Sellers&rsquo; Transaction Expenses and will be paid by Buyer; (ii) all filing fees incurred
in connection with obtaining the HSR Clearance or any other filing required by Antitrust Law, will be paid by Buyer; and (iii)
any fees or expenses incurred in connection with obtaining the &ldquo;tail&rdquo; insurance policies required pursuant</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">to
<U>Section 5.10</U> will be paid by Buyer. If this Agreement is terminated prior to consummation of the Closing, each Party will
pay all fees and expenses incurred by such Party in connection with this Agreement and the transactions contemplated by this Agreement
or otherwise required by applicable Law. If the Closing occurs, all gross receipts, excise, transfer, property, documentary, sales,
use, stamp, registration and other similar Taxes, and all conveyance fees, recording charges and other similar fees and charges
(including any penalties and interest) incurred in connection with the consummation of the transactions contemplated by this Agreement
(collectively, &ldquo;Transfer Taxes&rdquo;), shall be borne 50% by Buyer and 50% by the Company Shareholders (as a Sellers&rsquo;
Transaction Expense). Buyer will prepare and file, at its own expense, any Tax Returns and other documentation with respect to
all such Taxes, fees and charges, and the Parties will, and will cause their Affiliates to, join in the execution of such Tax
Returns and other documentation to the extent required by applicable Law; <I>provided</I>, <I>that</I>, Sellers&rsquo; Representative
shall have the right to review and approve (not to be unreasonably withheld, conditioned or delayed) any Tax Return in respect
of Transfer Taxes required by applicable Law to be executed by Sellers&rsquo; Representative or any of its Affiliates.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Post-Closing
Record Retention and Access</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">For
a period of six years after the Closing Date, Buyer will preserve and retain, and cause the Company Entities to preserve and retain,
and maintain in an accessible form, all corporate, accounting, Tax, legal, auditing and other books and records of the Company
Entities relating to the conduct of the business and operations of the Company Entities prior to the Closing Date in a manner
consistent with Buyer&rsquo;s ordinary course records retention practices.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">From
and after the Closing, Buyer will provide, and will cause the Company Entities to provide, the Sellers&rsquo; Representative and
its authorized Representatives with reasonable access (for the purpose of examining and copying), during normal business hours
and upon reasonable notice in a manner so as not to unreasonably interfere with the normal business operations of Buyer or the
Company Entities, to any of the books and records and other materials in the possession of the Company Entities relating to periods
prior to the Closing Date to the extent (a) reasonably required by a Company Shareholder in connection with any Tax audit or other
action by a Governmental Authority with respect to such Company Shareholder&rsquo;s ownership of Company Shares prior to the Effective
Time or (b) related to the defense of a claim made by a third party (other than Buyer or its Affiliates). Notwithstanding anything
herein to the contrary, no access, disclosure or copying pursuant to this <U>Section <B>&lrm;</B>5.12</U> shall be permitted (i)
for a purpose related to a dispute or potential dispute with Buyer and the Company Entities or any of their respective Affiliates,
or (ii) if it would result in a loss of any attorney-client privilege, violate any confidentiality agreement or any applicable
Law; <I>provided</I> that, in the case of this clause (ii), Buyer and the Company Entities and the Sellers&rsquo; Representative
shall cooperate in good faith to develop substitute arrangements, to the extent reasonably possible, that do not result in the
loss of such privilege, breach of such agreement or violation of such applicable Law.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Tax
Matters; Tax Returns</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
will, and will cause each of the Company Entities to, and the Sellers&rsquo; Representative will, cooperate fully, as and to the
extent reasonably requested by the other Party, in connection with the filing of Tax Returns with respect to Pre-Closing Tax Periods
and any Tax Matter, including, for the avoidance of doubt, any refund claims under <U>Section 5.13(f)</U>. Such cooperation will
include the retention and (upon the other Party&rsquo;s request) the provision of records and information that are reasonably
relevant to any such Tax Return or Tax Matter and making employees available on a mutually convenient basis to provide additional
information and explanation of any material provided hereunder. The Company Entities will retain all books and records with respect
to Tax matters pertinent to the Company Entities relating to any Tax periods and will abide by all record retention agreements
entered into with any Taxing Authority. Buyer and the Sellers&rsquo; Representative further agree, upon request, to use their</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">reasonable
best efforts to obtain any certificate or other document from any Taxing Authority or any other Person and to take any other action
as may be necessary to mitigate, reduce or eliminate any Tax that could be imposed on any Party or any Company Shareholder with
respect to the consummation of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Parties will, to the extent permitted or required under applicable Law, treat the Closing Date as the last day of the taxable
period of the Company Entities for all Tax purposes. For the purposes of this Agreement, in the case of any taxable period that
includes (but does not end on) the Closing Date (a &ldquo;<U>Straddle Period</U>&rdquo;), the amount of any Taxes based on or
measured by income, receipts or payroll of the Company Entities for any portion of the taxable period ending on the Closing Date
will be determined based on an interim closing of the books as of the close of business on the Closing Date, and the amount of
other Taxes of the Company Entities for a Straddle Period that relates to the portion of the taxable period ending on the Closing
Date will be deemed to be the amount of such Tax for the entire taxable period multiplied by a fraction the numerator of which
is the number of days in the taxable period ending on the Closing Date and the denominator of which is the number of days in such
Straddle Period; <I>provided</I> that exemptions, allowances or deductions that are calculated on an annual basis (including depreciation
and amortization deductions), other than with respect to property placed in service after the Closing, shall be allocated on a
per diem basis; <I>provided</I>, <I>further</I>, that for purposes of such allocation, transactions occurring or actions taken
on the Closing Date but after the Closing by Buyer or by, or with respect to, any Company Entity that are outside the ordinary
course of business and not expressly contemplated by this Agreement shall be treated as occurring after the Closing Date; provided,
further, that all Transaction Tax Deductions shall be allocated to a Pre-Closing Tax Period.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">With
respect to Tax Returns in respect of income taxes of the Company Entities for Pre-Closing Tax Periods that are to be filed after
the Closing Date and before the later of (x) the final determination of the Aggregate Closing Consideration pursuant to Section
1.12 and (y) the payment of all amounts due to Company Shareholders under Section 5.13(f): (i) other than with respect to Tax
Returns relating to Tax Refunds, Buyer shall prepare such Tax Returns (or cause such Tax Returns to be prepared) in accordance
with the past custom and practice of the Company Entities (except as otherwise required by applicable Law); (ii) such Tax Returns
shall reflect all applicable Transaction Tax Deductions in the portion of such Tax Returns ending on the Closing Date; and (iii)
if and to the extent any Tax liability reflected on such Tax Return could reasonably be expected to reduce the Aggregate Closing
Consideration or the Tax Refunds, Buyer shall provide a copy of each such Tax Return to Sellers&rsquo; Representative for its
review and comment at least fifteen (15) days prior to the deadline for filing such Tax Return (taking into account applicable
extensions), and Buyer shall reflect all reasonable comments made by the Sellers&rsquo; Representative within ten (10) days after
Buyer provides such Tax Returns.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Following the Closing and until the later of (x) the final determination of the Aggregate
Closing Consideration pursuant to Section 1.12 and (y) the payment of all amounts due to Company Shareholders under Section 5.13(f),
without the prior written consent of the Sellers&rsquo; Representative, the Buyer shall not, and shall cause the Company Entities
not to, (i) amend, refile, or otherwise modify any Tax Return in respect of income taxes of any Company Entity with respect to
any Pre-Closing Tax Period, (ii) make, change, rescind, revoke, or otherwise modify any Tax election or adopt or change any accounting
method, period, or practices, in each case that has retroactive effect to any Pre-Closing Tax Period of any Company Entity in
respect of income taxes, (iii) extend or waive the applicable statute of limitations with respect to a Tax or a Tax Return of
any Company Entity with respect to any Pre-Closing Tax Period in respect of income taxes, (iv) enter into any voluntary disclosure
agreement with any Taxing Authority with respect to Taxes or Tax Returns of any Company Entity in respect of income taxes, (v)
enter into any closing agreement or otherwise settle (in whole or in part) any Tax audit, claim, examination, action, litigation,
suit, or other proceeding with respect to any Company Entity for a Pre-Closing Tax Period in respect of income taxes, (vi) surrender
any right to claim a refund or credit of income</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Taxes
of any Company Entity, or (vii) initiate discussions or examinations with any Taxing Authority in respect of income taxes or make
any voluntary disclosures regarding income Taxes of any Company Entity with respect to any Pre-Closing Tax Period, in each case
of (i) through (vii), to the extent any such action could reasonably be expected to reduce the Aggregate Closing Consideration
or the Tax Refunds.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Parties acknowledge and agree that for U.S. federal (and applicable state and local) income Tax purposes the transfer by the Company
of any shares of common stock and warrants to acquire shares of common stock, of Northwest Biotherapeutics, Inc. to the Company
Shareholders in partial redemption of their equity interests in the Company prior to the Closing (the &ldquo;<U>Redemption Transaction</U>&rdquo;)
is intended to be integrated with the Company Shareholders&rsquo; sale of Company Shares to Buyer pursuant to this Agreement and
treated as a sale or exchange of such equity interests in the Company pursuant to <I>Zenz v. Quinlivan</I>, 213 F.2D 917 (6th
Cir. 1954). The Company shall provide Buyer with drafts of documents that will effect the Redemption Transaction at least five
Business Days before the Redemption Transaction will occur and reflect all reasonable and timely comments from Buyer with respect
to such document and the Redemption Transaction. Unless otherwise required by a &ldquo;determination&rdquo; within the meaning
of Code Section 1313(a) (or any similar provision of state or local Tax Law), no Party shall take any position (on any Tax Return
or otherwise) that is inconsistent with such intended Tax treatment for U.S. federal (or applicable state and local) income Tax
purposes.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Except
to the extent reflected as a current asset and taken into account in the final calculation of Net Working Capital or Specified
Current Taxes, the Company Shareholders shall be entitled to any refund of Taxes (including any interest paid thereon) resulting
from the IRS audit of the 2013 taxable year of the Company or any carryback of any net operating losses for a Pre-Closing Tax
Period with respect to U.S. federal income Taxes pursuant to the CARES Act (a &ldquo;<U>Tax Refund</U>&rdquo;) of the Company
or any of its Subsidiaries. Within five (5) Business Days after receipt by Buyer, the Company or any of its Subsidiaries, or any
Affiliate thereof, of any Tax Refund to which the Company Shareholders are entitled hereunder, Buyer shall deliver and pay over,
by wire transfer of immediately available funds, the amount of such Tax Refund to the Company Shareholders. Buyer, the Company
and its Subsidiaries consent and agree that the Company and its Subsidiaries will use reasonable best efforts to execute such
documents, take such additional actions and cooperate to maximize all Tax Refunds to which the Company Shareholders are entitled
hereunder, including, without limitation, by electing to carry back any net operating loss or tax credit from the Pre-Closing
Tax Period to prior taxable periods to the fullest extent permitted by law, including any net operating losses from the 2018 taxable
year, preparing and filing amended Tax Returns, preparing and filing IRS Form 4466 and any corresponding state or local Tax forms,
and by using any available short-form or accelerated procedures (e.g., by filing IRS Form 1139 and any corresponding state or
local Tax forms). Buyer and the Company or its Subsidiaries will prepare and file, or cause to be prepared and filed, as soon
as practicable following the Closing Date, any claim for a Tax Refund resulting from such actions as part of the preparation and
filing of the Pre-Closing Tax Returns. Buyer shall not, and shall cause the Company and its Subsidiaries, and any Affiliate thereof,
not to, forfeit, fail to collect, or otherwise minimize or delay any Tax Refund to which the Company Shareholders would be entitled
hereunder, whether through any election to waive any carryback of a net operating loss or otherwise.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Resignations</U>.
Except as otherwise instructed by Buyer, the Company will deliver to Buyer written resignations, effective as of the Closing Date,
of each of the officers and members of the board of directors or functional equivalent of each of the Company Entities.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Section
280G Matters</U>. The Company shall use reasonable best efforts to seek, prior to the initiation of the stockholder approval described
in this Section &lrm;5.15, from each Person to whom any payment or benefit is required or proposed to be made that could constitute
&ldquo;parachute payments&rdquo; under Section 280G(b)(2) of the Code and the Treasury Regulations promulgated thereunder (&ldquo;Section
280G Payments&rdquo;), a written agreement waiving such Person&rsquo;s right to receive some or all of such payment or </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">benefit
(the &ldquo;<U>Waived Benefits</U>&rdquo;), to the extent necessary so that all remaining payments and benefits applicable to
such Person shall not be deemed a parachute payment, and accepting in substitution for the Waived Benefits the right to receive
the Waived Benefits only if approved by the stockholders of the Company in a manner that complies with Section 280G(b)(5)(B) of
the Code and the Treasury Regulations issued thereunder. Following the waiver procedure, and at least one (1) day prior to the
Closing Date, the Company shall solicit the approval by such number of stockholders of the Company in a manner that complies with
the terms of Section&nbsp;280G(b)(5)(B) of the Code and the Treasury Regulations thereunder, of the right of each Person to receive
or retain, as applicable, such Person&rsquo;s Waived Benefits, provided that in no event shall this <U>Section &lrm;5.15</U> be
construed to require the Company to compel any Person to waive any existing rights under any Contract or agreement that such Person
has with the Company or any other Person, and in no event shall the Company be deemed in breach of this <U>Section &lrm;5.15</U>
if any such Person refuses to waive any such rights or if the equityholders fail to approve any Waived Benefits. To the extent
Buyer enters into (or enters into a legally binding promise to provide) any arrangements with any Person that could constitute
a Section 280G Payment prior to the Closing Date (the &ldquo;<U>Buyer Arrangements</U>&rdquo;), Buyer will provide to the Company
no less than five (5) days prior to the Closing Date a copy or written description of any Buyer Arrangements and the estimated
value of such Buyer Arrangements, and such Buyer Arrangements shall be included in the Waived Benefits and related approval materials
so long as such Buyer Arrangements are timely provided pursuant to this <U>Section &lrm;5.15</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investigation;
No Other Representations; Non-Reliance</U>. Buyer and Merger Sub acknowledge and agree that the Buyer Parties have independently
conducted a due diligence review and analysis of the business, operations, properties, technology, assets, liabilities, results
of operations, condition (financial or otherwise) and prospects of the Company Entities and, in connection therewith, had access
to the personnel, properties, premises and records of the Company Entities for such purpose. In entering into this Agreement,
Buyer and Merger Sub acknowledge and agree that the Buyer Parties have relied solely on the aforementioned due diligence review
and analysis and not on any factual representations or other statements, promises, projections or opinions of the Company Entities
or any Company Shareholders or any of their Representatives or any other Person, except for the specific representations and warranties
made by the Company in <U>&lrm;Article 3</U>, in each case, as qualified by the Disclosure Schedules (&ldquo;<U>Express Representations</U>&rdquo;).
Buyer and Merger Sub each acknowledge and agree that, without limiting any representations and warranties in any Related Agreement:
(i) except for the Express Representations, no Company Entity or any other Person is making and has not made any representation
and warranty, express or implied, at law or in equity, in respect of any Company Entity or any of their respective businesses,
assets, liabilities, operations, prospects or condition (financial or otherwise), including with respect to merchantability or
fitness for any particular purpose of any assets, the nature or extent of any liabilities, the prospects of the business, the
effectiveness or the success of any operations, or the accuracy or completeness of any confidential information memoranda, management
presentations, projections, documents, material or other information (financial or otherwise) regarding the Company Entities furnished
or made available to any Buyer Party in any data room, management presentation or in any other manner or form in expectation of,
or in connection with, the transactions contemplated hereby; (ii)&nbsp;except for the Express Representations, (x) no Buyer Party
is relying on, and no Buyer Party has relied on, any representations and warranties that may have been made by the Company or
any other Person and (y) the Company and each Company Shareholder disclaim any representation and warranty made by any other Person;
and (iii) no Company Entity or any other Person has any obligation or duty to make any disclosures other than those required to
be disclosed on the Disclosure Schedules in order to make the Express Representations true and correct. Without limiting the generality
of any of the foregoing, Buyer and Merger Sub each acknowledge and agree that: (A) without limiting any representations and warranties
in any Related Agreement, no Company Entity or any other Person makes any representation or warranty regarding any third party
beneficiary rights or other rights which any Buyer Party might claim under any studies, reports, tests or analyses prepared by
any third parties for the Company Entities or any of their Affiliates, even if the same were made available for review by the
Buyer Parties, and (B) none of the documents, information or other </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">materials
provided to any Buyer Party by or on behalf of the Company Entities or their Affiliates or Representatives constitutes legal advice
and Buyer and Merger Sub waive all rights to assert that it received any legal advice therefrom or that it had any sort of attorney-client
relationship with any of such Persons.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">5.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Employee
Matters</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">For
purposes of eligibility to participate, vesting and, with respect to severance and vacation benefits, determining level of benefits,
under the employee benefit plans of Buyer and its Affiliates, each employee of the Company Entities that continues to provide
services to the Company Entities following the Closing shall be credited with his or her years of service with the applicable
Company Entity and their respective predecessors before the Closing Date, to the same extent as such employee was entitled, before
the Closing Date, to credit for such service; <I>provided</I> that the foregoing shall not apply to the extent that its application
would result in a duplication of benefits.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Without
limiting the generality of Section 7.17, nothing in this Section 5.17 express or implied, (i) is intended to or shall confer upon
any Person other than the parties hereto and their respective successors and assigns, including any current or former Service
Provider, any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, (ii) shall establish or
constitute an amendment, termination or modification of, or an undertaking to establish, amend, terminate or modify, any benefit
plan, program, agreement or arrangement, (iii) shall alter or limit the ability of Buyer or any of its Subsidiaries (or, following
the Effective Time, the surviving corporation or any of its Subsidiaries) to amend, modify or terminate any benefit plan, program,
agreement or arrangement at any time assumed, established, sponsored or maintained by any of them or (iv) shall create any obligation
on the part of Buyer or its Subsidiaries (or, following the Effective Time, the surviving corporation or its Subsidiaries) to
employ or engage any Service Provider for any period following the Effective Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
6 </FONT><FONT STYLE="font-size: 10pt"><U><BR>
<BR>
TERMINATION</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Termination</U>.
Notwithstanding anything in this Agreement to the contrary, this Agreement may be terminated and the transactions contemplated
by this Agreement abandoned at any time prior to the Closing only as follows:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
the mutual written consent of Buyer and the Sellers&rsquo; Representative;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
Buyer providing written notice to the Sellers&rsquo; Representative and the Company, if there has been a violation or breach of
any covenant or agreement by, or inaccuracy of any representation or warranty of, the Company contained in this Agreement that
has prevented or would prevent the satisfaction of any condition set forth in <U>Section <B>&lrm;</B>2.3(a)</U> or <U>Section
<B>&lrm;</B>2.3(b)</U> (and such violation, breach or inaccuracy has not been waived by Buyer) and such violation, breach or inaccuracy
is not capable of being cured or, if capable of being cured, has continued without cure by the Company until the earlier of (i)
the Outside Date and (ii) 30 days after written notice thereof from Buyer; <I>provided</I> that the right to terminate this Agreement
pursuant to this <U>Section <B>&lrm;</B>6.1<B>&lrm;</B>(b)</U> will not be available to Buyer in the event that there has been
a violation or breach of any covenant or agreement by, or inaccuracy of any representation or warranty of, Buyer or Merger Sub
contained in this Agreement that has prevented or would prevent satisfaction of any condition set forth in <U>Section <B>&lrm;</B>2.2(a)</U>&nbsp;or <U>Section <B>&lrm;</B>2.2(b)</U> (and such violation, breach or in accuracy has not been waived by the Sellers&rsquo; Representative);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
the Sellers&rsquo; Representative providing written notice to Buyer, if there has been a violation or breach of any covenant or
agreement by, or inaccuracy of any representation or warranty of,</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Buyer
or Merger Sub contained in this Agreement that has prevented or would prevent the satisfaction of any condition set forth in <U>Section
<B>&lrm;</B>2.2(a)</U> or <U>Section <B>&lrm;</B>2.2(b)</U> (and such violation or breach has not been waived by the Sellers&rsquo;
Representative (on behalf of the Company)) and such violation, breach or inaccuracy is not capable of being cured or, if capable
of being cured, has continued without cure by the Buyer until the earlier of (i) the Outside Date and (ii) 30 days after written
notice thereof from the Sellers&rsquo; Representative; <I>provided </I>that the right to terminate this Agreement pursuant to
this <U>Section&nbsp;<B>&lrm;</B>6.1<B>&lrm;</B>(c)</U> will not be available to the Sellers&rsquo; Representative in the event
that there has been a material violation or material breach of any covenant or agreement by, or inaccuracy of any representation
or warranty of, the Company contained in this Agreement that has prevented or would prevent satisfaction of any condition set
forth in <U>Section <B>&lrm;</B>2.3(a)</U> or <U>Section <B>&lrm;</B>2.3(b)</U> (and such violation, breach or inaccuracy has
not been waived by Buyer);</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
(i) the Sellers&rsquo; Representative providing written notice to Buyer or (ii) Buyer providing written notice to the
Sellers&rsquo; Representative and the Company, in each case, if the transactions contemplated by this Agreement have not been
consummated on or prior to May 17, 2021 (as such date may be extended pursuant to the following proviso, the
&ldquo;<U>Outside Date</U>&rdquo;); <I>provided</I>, that, if on such date, one or more of the conditions to the Closing set
forth in (A) <U>Section <B>&lrm;</B>2.1(a) </U>and (B) <U>Section <B>&lrm;</B>2.1(b)</U> (if, in the case of clause (B), the
applicable Law relates to any of the matters referenced in <U>Section <B>&lrm;</B>2.1(a)</U>) shall not have been satisfied,
but all other conditions to the Closing shall have been satisfied (or in the case of conditions that by their terms are to be
satisfied at the Closing, shall be capable of being satisfied on such date) or waived, then the Outside Date shall be
extended to and including August 17, 2021, if either the Sellers&rsquo; Representative or Buyer notifies the other in writing
on or prior to May 17, 2021, of its election to extend the Outside Date to such date; <I>provided</I>, further, that (i) Buyer
will not be entitled to terminate this Agreement pursuant to this <U>Section <B>&lrm;</B>6.1(d)</U> if Buyer&rsquo;s or
Merger Sub&rsquo;s breach of this Agreement has substantially contributed to the prevention of the consummation of the
transactions contemplated by this Agreement at or prior to such time and (ii) the Sellers&rsquo; Representative will not be
entitled to terminate this Agreement pursuant to this <U>Section <B>&lrm;</B>6.1(d)</U>&nbsp;if the Company&rsquo;s breach of this
Agreement has substantially contributed to the prevention of the consummation of the transactions contemplated by this
Agreement at or prior to such time;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
the Sellers&rsquo; Representative providing written notice to Buyer or Buyer providing written notice to the Sellers&rsquo; Representative
and the Company if there is any final, non-appealable Law enacted following the date hereof or order issued by a court or Governmental
Authority of competent jurisdiction enjoining, restraining, preventing or prohibiting consummation of the Closing or making the
consummation of the Closing illegal; <I>provided</I>, that the right to terminate this Agreement under pursuant to this <U>Section
<B>&lrm;</B>6.1(e)</U> shall not be available to a Party if the issuance of such final, non-appealable order was primarily due
to the failure of such Party to perform any of its obligations under this Agreement or if such Party shall have failed to comply
with its obligations under <U>Section <B>&lrm;</B>5.7</U>;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
Buyer providing written notice to the Sellers&rsquo; Representative and the Company, if the Company fails to deliver to Buyer,
by 11:59 p.m. Eastern Time on February 22, 2021, a copy of the duly executed and delivered Company Shareholder Approval.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Effect
of Termination</U>.&nbsp;In the event of any termination of this Agreement by Buyer or the Sellers&rsquo; Representative as provided
in <U>Section &lrm;6.1</U>, (i) this Agreement will thereafter become void and of no further force or effect (except that this
<U>Section &lrm;6.2</U>, <U>Section &lrm;5.5</U>, <U>Section &lrm;5.6</U>, <U>Section &lrm;5.11</U> and &lrm;<U>Article 7</U>
(except for <U>Section &lrm;7.18</U>) will survive the termination of this Agreement and will be enforceable by the Parties) and
(ii) there will be no liability or obligation on the part of Buyer, Merger Sub, the Company or the Sellers&rsquo; Representative
to any other Party with respect to this Agreement; <I>provided</I> that, notwithstanding this <U>Section &lrm;6.2</U>, (1) liability
may exist for breach of, or otherwise with respect to, the provisions of this Agreement specified in the parenthetical contained
in <U>clause (i)</U> of this <U>Section &lrm;6.2</U> and (2) no Party will be relieved from liability for any willful and intentional
breach of any covenant of this Agreement by such</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Party
arising prior to such termination; <I>provided</I>, <I>further</I>, that if (A) Buyer or Merger Sub do not cause the Closing
to occur in circumstances in which all of the conditions set forth in <U>Section &lrm;2.1</U> and <U>Section &lrm;2.3</U>
have been satisfied or waived or (B) the Company does not cause the Closing to occur in circumstances in which all of the
conditions set forth in <U>Section &lrm;2.1</U> and <U>Section 2.2</U> have been satisfied or waived, such failure shall
be deemed to be a willful and intentional breach of this Agreement by Buyer and Merger Sub or the Company, as applicable.
Nothing in this <U>Section 6.2</U> will be deemed to impair the right of any Party to compel specific performance by another
Party of its obligations under this Agreement. In the event of the termination of this Agreement, the Confidentiality
Agreement will survive the termination of this Agreement for a period of two years following the date of such termination
(and, notwithstanding anything contained in this Agreement or the Confidentiality Agreement to the contrary, the
Confidentiality Agreement&rsquo;s term will automatically be amended to be extended for such additional two year
period).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
7</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000"></FONT><FONT STYLE="font-size: 10pt"><U><BR>
MISCELLANEOUS</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Survival of Representations and Warranties and Certain Covenants</U>.

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary contained herein, none of the representations, warranties, covenants or agreements of the Parties in
this Agreement or in any instrument delivered by the Parties pursuant to this Agreement shall survive the Closing, such that no
claim for breach of any such representation, warranty, covenant or agreement may be brought after the Closing with respect thereto
against any of the Company Entities, or any of the Seller Parties, and, absent Fraud, there will be no liability of the Company
Entities or any of the Seller Parties in respect thereof, whether such liability has accrued prior to or after the Closing, on
the part of such Person; <I>provided</I> that this <U>Section <B>&lrm;</B>7.1(a)</U> shall not limit any covenant or agreement
of the Parties which by its terms contemplates performance after the Closing (including, for the avoidance of doubt, <U>Section
<B>&lrm;</B>1.12</U>) until such time that such covenant or agreement is fully performed or no longer operative. Notwithstanding
anything in this Agreement, for the avoidance of doubt, nothing in this <U>Section <B>&lrm;</B>7.1</U> shall relieve any Person
from any liability for Fraud committed by such Person.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
of Buyer and Merger Sub, for themselves and on behalf of the other Buyer Parties, acknowledges and agrees that, from and after
the Closing, except for any rights or obligations under this Agreement or the Related Agreements or any other covenants or agreements
which by their terms contemplate performance after the Closing (including in connection with disputes under <U>Section <B>&lrm;</B>1.12(d)</U>,
which disputes will be resolved in accordance with the dispute mechanics set forth in such section), to the fullest extent permitted
under applicable Law, any and all rights, claims and causes of action it may have against any of the Seller Parties relating to
the operation of the Surviving Company or any of its businesses or relating to the subject matter of this Agreement or any Related
Agreement, or as a result of any of the transactions contemplated hereby or thereby, whether arising under, or based upon, any
federal, state, local or foreign Law or otherwise (including any right, whether arising at law or in equity, to seek indemnification,
contribution, cost recovery, damages or any other recourse or remedy, including as may arise under common law) are hereby irrevocably
waived, except for Fraud.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Parties hereby acknowledge and agree that any claim, demand or cause of action (whether in contract or in tort, at law or in equity,
granted by statute or predicated on any other cognizable theory) that arises under or by reason of, or is based on, in connection
with or otherwise relates to, this Agreement or the transactions contemplated hereby (including the sale process and the negotiation,
execution and performance of this Agreement) may be made or brought against only a Party, and no Person who is not a Party, including
any past, present or future member, partner, equityholder, Affiliate or Representative of, or any financial advisor or lender
to, any Party, or any past, present or future member,</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">partner,
equityholder, Affiliate or Representative of, or any financial advisor or lender to, any of the foregoing, shall have any liability
or obligation in respect of any such claim, demand or cause of action.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Parties hereby: (i) acknowledge and agree that the limitations on liability set forth herein were expressly bargained for and
are a material inducement for the Parties to enter into this Agreement and consummate the transactions contemplated hereby; (ii)
knowingly, voluntarily and irrevocably waive any rights and remedies to which they would otherwise be entitled absent such limitations;
and (iii) covenant not to make or bring any claim, demand or cause of action not permitted by this <U>Section 7.1</U>, in all
cases, whether in contract or in tort, at law or in equity, granted by statute or predicated on any other cognizable theory (including
with respect to any matters arising under the Comprehensive Environmental Response, Compensation, and Liability Act or any other
Environmental Laws). The Parties intend that this <U>Article VII</U> alter all applicable statutes of limitation.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Sellers&rsquo;
Representative</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Effective
as of the date hereof, Mercury Fund 2 Holdco LLC hereby is constituted and appointed as the Sellers&rsquo; Representative. For
purposes of this Agreement, the term &ldquo;<U>Sellers&rsquo; Representative</U>&rdquo; will mean the representative, true and
lawful agent, proxy and attorney in fact of the Company Shareholders for all purposes of this Agreement, the Escrow Agreement,
the Paying Agent Agreement and any other Related Agreement, with full power and authority on such Person&rsquo;s behalf. The Sellers&rsquo;
Representative will have such powers and authority as are necessary or appropriate to carry out the functions assigned to it under
this Agreement and any Related Agreement, including to: (i)&nbsp;consummate the transactions contemplated by this Agreement, (ii)&nbsp;pay
such Person&rsquo;s expenses (whether incurred on or after the date hereof) incurred in connection with the negotiation and performance
of this Agreement, (iii)&nbsp;receive, give receipt and disburse any funds received hereunder or under the Paying Agent Agreement
or under the Escrow Agreement on behalf of such Person and to holdback from disbursement any such funds to the extent it reasonably
determines may be necessary in accordance with the terms hereof, (iv) execute and deliver on behalf of such Person any Letter
of Transmittal and such further instruments as Buyer reasonably requests, (v)&nbsp;execute and deliver on behalf of such Person
all documents contemplated by this Agreement and any amendment or waiver hereto or thereto or to the Paying Agent Agreement, Escrow
Agreement or any other Related Agreement (which will be binding on all Seller Parties except as expressly set forth herein or
therein), (vi)&nbsp;take all other actions to be taken by or on behalf of such Person in connection herewith, (vii)&nbsp;negotiate,
settle, compromise and otherwise handle all disputes under this Agreement, including entering into agreements to effect the foregoing
(which will be binding on all Seller Parties) (it being understood action by the Sellers&rsquo; Representative will be the sole
and exclusive means of asserting or addressing any claims on behalf of Seller Parties, and no Seller Party will have any right
to act on its own behalf with respect to any such matters, other than any claim or dispute against the Sellers&rsquo; Representative),
(viii)&nbsp;give and receive notices on behalf of such Person, (ix) do each and every act and exercise any and all rights such
Person is, or the Company Shareholders collectively are, permitted or required to do or exercise under this Agreement and (x)&nbsp;authorize
the release of funds to the Buyer Parties under this Agreement, the Escrow Agreement and each other Related Agreement and to take
all other actions or refrain from taking all other actions that may be taken by the Sellers&rsquo; Representative under the terms
of this Agreement, the Escrow Agreement, the Paying Agent Agreement or any other Related Agreement. The Company Shareholders,
by approving the principal terms of the Merger and/or accepting the consideration payable to them hereunder, irrevocably grant
unto the Sellers&rsquo; Representative full power and authority to do and perform each and every act and thing necessary or desirable
to be done in connection with the transactions contemplated by this Agreement, as fully to all intents and purposes as the Company
Shareholders might or could do; <I>provided</I>, <I>however</I>, that the Sellers&rsquo; Representative will have no obligation
to act on behalf of the Company Shareholders. Each of the Company Shareholders agrees that such agency is coupled with an interest,
is therefor irrevocable without the consent of the Sellers&rsquo; Representative and will survive the death, incapacity or bankruptcy
of any such Company Shareholder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">All
decisions, actions, consents and instructions of the Sellers&rsquo; Representative will be final and binding on the Company Shareholders
and each such Company Shareholder will not have any right to object, dissent, protest or otherwise contest the same, except in
the case of fraud or bad faith by the Sellers&rsquo; Representative. All actions, notices, communications and determinations by
the Sellers&rsquo; Representative to carry out such functions will conclusively be deemed to have been authorized by, and will
be binding upon, the Company Shareholders. Neither the Sellers&rsquo; Representative nor any agent employed by the Sellers&rsquo;
Representative will incur any liability to the Company Shareholders relating to the performance of its duties hereunder except
for actions or omissions by the Sellers&rsquo; Representative or such agent constituting fraud or bad faith, and the Sellers&rsquo;
Representative will be entitled to full indemnification against any Loss arising out of actions taken or omitted to be taken in
its capacity as Sellers&rsquo; Representative (except for those arising out of the Sellers&rsquo; Representative&rsquo;s fraud
or bad faith), including the costs and expenses of investigation, defense, settlement or adjudication of claims, from the Company
Shareholders (including from funds paid to the Sellers&rsquo; Representative under this Agreement and/or otherwise received by
it in its capacity as Sellers&rsquo; Representative, or funds to be distributed to the Company Shareholders under this Agreement
at its direction, pursuant to or in connection with this Agreement (including under the Escrow Agreement, the Paying Agent Agreement
or any other Related Agreement)). The Sellers&rsquo; Representative will be entitled to engage such Representatives as it deems
necessary in connection with exercising its powers and performing its functions hereunder and (in the absence of fraud or bad
faith on the part of the Sellers&rsquo; Representative) will be entitled to conclusively rely on the opinions and advice of such
Persons in all matters. The Sellers&rsquo; Representative will not have by reason of this Agreement a fiduciary relationship in
respect of any Company Shareholder, except in respect of amounts actually received on behalf of any such Company Shareholder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company Shareholders will cooperate with the Sellers&rsquo; Representative and any accountants, attorneys or other agents whom
the Sellers&rsquo; Representative may retain to assist in carrying out the Sellers&rsquo; Representative&rsquo;s duties hereunder.
The Company Shareholders will reimburse the Sellers&rsquo; Representative for all costs and expenses (including professional and
attorneys&rsquo; fees) incurred, and indemnify the Sellers&rsquo; Representative for all Losses sustained, by the Sellers&rsquo;
Representative in carrying out its duties hereunder individually and ratably on a pro rata basis based on their fully-diluted
ownership percentages pursuant to this Agreement, and not jointly and severally.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Sellers&rsquo; Representative may resign at any time. In the event the Sellers&rsquo; Representative has resigned, been removed
or becomes unable to perform the Sellers&rsquo; Representative&rsquo;s responsibilities under this Agreement, a new Sellers&rsquo;
Representative may only be appointed by the Sellers&rsquo; Representative, such appointment to become effective upon the written
acceptance thereof by the new Sellers&rsquo; Representative and, upon such written acceptance, in its capacity as the substitute
Sellers&rsquo; Representative, the substitute Sellers&rsquo; Representative will (i) be deemed to be the Sellers&rsquo; Representative
for all purposes of this Agreement and (ii) exercise the rights and powers of, and be entitled to the indemnity, reimbursement
and other benefits of, the Sellers&rsquo; Representative hereunder. Written notice of any such resignation or appointment of the
Sellers&rsquo; Representative will be delivered by the Sellers&rsquo; Representative to Buyer promptly after such action is taken.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">At
the Effective Time, Buyer will deliver cash to or as directed by the Sellers&rsquo; Representative in an amount equal to $500,000
(the &ldquo;<U>Sellers&rsquo; Representative Expense Fund</U>&rdquo;) to be held in trust to cover and reimburse the fees and
expenses (including fees and expenses of its Representatives and experts) incurred by the Sellers&rsquo; Representative (for itself
and for its Representatives) in its capacity as such (or any of its Representatives in connection therewith) for its obligations
in connection with this Agreement and the transactions contemplated by this Agreement. The Sellers&rsquo; Representative will
disburse in accordance with the Distribution Schedule to the Company Shareholders and to the Surviving Company (for further distribution
to former holders of Company Options in accordance with the Distribution Schedule) the remaining balance of the Sellers&rsquo;
Representative Expense Fund as and when determined by</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">the
Sellers&rsquo; Representative in its sole discretion. In furtherance of the foregoing, notwithstanding anything in this Agreement
to the contrary, the Sellers&rsquo; Representative will have the power and authority to set aside and retain additional funds
paid to or received by it, or direct payment of additional funds to be paid to the Company Shareholders or Company Optionholders
pursuant to this Agreement at Closing or thereafter (including to establish such reserves as the Sellers&rsquo; Representative
determines in good faith to be appropriate for the Sellers&rsquo; Representative expenses that are not known or determinable).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer,
the Buyer Parties and their respective Affiliates, the Paying Agent and the Escrow Agent will be entitled to rely on, and will
be fully protected in relying on, the authority of the Sellers&rsquo; Representative as set forth in this <U>Section&nbsp;<B>&lrm;</B>7.2</U>&nbsp;and
will not be obliged to make any inquiries into the authority of the Sellers&rsquo; Representative. Buyer, the Buyer Parties and
their respective Affiliates, the Paying Agent and the Escrow Agent will have no liability whatsoever to any Seller Party or any
other constituencies for any acts or omissions of the Sellers&rsquo; Representative, or any acts or omissions taken or not taken
by Buyer or any other Person at the direction of the Sellers&rsquo; Representative. The relationship created herein is not to
be construed as a joint venture or any form of partnership between or among the Sellers&rsquo; Representative and any Company
Shareholder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; color: #010000">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">It
is acknowledged by each of the Parties that the Company Entities and the Sellers&rsquo; Representative (and their respective Affiliates)
have retained Kirkland &amp; Ellis LLP (&ldquo;<U>Sellers&rsquo; Counsel</U>&rdquo;) to act as their counsel in connection with
the transactions contemplated by this Agreement and the Related Agreements and that Sellers&rsquo; Counsel has not acted as counsel
for any other Person in connection with the transactions contemplated by this Agreement and that no other Party or Person has
the status of a client of Sellers&rsquo; Counsel for conflict of interest or any other purposes as a result thereof. The Parties
hereby agree that, in the event that a dispute arises between Buyer, any Company Entity or any of their respective Affiliates,
on the one hand, and the Sellers&rsquo; Representative or any of its Affiliates or any Company Shareholder, on the other hand,
Sellers&rsquo; Counsel may represent the Sellers&rsquo; Representative or any of its Affiliates or any Company Shareholder in
such dispute even though the interests of the Sellers&rsquo; Representative or any of its Affiliates may be directly adverse to
Buyer, any Company Entity or any of their respective Affiliates and even though Sellers&rsquo; Counsel may have represented any
Company Entity in a matter substantially related to such dispute, and each of Buyer and the Surviving Company hereby waive on
behalf of itself and their respective Affiliates (including the Company Entities) any conflict of interest in connection with
such representation by Sellers&rsquo; Counsel. Each of Buyer and the Company further agrees that, as to all communications among
Sellers&rsquo; Counsel, any Company Entity and any Company Shareholder prior to or at the Closing that relate in any way to the
negotiation, preparation, execution and delivery of this Agreement or any Related Agreement and the consummation of the transactions
contemplated hereby and thereby, the attorney-client privilege, the expectation of client confidence and all other rights to any
evidentiary privilege shall pass and belong to the Sellers&rsquo; Representative and its Affiliates, as applicable, will be exclusively
controlled by the Sellers&rsquo; Representative and its Affiliates and will not pass to or be claimed or accessed by Buyer, any
Company Entity or any of their respective Affiliates. In furtherance of the foregoing, the ownership and control of all files
relating to the representation of the Company Entities and Company Shareholders by Sellers&rsquo; Counsel relating in any way
to the negotiation, preparation, execution and delivery of this Agreement and the Related Agreements and the consummation of the
transactions contemplated hereby and thereby prior to the Closing shall transfer to the Sellers&rsquo; Representative and its
Affiliates and none of Buyer or the Company Entities shall have any rights in respect of or access to such files without the prior
written consent of the Sellers&rsquo; Representative. Notwithstanding the foregoing, in the event that a dispute arises between
Buyer or any Company Entity, on the one hand, and a Person other than a party to this Agreement, on the other hand, after the
Closing, Buyer or the applicable Company Entity may assert the attorney-client privilege to prevent disclosure to such third party
of confidential communications by Sellers&rsquo; Counsel. Upon request of the Sellers&rsquo; Representative, Buyer and the Company
Entities will promptly deliver to the Sellers&rsquo; Representative (or, in the case of electronic records, permanently delete)
all records and communications that include any of the foregoing materials</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">and
neither Buyer nor any of the Company Entities will retain any copies of such records or communications or have any access to them.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Amendment
and Waiver</U>.&nbsp;This Agreement may not be amended, altered, modified or waived except by a written instrument executed by
Buyer, the Company and, following the Closing, the Sellers&rsquo; Representative, subject to Section &lrm;2.4 with respect to
the waiver of conditions to Closing as of the Closing. No course of dealing between or among any Persons having any interest in
this Agreement will be deemed effective to modify, amend or discharge any part of this Agreement or any rights or obligations
of any Person under or by reason of this Agreement. No waiver of any of the provisions of this Agreement will be deemed or will
constitute a waiver of any other provisions, whether or not similar, nor will any waiver constitute a continuing waiver. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>.&nbsp;All
notices, requests, demands and other communications required or permitted hereunder will be in writing and will be deemed to have
been duly given only (a) one Business Day after being delivered by hand, (b) five Business Days after being mailed certified return
receipt requested with postage paid, (c) one Business Day after being couriered by overnight receipted courier service, (d) on
the date of transmission via e-mail or (e) on the date of rejection or refusal of any attempted delivery by one of the preceding
methods to each Party at its address set forth below (or such other address as it may from time to time designate in writing to
the other Parties):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt"><U>If
to any Company Shareholder, or, prior to the Closing, the Company, then to</U>:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt">Cognate BioServices, Inc.</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">4600 East Shelby Drive</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Memphis, TN 38118</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="width: 72%"><FONT STYLE="font-size: 10pt">J. Kelly Ganjei</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Email: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">kganjei@cognatebioservices.com </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">legal@cognatebioservices.com </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt"><U>with copies to (which will not constitute notice)</U>:</TD>
    <TD STYLE="width: 52%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 29%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 51%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt">Kirkland&nbsp;&amp; Ellis LLP</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">300 North LaSalle</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chicago, Illinois 60654</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="width: 72%"><FONT STYLE="font-size: 10pt">Jeremy S. Liss, P.C.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Adam M. Wexner, P.C.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">jliss@kirkland.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">adam.wexner@kirkland.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt"><U>Notices to the Sellers&rsquo; Representative</U>:</FONT></TD>
    <TD STYLE="width: 52%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 1in"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 1in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt">Mercury Fund 2 Holdco LLC</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">c/o EW Healthcare Partners Fund 2, L.P.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">21 Waterway Avenue, Suite 225</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The Woodlands, TX 77380</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Attention: </FONT></TD>
    <TD STYLE="width: 72%"><FONT STYLE="font-size: 10pt">Evis Hurserver</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Richard Kolodziejcyk</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Email: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">evis@ewhealthcare.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">rkolodziejcyk@ewhealthcare.com</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt"><U>with copies to (which will not constitute notice)</U>:</U></FONT></TD>
    <TD STYLE="width: 52%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirkland&nbsp;&amp; Ellis
    LLP</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300 North LaSalle</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chicago, Illinois 60654</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="width: 72%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeremy S. Liss, P.C.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam M. Wexner, P.C.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jliss@kirkland.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adam.wexner@kirkland.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 54%"><FONT STYLE="font-size: 10pt"><U>If to Buyer or Merger Sub, or, after the Closing, to the Company,
    then to</U>:</FONT></TD>
    <TD STYLE="width: 26%">&nbsp;</TD></TR>
</TABLE></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt">c/o Charles River Laboratories International, Inc.</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 22%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">251 Ballardvale Street</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Wilmington, Massachusetts 01887</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Attention: </FONT></TD>
    <TD STYLE="width: 72%"><FONT STYLE="font-size: 10pt">Matthew Daniel, Corporate Senior Vice President, </FONT></TD>
    <TD STYLE="width: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 22%"><FONT STYLE="font-size: 10pt"></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>General Counsel</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Email: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">matthew.daniel@crl.com</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 1in"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 54%"><FONT STYLE="font-size: 10pt"><U>with copies (which will
not constitute notice) to</U>:</U></FONT></TD>
    <TD STYLE="width: 26%">&nbsp;</TD></TR>
</TABLE></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 1in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 10pt">Davis Polk &amp; Wardwell LLP</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">450 Lexington Avenue</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">New York, New York 10017</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Attention: </FONT></TD>
    <TD STYLE="width: 72%"><FONT STYLE="font-size: 10pt">Michael Davis</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">michael.davis@davispolk.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Assignment</U>.&nbsp;This
Agreement and all of the provisions hereof will be binding on and inure to the benefit of each of the Parties and their respective
heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, benefits or obligations set forth in this
Agreement may be assigned (including by operation of law) by any of the Parties without the prior written consent of Buyer, the
Company and the Sellers&rsquo; Representative and any attempted assignment without such prior written consent will be void, except
that, Buyer may assign its rights and obligations under this Agreement, in whole or from time to time in part, to (i) one or more
of its Affiliates or (ii) to any acquirer of all or substantially all of the consolidated assets of Buyer; <I>provided</I> that
such transfer or assignment shall not relieve Buyer of its obligations hereunder or enlarge, alter or change any obligation of
any other party hereto or due to Buyer.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>.&nbsp;Whenever
possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable Law,
but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law in any jurisdiction, such provision
will be ineffective only to the extent of such prohibition or invalidity and only in such jurisdiction, without invalidating the
remainder of such provision or the remaining provisions of this Agreement in such jurisdiction or any provision of this Agreement
in any other jurisdiction.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Strict Construction</U>.&nbsp;Notwithstanding the fact that this Agreement has been drafted or prepared by one of the Parties, each
of the Parties confirms that they and their respective counsel have reviewed, negotiated and adopted this Agreement as the joint
agreement and understanding of the Parties and the language used in this Agreement will be deemed to be the language chosen by
the Parties to express their mutual intent, and no rule of strict construction will be applied against any Person. In the event
an ambiguity or question of intent or interpretation arises with respect to this Agreement, the terms and provisions of the execution
version of this Agreement will control and prior drafts of this Agreement will </FONT></P></U>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">not
be considered or analyzed for any purpose (including in support of parol evidence proffered by any Person in connection with this
Agreement).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Captions</U>.
 The headings and captions used in this Agreement, the table of contents to this Agreement and descriptions of the Disclosure
Schedules are for convenience of reference only and do not constitute a part of this Agreement and will not be deemed to limit,
characterize or in any way affect any provision of this Agreement, and all provisions of this Agreement will be enforced and construed
as if they had not been used in this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Complete
Agreement</U>.&nbsp;This Agreement, together with the schedules (including the Disclosure Schedules) and exhibits referred to
herein, the Confidentiality Agreement, the Escrow Agreement, the Paying Agent Agreement and any other agreements and exhibits
referred to herein or therein, whether executed and delivered on or after the date hereof, contain the complete agreement among
the Parties and supersede any prior understandings, agreements or representations by or between such Parties, whether written
or oral, or any prior course of dealing among them, which may have related to the subject matter hereof in any way.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Interpretation</U>.&nbsp;Whenever
the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement they will be deemed
to be followed by the words &ldquo;without limitation.&rdquo; The phrase &ldquo;to the extent&rdquo; means &ldquo;the degree by
which&rdquo; and not &ldquo;if&rdquo; for all purposes of this Agreement. Words denoting any gender will include all genders (including
the neutral gender). Where a word is defined in this Agreement, references to the singular will include references to the plural
and vice versa. Where specific language is used to clarify by example a general statement contained in this Agreement, such specific
language will not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates.
A reference to any party to this Agreement or any other agreement or document will include such party&rsquo;s successors and permitted
assigns. All references to &ldquo;$&rdquo; and dollars will be deemed to refer to United States currency unless otherwise specifically
provided. All references to a day or days will be deemed to refer to a calendar day or calendar days, as applicable, unless otherwise
specifically provided and whenever action is required on a day that is not a Business Day such action may be validly taken on
the next Business Day. Any reference to any agreement or Contract in this Agreement will be a reference to such agreement or Contract
as amended, restated, modified, supplemented and/or waived; <I>provided</I>, that with respect to any Contract listed on the Disclosure
Schedules, all such material amendments, modifications or supplements must also be listed in the appropriate schedule. All references
to an Article, Section, Schedule or Exhibit will be deemed to refer to such Article, Section, Schedule or Exhibit of this Agreement,
unless otherwise specified. The terms &ldquo;hereby,&rdquo; &ldquo;hereof,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereinafter,&rdquo;
&ldquo;hereunder&rdquo; and derivative words refer to this entire Agreement, unless the context otherwise requires. The words
&ldquo;either,&rdquo; &ldquo;or,&rdquo; &ldquo;neither,&rdquo; &ldquo;nor&rdquo; and &ldquo;any&rdquo; are not exclusive. The
phrases &ldquo;to the Knowledge of the Company,&rdquo; &ldquo;to the Knowledge of the Company Entities,&rdquo; &ldquo;to the Company&rsquo;s
Knowledge,&rdquo; &ldquo;to the Company Entities&rsquo; Knowledge,&rdquo; &ldquo;known to the Company&rdquo; and &ldquo;known
to the Company Entities&rdquo; (and equivalent phrases with respect to any other Party) and phrases of similar import or effect
are used in this Agreement to qualify and limit the scope of any representation or warranty in which they appear and are not affirmations
of any Person&rsquo;s &ldquo;superior knowledge&rdquo; that the representation or warranty in which they are used is true. The
words &ldquo;shall&rdquo; and &ldquo;will&rdquo; denote a directive and obligation, and not an option. The contents of the Disclosure
Schedules and each of the Exhibits form an integral part of this Agreement and any reference to &ldquo;this Agreement&rdquo; will
be deemed to include the Disclosure Schedules and each such Exhibit. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Disclosure
Schedules</U>.&nbsp;Notwithstanding the fact that the Disclosure Schedules are arranged by sections corresponding to the sections
in this Agreement or that a particular section of this Agreement makes reference to a specific section of the Disclosure Schedules
and notwithstanding that a particular representation and warranty may not make a reference to the Disclosure Schedules, any reference
in a particular section of the Disclosure Schedules shall be deemed to be an exception to (or, as applicable, a </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">disclosure
for purposes of) any other representations and warranties that are contained in this Agreement, but only if the relevance of that
reference as an exception to (or a disclosure for purposes of) such representations and warranties is reasonably apparent on the
face of such disclosure. The inclusion of information in the Disclosure Schedules will not be construed as, and will not constitute,
an admission or agreement that a violation, right of termination, default, liability or other obligation of any kind exists with
respect to any item, nor will it be construed as or constitute an admission or agreement that such information is material to
any of the Company Entities. In addition, matters reflected in the Disclosure Schedules are not necessarily limited to matters
required by this Agreement to be reflected in the Disclosure Schedules. Such additional matters are set forth for informational
purposes only. Neither the specification of any dollar amount in any representation, warranty or covenant contained in this Agreement
nor the inclusion of any specific item in the Disclosure Schedules is intended to imply that such amount, or higher or lower amounts,
or the item so included or other items, are or are not material, and no Person will use the fact of the setting forth of any such
amount or the inclusion of any such item in any dispute or controversy between the Parties as to whether any obligation, item
or matter not described in this Agreement or included in the Disclosure Schedules is or is not material for purposes of this Agreement.
Further, neither the specification of any item or matter in any representation, warranty or covenant contained in this Agreement
nor the inclusion of any specific item in the Disclosure Schedules is intended to imply that such item or matter, or other items
or matters, are or are not in the ordinary course of business, and no Person will use the fact of setting forth or the inclusion
of any such item or matter in any dispute or controversy between the Parties as to whether any obligation, item or matter not
described in this Agreement or included in the Disclosure Schedules is or is not in the ordinary course of business for purposes
of this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Counterparts</U>.&nbsp;This
Agreement and any Related Agreement may be executed by electronic transmission (i.e., facsimile or electronically transmitted
portable document format (PDF) or DocuSign or similar electronic signature) and in counterparts any one of which need not contain
the signatures of more than one Party, but all such counterparts taken together will constitute one and the same instrument.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Governing
Law</U>.&nbsp;This Agreement, and all claims or causes of action (whether at law or in equity, in contract or in tort) that may
be based on, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement, or the
transactions contemplated by this Agreement, will be governed by and construed in accordance with the domestic Laws of the State
of Delaware without giving effect to any choice of Law or conflict of Law provision or rule (whether of the State of Delaware
or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>CONSENT
TO JURISDICTION</U>.&nbsp;SUBJECT TO THE PROVISIONS OF <U>SECTION &lrm;1.12(e)</U> (WHICH WILL GOVERN ANY DISPUTE ARISING THEREUNDER),
WITHOUT LIMITING ANY PARTY FROM ENFORCING ANY JUDGMENT OR SEEKING SPECIFIC PERFORMANCE AS AN INTERIM MEASURE IN ANY APPROPRIATE
JURISDICTION AND VENUE, EACH OF THE PARTIES IRREVOCABLY AGREES THAT ANY PROCEEDING BASED HEREON, OR ARISING OUT OF, UNDER OR IN
CONNECTION WITH THIS AGREEMENT BETWEEN OR AMONG SUCH PARTIES WILL BE BROUGHT AND MAINTAINED EXCLUSIVELY IN THE DELAWARE COURT
OF CHANCERY, AND ONLY STATE APPELLATE COURTS THEREFROM WITHIN THE STATE OF DELAWARE (UNLESS THE DELAWARE COURT OF CHANCERY DECLINES
TO ACCEPT JURISDICTION OVER A PARTICULAR MATTER, IN WHICH CASE, IN ANY STATE OR FEDERAL COURT LOCATED IN THE STATE OF DELAWARE).
EACH PARTY ALSO AGREES NOT TO BRING ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
BY THIS AGREEMENT IN ANY OTHER COURT (OTHER THAN UPON THE APPEAL OF ANY JUDGMENT, DECISION OR ACTION OF ANY SUCH COURT LOCATED
IN DELAWARE OR, AS APPLICABLE, ANY FEDERAL APPELLATE COURT <FONT STYLE="font-size: 10pt">THAT
INCLUDES THE STATE OF DELAWARE WITHIN ITS JURISDICTION). BY EXECUTION </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">AND DELIVERY OF THIS
AGREEMENT, EACH PARTY IRREVOCABLY SUBMITS TO THE JURISDICTION OF SUCH COURTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY WITH RESPECT
TO SUCH PROCEEDING. THE PARTIES IRREVOCABLY AGREE THAT VENUE WOULD BE PROPER IN SUCH COURT, AND HEREBY WAIVE ANY OBJECTION THAT
ANY SUCH COURT IS AN IMPROPER OR INCONVENIENT FORUM FOR THE RESOLUTION OF SUCH PROCEEDING. EACH OF THE PARTIES FURTHER IRREVOCABLY
AND UNCONDITIONALLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN <U>SECTION &lrm;7.4</U>. <FONT STYLE="text-transform: uppercase">Nothing
in this Agreement will affect the right of any party to serve process in any other manner permitted by law</FONT>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>WAIVER
OF JURY TRIAL</U>. THE PARTIES EACH HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT IT MAY HAVE TO
TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (I)&nbsp;ARISING UNDER THIS AGREEMENT OR (II) IN ANY WAY CONNECTED
WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED TO
THIS AGREEMENT, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. THE
PARTIES EACH HEREBY AGREE AND CONSENT THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION WILL BE DECIDED BY COURT TRIAL WITHOUT
A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF
THE CONSENT OF THE PARTIES TO THE IRREVOCABLE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HAVE BEEN INDUCED TO ENTER
INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION &lrm;7.15</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Prevailing
Party</U>. In the event any Proceeding is commenced or threatened by any Person (the &ldquo;<U>Claiming Party</U>&rdquo;) to enforce
its rights under this Agreement against any other Person (the &ldquo;<U>Defending Party</U>&rdquo;), if the Defending Party is
the prevailing party in such Proceeding, all fees, costs and expenses, including reasonable attorneys&rsquo; fees and court costs,
incurred by the Defending Party in such Proceeding will be reimbursed by the Claiming Party; <I>provided</I> that if the Defending
Party prevails in part, and loses in part, in such Proceeding, the court, arbitrator or other adjudicator presiding over such
Proceeding will award a reimbursement of the fees, costs and expenses incurred by the Defending Party on an equitable basis. For
purposes hereof, and without limitation, the Defending Party will be deemed to have prevailed in any Proceeding described in the
immediately preceding sentence if the Claiming Party commences or threatens any such Proceeding and (a) such underlying claim(s)
are subsequently dropped, voluntarily dismissed or voluntarily reduced and/or (b) the Defending Party defeats any such claim(s).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Third-Party
Beneficiaries and Obligations</U>. This Agreement will inure to the benefit of and be binding on the Parties and their respective
successors and permitted assigns and such Persons are intended third party beneficiaries hereof. Nothing in this Agreement, express
or implied, is intended to or will confer on any Person other than the Parties and their respective successors and permitted assigns
any rights, remedies or liabilities under or by reason of this Agreement, other than as expressly and specifically set forth in
<U>Section &lrm;5.10</U>, <U>Section 7.1</U>, <U>Section &lrm;7.2</U>, <U>Section 7.5</U> and this <U>Section &lrm;7.17</U>, as
applicable, each of which is intended to be for the benefit of the Persons covered thereby or paid thereunder and may be enforced
by such Persons. The representations and warranties in this Agreement are the product of negotiations among the Parties and are
for the sole benefit of the Parties. Any inaccuracies in such <FONT STYLE="font-size: 10pt">representations
and warranties are subject to waiver by the Parties in accordance with this Agreement </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">without
notice or liability to any other Person. In some instances, the representations and warranties in this Agreement may represent
an allocation among the Parties of risks associated with particular matters regardless of the knowledge of any of the Parties.
Consequently, Persons other than the Parties may not rely on the representations and warranties in this Agreement as characterizations
of actual facts or circumstances as of the date hereof or as of any other date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Specific
Performance</U>. The Parties agree and stipulate that irreparable damage, for which monetary relief, even if available, would
not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its
specific terms or is otherwise breached, including if the Parties fail to take any action required of them hereunder to consummate
the transactions contemplated by this Agreement. It is accordingly agreed that the Parties will be entitled to equitable relief,
without proof of actual damages, including an injunction or injunctions, specific performance or other equitable relief to prevent
or restrain breaches or threatened breaches of this Agreement and to enforce specifically the terms of this Agreement (including
an order sought by the Sellers&rsquo; Representative to cause Buyer and Merger Sub to consummate the Merger and the other transactions
contemplated hereby at Closing), in addition to any other remedy to which they are entitled at law or in equity for any such breach
or threatened breach or termination. Each Party further acknowledges and agrees that no other Party or any other Person shall
be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy
referred to in this <U>Section &lrm;7.18</U> and each Party irrevocably waives any right it may have to require the obtaining,
furnishing or posting of any such bond or similar instrument. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Partnership Created</U>. In no event will this Agreement be deemed to create a partnership between the Company or any of its Affiliates,
on the one hand, and Buyer or any of its Affiliates, on the other hand, and in no event will any fiduciary or similar duty be
deemed owed by the Company or any of its Affiliates to Buyer or any of its Affiliates.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Deliveries</U>.
 For purposes of this Agreement, if a Company Entity or a Person acting on their behalf posts a document to any online data room
hosted on behalf of the Company by Datasite or any other third-party twenty four hours prior to the date hereof and accessible
by Buyer and its Representatives, such document will be deemed to have been &ldquo;delivered,&rdquo; &ldquo;furnished&rdquo; or
&ldquo;made available&rdquo; (or any phrase of similar import) to Buyer and its Representatives.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Non-Recourse</U>.
 This Agreement may only be enforced against, and any claim or suit based on, arising out of or related to this Agreement or the
negotiation, execution or performance of this Agreement may only be brought against, the named Parties to this Agreement and then
only with respect to the specific obligations set forth herein with respect to the named Parties to this Agreement. No Person
who is not a named party to this Agreement, including any past, present or future director, manager, officer, employee, incorporator,
member, partner, direct or indirect equityholder, Affiliate or Representative of Buyer, Merger Sub, the Company, the Company Entities
or any of their respective Affiliates will have or be subject to any liability or indemnification obligation (whether in contract
or in tort) to any other Person resulting from (nor will any other Person have any claim with respect to) (i)&nbsp;the distribution
to Buyer, Merger Sub or their Representatives or Buyer&rsquo;s, Merger Sub&rsquo;s or their Representatives&rsquo; use of or reliance
on any information, documents, projections, forecasts or other material made available to Buyer or Merger Sub in certain &ldquo;data
rooms,&rdquo; confidential information memoranda or management presentations in expectation of, or in connection with, the transactions
contemplated by this Agreement or (ii)&nbsp;any claim based on, in respect of or by reason of the sale and purchase of the Company
Entities, including any alleged non-disclosure or misrepresentations made by any such Persons or other Persons, in each case,
regardless of the legal theory under which such liability or obligation may be sought to be imposed, whether sounding in contract
or tort, or whether at law or in equity, or otherwise; and each Party waives and releases all such liabilities and obligations
against any such Persons.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;</U></FONT><U><FONT STYLE="font-size: 10pt">Recitals</FONT></U><FONT STYLE="font-size: 10pt">.
 The Recitals to this Agreement are hereby incorporated as material provisions of this Agreement as if restated in full herein.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">7.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Time
of Essence</U>.  With regard to all dates and time periods set forth or referred to in this Agreement, time is of the essence.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: uppercase; color: #010000">Article
8 </FONT><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><U><BR>
DEFINITIONS</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Accounting
Principles</U>&rdquo; means the accounting principles set forth on <U>Exhibit G</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Additional
Consideration</U>&rdquo; the amounts payable, if any, in respect of such Company Securities upon disbursement of (i) the purchase
price adjustment pursuant to the terms of <U>Section&nbsp;&lrm;1.12</U> (including any release from the Purchase Price Adjustment
Escrow Account) and (ii) the Sellers&rsquo; Representative Expense Fund pursuant to the terms of <U>Section&nbsp;&lrm;7.2</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Adjustment
Amount</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(f)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Adjustment
Calculation Time</U>&rdquo; means 11:59&nbsp;p.m. local time in New York, New York, on the day immediately prior to the Effective
Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
of any particular Person means any other Person controlling, controlled by or under common control with such Person.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Affiliated
Group</U>&rdquo; means, with respect to any particular Person, an affiliated group as defined in Section&nbsp;1504 of the Code
(or any analogous combined, consolidated or unitary group defined under state, local or non-U.S. income Tax Law) of which such
Person is or has been a member.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Aggregate
Closing Consideration</U>&rdquo; means (i) the Base Purchase Price, <U>plus</U> (ii)&nbsp;the Closing Cash, <U>minus</U> (iii)
the Closing Indebtedness, <U>minus</U> (iv) the Unpaid Sellers&rsquo; Transaction Expenses, <U>plus</U> (v) the Closing Net Working
Capital Surplus (if any), <U>minus</U> (vi) the Closing Net Working Capital Deficit (if any), <U>minus</U> (vii) the Sellers&rsquo;
Representative Expense Fund.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Anti-Corruption
Laws</U>&rdquo; means the U.S. Foreign Corrupt Practices Act, U.K. Bribery Act, and all other applicable anti-corruption laws.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Antitrust
Law</U>&rdquo; means the Sherman Act, 15&nbsp;U.S.C. &sect;&sect;&nbsp;1-7, as amended; the Clayton Act, 15&nbsp;U.S.C. &sect;&sect;&nbsp;12-27,
29 U.S.C. &sect;&sect;&nbsp;52-53, as amended; the HSR Act; the Federal Trade Commission Act, 15&nbsp;U.S.C. &sect;&sect;&nbsp;41-58,
as amended; and all other federal, state and non-U.S. Laws, Orders and administrative or judicial doctrines that are designed
or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Arbiter</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;&lrm;1.12(e)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Base
Purchase Price</U>&rdquo; means (i) $875,000,000 <I>minus </I>(ii) the Rollover Amount.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than a Saturday, Sunday or any other day on which commercial banks located in New York, New
York are closed for business as a result of a federal, state or local holiday.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Buyer</U>&rdquo;
has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Buyer
Parties</U>&rdquo; means Buyer, Merger Sub and their respective Affiliates (including, solely after the Closing, the Company Entities)
and each of their respective former, current or future Affiliates, officers, directors, employees, partners, members, direct or
indirect equityholders, direct or indirect controlling or controlled persons, Representatives, successors and permitted assigns.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>CARES
Act</U>&rdquo; means the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. 116-136).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Cash</U>&rdquo;
means, all cash and cash equivalents (but, for the avoidance of doubt, excluding any marketable securities) of the Company Entities,
in each case, as determined in accordance with the Accounting Principles. For purposes of clarity and without duplication, Cash
shall (a) be increased for (i) checks received by the Company Entities prior to the Adjustment Calculation Time and (ii) wire
transfers, ACH transfers and other electronic payments to the Company Entities initiated prior to the Adjustment Calculation Time,
in each case, unless the receivables associated with such checks, transfers or payments are included as current assets in Closing
Net Working Capital, and (b) be reduced for checks issued by the Company Group but not cleared as of the Adjustment Calculation
Time, unless the payables associated with such checks are included as current liabilities in Closing Net Working Capital.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Certificate
of Merger</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.2</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;&lrm;1.2</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Cash</U>&rdquo; means, without duplication, the aggregate amount of Cash as of the Adjustment Calculation Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.2</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Indebtedness</U>&rdquo; means the amount of Indebtedness as of the Adjustment Calculation Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Net Working Capital</U>&rdquo; means Net Working Capital as of the Adjustment Calculation Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Net Working Capital Deficit</U>&rdquo; means if Net Working Capital as of the Adjustment Calculation Time is less than the Target
Net Working Capital, an amount equal to the absolute value of the Target Net Working Capital <U>minus</U> such Net Working Capital.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Net Working Capital Surplus</U>&rdquo; means if Net Working Capital as of the Adjustment Calculation Time is greater than the
Target Net Working Capital, an amount equal to the absolute value of such Net Working Capital <U>minus</U> the Target Net Working
Capital.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Option Amount</U>&rdquo; has the meaning set forth in <U>Section &lrm;1.7(c)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Repaid Indebtedness</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.11</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Statement</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(c)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Entities</U>&rdquo; means the Company and each of its Subsidiaries.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Intellectual Property</U>&rdquo; means all Intellectual Property owned by or licensed to any of the Company Entities or for which
any Company Entity has obtained a covenant not to be sued.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Material Adverse Effect</U>&rdquo; means any event, change, occurrence or effect (collectively, &ldquo;<U>Events</U>&rdquo;) that,
individually or in the aggregate, has had or would reasonably be expected to have a material and adverse effect on (x) the business,
financial condition or operating results of the Company Entities taken as a whole or (y) the Company&rsquo;s ability to consummate
the Closing; <I>provided</I> that, in the case of the foregoing clause (x), no adverse Events to the extent arising from or relating
to any of the following will be deemed to constitute or will be taken into account in determining whether there has been, a Company
Material Adverse Effect: (i) general business, industry or economic conditions, including such conditions related to the business
of the Company Entities or the industry in which the Company Entities operate, (ii) national or international political or social
conditions (including social unrest), (iii) changes in financial, capital, banking or securities markets in the United States
or any other country, (iv) any &ldquo;act of God,&rdquo; including weather, natural disasters, any earthquake, hurricane, tsunami,
tornado, flood, mudslide, fire or other disaster, change in weather, meteorological conditions or climate, or any other force
majeure event, (v) any epidemic, pandemic or disease outbreak (including COVID-19), or any law providing for business closures,
&ldquo;sheltering-in-place,&rdquo; social distancing or other restrictions that relate to, or arise out of, such epidemic, pandemic
or disease outbreak (including COVID-19) or any such law or interpretation thereof following the date hereof, (vi) changes in
GAAP or interpretations thereof, (vii) the taking of any action expressly required to be taken by this Agreement, (viii) changes
in Law or interpretations thereof, (viii)&nbsp;the announcement or execution of this Agreement or the transactions contemplated
by this Agreement, the pendency thereof or the identity, nature or ownership of Buyer (it being understood and agreed that the
foregoing shall not apply with respect to any representation or warranty that is intended to address the consequences of the execution,
delivery or performance of this Agreement or the consummation of the transactions contemplated hereby), (ix) any failure, in and
of itself, of any of the Company Entities to meet or achieve any projections, forecasts, estimates, plans, predictions, performance
metrics or operating statistics or the inputs into such items (whether or not shared with Buyer or its Affiliates or Representatives);
<I>provided</I> that this <U>clause (ix)</U> will not prevent a determination that any Event underlying such failure to meet projections
or forecasts has resulted in a Company Material Adverse Effect (to the extent such Event is not otherwise excluded from this definition
of Company Material Adverse Effect), (x) actions taken or omitted at the written request of Buyer, (xi) actions not taken due
to the failure of Buyer to give its prior written consent to any of the actions restricted by <U>Section &lrm;5.1</U>, (xii) Buyer&rsquo;s
compliance with its obligations under <U>Section &lrm;5.8</U> or the application of Antitrust Laws (including any litigation or
other action or order arising under such laws) to the transactions contemplated hereby; <I>provided</I>, <I>however,</I> that
if any Event described in clauses (i) through (vi) has a disproportionate effect on the Company Entities, taken as a whole, relative
to other participants within the industry in which the Company Entities operate, the disproportionate impact thereof shall be
taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Material Contracts</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;3.9</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Options</U>&rdquo; means options to purchase Company Shares granted under the Company Amended and Restated 2018 Equity Incentive
Plan.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Owned Intellectual Property</U>&rdquo; means any and all Intellectual Property owned, or purported to be owned, by any of the
Company Entities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Equityholders</U>&rdquo; means the holders of Company Securities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Securities</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;3.3(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Shareholders</U>&rdquo; means the holders of Company Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Company
Shares</U>&rdquo; means shares of common stock and Series A and Series B preferred stock, each with a par value $.001 per share,
of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Confidentiality
Agreement</U>&rdquo; means the Confidentiality Agreement, by and between the Company and Buyer, dated as of August 13, 2019.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Contract</U>&rdquo;
means any written or oral agreement, contract, subcontract, lease, instrument, or other legally binding commitment including any
exhibits, annexes, appendices or attachments thereto, and any amendments, modifications, supplements, extension or renewals thereto.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>COVID-19</U>&rdquo;
means SARS-CoV-2 or COVID-19, and any evolutions or derivatives thereof or related or associated epidemics, pandemic or disease
outbreaks.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>COVID-19
Measures</U>&rdquo; means any quarantine, &ldquo;shelter in place,&rdquo; &ldquo;stay at home,&rdquo; workforce reduction, social
distancing, shut down, closure, sequester or any other Law, Order, directive, guidelines or recommendations by any Governmental
Authority in connection with or in response to COVID-19).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Credit
Facility</U>&rdquo; means the Term Loan Agreement, dated as of February 12, 2020, by and among the Company, CRG Servicing LLC
and the other parties thereto.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>D&amp;O
Indemnified Parties</U>&rdquo; has the meaning set forth in <U>Section &lrm;5.10(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules delivered to Buyer by the Company on the date of this Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Distribution
Schedule</U>&rdquo; means a schedule setting forth the following information: (i) each Company Equityholder&rsquo;s name, address
and email address, (ii) the number of Company Securities held as of immediately prior to the Effective Time by such Company Equityholder
and (iii) with respect to the Company Equityholders, the manner in which the (A)&nbsp;Estimated Aggregate Closing Consideration
and (B) any Additional Consideration are, in each case, to be allocated among the Company Equityholders, which, for the avoidance
of doubt, will be prepared in accordance with the Organizational Documents of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>DGCL</U>&rdquo;
has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Effective
Time</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.2</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Employee
Benefit Plan</U>&rdquo; means each (a) &ldquo;employee benefit plan&rdquo; (as such term is defined in Section&nbsp;3(3) of ERISA),
(b) individual employment, consulting, severance, change in control, retention or transaction bonus plan, agreement or arrangement
and (c) each other material employee benefit plan, program or arrangement, in each case (i) that is maintained, sponsored or contributed
to by the Company</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">or
any other Company Entity on behalf of its current or former Service Providers or (ii) for which the Company or any other Company
Entity has any liability, in each case excluding any plan, program or arrangement that is maintained or administered by a Governmental
Authority.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Environmental
Laws</U>&rdquo; means any applicable Law concerning human health or safety, pollution or protection of the environment, or any
pollutants, contaminants, wastes, chemicals, or any other toxic, radioactive, ignitable, corrosive, reactive or otherwise hazardous
substances, wastes or materials.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>ERISA</U>&rdquo;
means the Employee Retirement Income Security Act of 1974, as amended.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Escrow
Agent</U>&rdquo; means U.S. Bank, N.A., as the Escrow Agent under the Escrow Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the Escrow Agreement, substantially in the form&nbsp;attached hereto as <U>Exhibit E</U>, with such
changes as reasonably requested by the Escrow Agent, to be entered into at the Closing by Buyer, the Sellers&rsquo; Representative
and the Escrow Agent.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Estimated
Aggregate Closing Consideration</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Estimated
Closing Cash</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Estimated
Closing Indebtedness</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Estimated
Closing Statement</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Estimated
Unpaid Sellers&rsquo; Transaction Expenses</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Events</U>&rdquo;
has the meaning set forth in the definition of &ldquo;Company Material Adverse Effect.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Excess
Amount</U>&rdquo; has the meaning set forth in <U>Section &lrm;1.12(g)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
means the United States Food and Drug Administration.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<FONT STYLE="font-weight: normal"><U>Fraud</U></FONT>&rdquo;
means the common law liability for actual fraud, as finally determined by a court of competent jurisdiction, in the making of
a specific representation or warranty expressly set forth in <U>&lrm;Article 3 </U>or <U>&lrm;Article 4</U>, as applicable, willfully
and knowingly committed by the Party making such express representation or warranty with the specific intent to deceive and mislead
another Party.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Fundamental
Representations</U>&rdquo; means the representations and warranties set forth in <U>Section&nbsp;&lrm;3.1</U>, <U>Section&nbsp;&lrm;3.2(a)</U>,
<U>Section&nbsp;&lrm;3.3(a)</U> and <U>Section &lrm;3.4(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Governmental
Authority</U>&rdquo; means any: (a) domestic or non-U.S. nation, state, commonwealth, province, territory, county, municipality,
district or other legal jurisdiction; (b)&nbsp;federal, state, local, municipal, non-U.S. or other government; (c) domestic or
non-U.S. governmental authority of any nature (including any governmental division, department, agency, commission, instrumentality,
official, organization, unit or body (accreditation or otherwise)); or (d) any court, tribunal, arbitrator or other arbitral body
(public or private).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Governmental
Health Program</U>&rdquo; means any federal healthcare program as defined in 42 U.S.C. &sect; 1320a-7b(f), including Medicare,
Medicaid, TRICARE, CHAMPVA, and state healthcare programs (as defined therein).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Government
Official</U>&rdquo; means any public or elected official or officer, employee (regardless of rank), or person acting on behalf
of a national, provincial, or local government, including a department, agency, instrumentality, state-owned or state&ndash;controlled
company, public international organization (such as the United Nations or World Bank), or non-U.S. political party, non-U.S. party
official or any candidate for political office. Officers, employees (regardless of rank), or persons acting on behalf of an entity
that is financed in large measure through public appropriations, is widely perceived to be performing government functions, or
has its key officers and directors appointed by a government will also be considered &ldquo;Government Officials.&rdquo;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Hazardous
Materials</U>&rdquo; means any pollutant or contaminant or any hazardous, radioactive or toxic materials, substances or wastes,
or any substance, waste or material having any constituent elements displaying any hazardous, toxic or radioactive characteristics,
including petroleum products or byproducts, friable asbestos, radioactive materials or substances, per- and polyfluoroalkyl substances
and polychlorinated biphenyls, including any substance or material regulated as such under Environmental Laws.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Healthcare
Laws</U>&rdquo; means all Laws applicable to the businesses of the Company Entities relating to healthcare, including the Federal
Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b); the Federal Civil Monetary Penalties Law (42 U.S.C. &sect; 1320a-7a); the False
Claims Act (31 U.S.C. &sect;&sect; 3729-3733); the Exclusion Laws (42 U.S.C. &sect; 1320a-7); and the Health Insurance Portability
and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (Title XIII
of the American Recovery and Reinvestment Act of 2009).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>HSR
Act</U>&rdquo; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>HSR
Clearance</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;2.1(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means, without duplication, the sum of (a)&nbsp;all principal and accrued (but unpaid) interest owing by the Company Entities
for debt for borrowed money of the Company Entities owed to any third party, including pursuant to the Credit Facility, (b)&nbsp;the
maximum gross amount of any &ldquo;earnouts&rdquo; or similar deferred purchase price, in each case, in connection with the Company
Entities&rsquo; acquisition of a business or enterprise or any other assets, property, goods or services (other than, for the
avoidance of doubt, trade payables incurred in the ordinary course of business to the extent included in Net Working Capital),
(c)&nbsp;all obligations of the Company Entities as lessee or lessees under leases that have been or should be, in accordance
with GAAP, recorded by the Company Entities as capital leases, (d)&nbsp;all change-in-control bonuses, transaction bonuses and
similar bonuses (such amounts, &ldquo;<U>Transaction Payments&rdquo;</U>), in each case, solely to the extent arising from the consummation
of the transactions contemplated by this Agreement (and not any other event, whether occurring before or after the Closing, unless
such event is at the direction or request of any of the Seller Parties) and not entered into by or at the direction of Buyer or
any of its Affiliates (including the employer portion of any payroll, employment or similar Taxes related thereto), but, in each
case, excluding any Tax gross-up payable in connection with Company Options (which amounts are addressed in clause&nbsp;(l) below),
(e) all indebtedness of the Company Entities evidenced by notes, bonds, debentures or other debt securities, (f) all obligations
of the Company Entities relating to interest rate, currency rate or commodity price protection, swap agreements, collar agreements
and other hedging agreements, (g) any obligations of the Company Entities in respect of letters of credit, performance bonds,
bankers acceptances, surety bonds or similar instruments (in each case, solely</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">to
the extent drawn), (h) Specified Current Taxes, (i) all obligations of the Company Entities then owing to any Company Shareholder
(other than pursuant to any employment arrangement), (j) any obligation of the Company Entities for accrued but unpaid outstanding
severance obligations, (k) an aggregate amount not to exceed $5,000,000 in respect of the AstraZeneca Deferred Revenue (as defined
and calculated in accordance with on <U>Exhibit G</U>), (l) any Tax gross-up triggered and payable in connection with Company
Options; <I>provided</I>, that, in no event shall the aggregate amount of Indebtedness pursuant to this clause (l) exceed $7,500,000;
and (m) any indebtedness or other obligations of any other Person of the type described in the preceding clauses (a) through (l)
guaranteed by, or secured by any of the assets of, any of the Company Entities; <I>provided</I> that, &ldquo;Indebtedness&rdquo;&nbsp;will
not include any item that would otherwise constitute &ldquo;Indebtedness&rdquo; that is (I)&nbsp;a liability related to inter-company
debt between the Company and any other Company Entity or any Company Entity and another Company Entity, (II)&nbsp;an undrawn obligation
in respect of letters of credit, performance bonds, bankers acceptances, surety bonds or similar instruments, (III)&nbsp;any fee
or expense to the extent incurred by or at the direction of Buyer, (IV) an operating lease obligation (determined in accordance
with GAAP) or (V) included in Net Working Capital or Seller&rsquo;s Transaction Expenses. For the avoidance of doubt, &ldquo;Indebtedness&rdquo;
shall include any accrued and unpaid interest with respect to any of the foregoing clauses (a)-(g) (including any penalties, fees
and premiums (including make-whole premiums) and all prepayment premiums, breakage costs and other amounts that may become due
as a result of the transactions contemplated hereby).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Insurance
Policies</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;3.20</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Intellectual
Property</U>&rdquo; means any and all intellectual property rights or similar proprietary rights throughout the world, including
all (i) patents, patent applications and patent disclosures (including continuations, continuations-in-part, divisionals, reexaminations,
reissues, extensions and equivalents of any of the foregoing); (ii)&nbsp;trademarks, service marks, trade dress, logos, internet
domain names and registrations and applications for registration thereof together with all of the goodwill associated therewith;
(iii) copyrights (registered or unregistered) and applications for registration thereof; and (iv) trade secrets, inventions (whether
patentable or unpatentable and whether or not reduced to practice), confidential information and know-how.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Interim
Period</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;5.1</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>International
Plan</U>&rdquo; means any Employee Benefit Plan that covers Service Providers located primarily outside of the United States.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Investment</U>&rdquo;
as applied to any Person means (i)&nbsp;any direct or indirect purchase or other acquisition (whether by loan, contribution of
capital, exchange or otherwise) by such Person of any note, obligation, instrument, unit, security or other ownership interest
(including partnership interest and joint venture interest) of any other Person and (ii)&nbsp;any capital contribution by such
Person to any other Person.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>IT
Assets</U>&rdquo; means computers, computer software, firmware, middleware, servers, workstations, routers, hubs, switches, data
communications lines, and all other information technology equipment, owned by any Company Entity or licensed or leased by any
Company Entity pursuant to written agreement (excluding any public networks).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Key
Employee</U>&rdquo; means an employee of any of the Company Entities whose annual base compensation is $225,000 or more or who
has the title of Vice President or above.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Knowledge</U>&rdquo;
means (i)&nbsp;in the case of the Company, the actual knowledge, as of the date hereof, of each Person set forth on <U>Schedule
V</U>, and (ii)&nbsp;in the case of
Buyer or Merger Sub, the actual knowledge, as of the date hereof, of Joseph LaPlume, Matthew Daniel, or Todd Engle.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Latest
Balance Sheet</U>&rdquo; has the meaning set forth in <U>Section &lrm;3.5(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Law</U>&rdquo;
means all laws, statutes, rules, regulations, ordinances, pronouncements, injunctions, judgments, rulings or other similar requirements
having the effect of law of, or issued enacted, adopted, promulgated or applied by, any Governmental Authority.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Leased
Real Property</U>&rdquo; means all leasehold and subleasehold estates and other rights to use or occupy any land, buildings, structures,
improvements, fixtures or other material interests in real property held by any of the Company Entities pursuant to any lease,
sublease, license, concession or other occupancy agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Letter
of Transmittal</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.9(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Liabilities</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;&lrm;3.5(b)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Lien</U>&rdquo;
means any mortgage, pledge, security interest, encumbrance, lien, easement, charge, lease, sublease, license or other adverse
claim of any kind in respect of any property or asset, including any restriction on the right to vote, sell or otherwise dispose
of any capital stock or other voting or equity interest or any restriction on the exercise of any attributes of ownership.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Lookback
Date</U>&rdquo; means January 1, 2018.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
means actual out-of-pocket losses, liabilities, damages or expenses (including reasonable attorneys&rsquo; fees and disbursements).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Material
Leases</U>&rdquo; means all leases, subleases, licenses, concessions and other agreements, including all amendments, extensions,
renewals, guaranties and other agreements with respect thereto, pursuant to which any Company Entity holds any Leased Real Property
and for which the annual rent obligation exceeds $150,000.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; has the meaning set forth in <U>Section &lrm;3.14(b)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Merger</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;&lrm;1.1</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Merger
Sub</U>&rdquo; has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Multiemployer
Plan</U>&rdquo; has the meaning set forth in Section&nbsp;3(37) of ERISA.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Net
Working Capital</U>&rdquo; means the result (whether positive or negative) of (i) the sum of the Company Entities&rsquo; current
asset accounts set forth on <U>Schedule II</U> determined on a consolidated basis in accordance with the Accounting Principles
<U>minus</U> (ii) the sum of the Company Entities&rsquo; current liability accounts set forth on the <U>Schedule II</U> determined
on a consolidated basis in accordance with the Accounting Principles. Cash, Indebtedness, Sellers&rsquo; Transaction Expenses,
all deferred non-income Tax assets and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">liabilities,
and all income Tax assets and liabilities (whether current or deferred) will be excluded from the calculation of the Net Working
Capital.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Notice
of Disagreement</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(d)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>OFAC</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;&lrm;3.15(d)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Order</U>&rdquo;
means any order, judgment, injunction, decree, ruling, decision, determination, verdict, sentence, subpoena, writ or award issued,
made, entered, rendered or otherwise put into effect by or under the authority of any Governmental Authority or arbitrator (whether
public or private).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Organizational
Documents</U>&rdquo; means, with respect to any Person that is an entity, whether or not written, such Person&rsquo;s organizational
documents, including the certificate of organization, incorporation or partnership, bylaws, operating agreement or partnership
agreement, joint venture and trust agreements, share certificates and any similar governing documents of any such Person.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Outside
Date</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;6.1(d)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Owned
Real Property</U>&rdquo; means all land, together with all buildings, structures, improvements and fixtures located thereon, and
all easements, servitudes and other interests and rights appurtenant thereto, owned by the Company Entities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Party</U>&rdquo;
or &ldquo;<U>Parties</U>&rdquo; has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Paying
Agent</U>&rdquo; means U.S. Bank, N.A., as the paying agent under the Paying Agent Agreement.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Paying
Agent Agreement</U>&rdquo; means the Paying Agent Agreement, substantially in the form&nbsp;attached hereto as <U>Exhibit F</U>,
with such changes as reasonably requested by the Paying Agent, to be entered into at the Closing by Buyer, and the Paying Agent.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Permit</U>&rdquo;
means all licenses, memberships, registrations, certifications, accreditations, permits, bonds, franchises, approvals, authorizations,
consents or orders of, notifications to or filings with any Governmental Authority, whether non-U.S., federal, state or local,
any industry association or standards compliance organization or any other Person, but excluding Intellectual Property.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Permitted
Liens</U>&rdquo; means (i) any restriction on transfer arising under applicable securities Laws, (ii) Liens for Taxes or other
governmental charges not yet due and payable as of the Closing Date or due but not delinquent or the amount or validity of which
is being contested in good faith by appropriate Proceedings by any of the Company Entities (and for which adequate reserves have
been made on the Company&rsquo;s balance sheet in accordance with GAAP), (iii) mechanics&rsquo;, carriers&rsquo;, workers&rsquo;,
repairers&rsquo; and other similar liens arising or incurred in the ordinary course of business relating to obligations not yet
due and payable, (iv) Liens arising under worker&rsquo;s compensation, unemployment insurance, social security, retirement and
similar legislation, (v)&nbsp;purchase money Liens and Liens securing rental payments under capital or operating lease arrangements
or license arrangements, (vi) informational statements filed under the Uniform Commercial Code with respect to operational leases,
(vii) Liens under the Credit Facility, (viii) Liens securing liabilities entered into in the ordinary course of business that
are specifically reflected in the Financial Statements or the notes thereto or not incurred in connection with the borrowing of
money, (ix)&nbsp;zoning, building code, conservation restriction and other land use regulations by Governmental Authorities that
do not materially interfere with the present or contemplated use or occupancy of the assets affected or materially detract from
the value of the assets affected, (x)&nbsp;non-exclusive licenses granted by</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">any
of the Company Entities in the ordinary course of business, (xi)&nbsp; easements, servitudes, covenants, conditions, restrictions
and other similar matters affecting title to any assets of the Company Entities and other title defects that do not materially
impair the present or contemplated use or occupancy of such assets in the operation of the business of the Company Entities taken
as a whole, (xii)&nbsp;Liens set forth in <U>Schedule III</U>, (xiii) all matters set forth with specificity on title policies
or surveys relating to Owned Real Property made available to Buyer prior to the date of this Agreement, (xiv) Liens that will
be released, waived or otherwise terminated in connection with the Closing, (xv) any Liens or restrictions on transfer set forth
in this Agreement, (xvi)&nbsp;Liens created by or resulting from actions of Buyer, Merger Sub or any of their Affiliates or Representatives,
(xvii) Liens of lessors, sublessors, or licensors arising under any lease arrangement or license, (xviii)&nbsp;with respect to
securities, restrictions on transfer generally arising under federal or state securities Laws, and (xix) other Liens that are
not and would not be reasonably expected to be material to the Company Entities, taken as a whole.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means any individual, sole proprietorship, partnership, joint venture, trust, unincorporated association, corporation, limited
liability company, entity or Governmental Authority.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Post-Closing
Tax Period</U>&rdquo; means a taxable period (or portion thereof) beginning after the Closing Date.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Pre-Closing
Tax Period</U>&rdquo; means a taxable period (or portion thereof) ending on or prior to the Closing Date (including, for purposes
of clarity, the portion through the end of the Closing Date for any Straddle Period).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means any action, suit, litigation, arbitration or mediation proceeding or prosecution (whether civil, criminal, administrative
or appellate).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Purchase
Price Adjustment Escrow Account</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.13(b)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Purchase
Price Adjustment Escrow Deposit Amount</U>&rdquo; means $15,000,000.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Purchase
Price Adjustment Escrow Funds</U>&rdquo; means the amounts held in the Purchase Price Adjustment Escrow Account, including any
dividends, interest, distributions and other income received in respect thereof, less any losses on investments thereof and less
distributions thereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Regulatory
Approvals</U>&rdquo; has the meaning set forth in <U>Section &lrm;5.8(c)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Regulatory
Laws</U>&rdquo; means all Laws applicable to the businesses of the Company Entities relating to the development, manufacture,
production, handling, or quality of biologics and their components, including the U.S. Food, Drug and Cosmetic Act (21 U.S.C.
&sect; 301 <I>et seq</I>.).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Related
Agreements</U>&rdquo; means each of the Escrow Agreement, the Paying Agent Agreement, the Rollover Agreements, the Support Agreements
and each of the other documents, certificates and instruments to be delivered hereunder.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Related
Party</U>&rdquo; means with respect to any specified Person, (a) any Affiliate of such specified Person, (b) any Person who serves
as a director, officer, general partner, managing member or in a similar capacity of such specified Person or any of its Affiliates
and (c) any immediate family member of any Person described in clause (a) or (b).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Remaining
Purchase Price Adjustment Escrow Funds</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;1.12(g)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Representative</U>&rdquo;
means, with respect to any Person, any director, officer, manager, member, partner (whether limited or general), principal, attorney,
employee, agent, advisor, consultant, accountant or any other Person acting in a representative capacity for such Person and,
in the case of Buyer, any existing or potential financing source (including Lenders and co-investors).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Rollover</U>&rdquo;
has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Rollover
Agreement</U>&rdquo; has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Rollover
Amount</U>&rdquo; means the aggregate cash consideration that would have been payable with respect to Rollover Option Shares and
Withheld Option Shares (each as defined in the Rollover Agreement) in connection with the Merger pursuant to the Distribution
Schedule assuming each such Rollover Option Share and Withheld Option Share received the same cash proceeds hereunder as other
shares of common stock of the Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Rollover
Holder</U>&rdquo; has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Rollover
Options</U>&rdquo; means the Company Options to be exchanged pursuant to the Rollover Agreements.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended from time to time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>SEC</U>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Seller
Parties</U>&rdquo; means the Company Shareholders and their respective Affiliates (other than the Company Entities) and to the
extent not inconsistent with the foregoing each of their and the Company Entities&rsquo; respective former, current or future
Affiliates, officers, directors, employees, partners, members, direct or indirect equityholders, direct or indirect controlling
or controlled Persons, Representatives, successors and permitted assigns.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Sellers&rsquo;
Counsel</U>&rdquo; has the meaning set forth in <U>Section &lrm;7.2(g)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Sellers&rsquo;
Representative</U>&rdquo; has the meaning set forth in <U>Section &lrm;7.2(a)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Sellers&rsquo;
Representative Expense Fund</U>&rdquo; has the meaning set forth in <U>Section&nbsp;&lrm;7.2(e)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Sellers&rsquo;
Transaction Expenses</U>&rdquo; means without duplication, any fees, costs or expenses (including those of investment bankers,
brokers, lawyers, accountants and other advisors) incurred by the Seller Parties (and, prior to the Closing, any of the Company
Entities) for which any of the Company Entities are liable, in each case, in connection with the negotiation, execution, delivery
and performance of this Agreement and the transactions contemplated by this Agreement, including the aggregate fees and expenses
of the Company Entities relating to the transactions contemplated hereby owed to (a) Morgan Stanley &amp; Co. LLC, (b) Kirkland
&amp; Ellis LLP, (c) Akin Gump Strauss Hauer &amp; Feld LLP and (d) any fees and expenses payable to any Seller Party under the
terms of any management, advisory or similar agreement (including as a result of the termination of such agreement) in effect
as of the Closing; <I>provided</I> that in no event will &ldquo;Sellers&rsquo; Transaction Expenses&rdquo; include (i) any fees,
expenses or other liabilities to the extent incurred by or at the written direction of Buyer in connection with obtaining the
consent, agreement or other approval of any Governmental Authority in connection with the transactions contemplated by this Agreement,
(ii)&nbsp;any Tax gross-up payable in connection with Company Options (which amounts are addressed in the definition of Indebtedness),
or (iii) any other liability or obligation incurred or arranged by or on behalf of Buyer or its Affiliates in connection with
the transactions contemplated by this Agreement</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">(including
any fees payable to any financing institution or the Company&rsquo;s accountants on behalf of Buyer or its Affiliates). Notwithstanding
the foregoing, &ldquo;Sellers&rsquo; Transaction Expenses&rdquo; will exclude all costs, fees and expenses and payment obligations
to the extent included in Closing Indebtedness or Closing Net Working Capital.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Service
Provider</U>&rdquo; means any director, officer, employee or individual independent contractor of any Company Entity.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt"><U>&ldquo;Specified
Current Taxes</U>&rdquo; shall mean, as of immediately prior to the Closing, the aggregate amount of (A) any unpaid income Tax
liabilities of each Company Entity for a Pre-Closing Tax Period that includes the Closing Date and any Pre-Closing Tax Period
ending in 2020, in each case, in respect of which Tax Returns have not yet been filed, and (B) any unsatisfied liabilities of
any Company Entity for any payroll Tax in respect of a Pre-Closing Tax Period, the payment of which has been delayed beyond the
Closing Date pursuant to Section 2302 of the CARES Act. The amount of any Taxes for any Straddle Period that are included in Specified
Current Taxes shall be determined by applying the methodology set forth in <U>Section &lrm;5.13(b)</U>. Specified Current Taxes
shall be calculated (i) in accordance with past practice (including reporting positions, elections, jurisdictions, and accounting
methods) of each Company Entity in preparing its Tax Returns; (ii) by not taking into account any reserves or liabilities with
respect to uncertain Tax positions; (iii) by excluding any deferred Tax liabilities; (iv) by excluding the Tax impact of any transactions
occurring on the Closing Date after the Closing outside the ordinary course of business and not expressly contemplated by this
Agreement; and (v) by excluding any Tax impact from the manner in which Buyer finances the transactions. For the avoidance of
doubt, (x) net operating losses, Transaction Tax Deductions and other Tax assets of each Company Entity will be taken into account
in the determination of Specified Current Taxes only to the extent they would actually reduce (but not below zero) the amount
of the Taxes owed by such Company Entity with respect to a Pre-Closing Tax Period, (y) in no event shall Specified Current Taxes
with respect to each Company Entity be a negative number, and (z) Specified Current Taxes with respect to each Company Entity
shall include (i) any income Taxes arising out of or resulting from any inclusion under Section 951 or Section 951A of the Code
(or any similar or corresponding provision of state or local law) in respect of any &ldquo;foreign corporation&rdquo; owned (directly
or indirectly) by any Company Entity to the extent such inclusion results (as determined using an interim closing of the books
method) from any transactions or ownership of assets occurring in a Pre-Closing Tax Period; (ii) any Taxes resulting from the
Redemption Transaction and (iii) any unpaid installment of any Company Entity under Section 965(h) of the Code.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Specified
Trademarks</U>&rdquo; means the trademarks owned by any of the Company Entities and identified in <U>Schedule IV</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Straddle
Period</U>&rdquo; has the meaning set forth in <U>Section &lrm;5.13(b)</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means, with respect to any Person, any corporation, partnership, limited liability company or other business entity of which (i)
if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency)
to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly,
by that Person or one or more of the other Subsidiaries of that Person or a combination thereof or (ii) if a partnership, limited
liability company or other business entity, a majority of the partnership, limited liability company or other similar ownership
interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries
of that Person or a combination thereof. For purposes hereof, a Person or Persons is deemed to have a majority ownership interest
in a partnership, limited liability company or other business entity if such Person or Persons is allocated a majority of partnership,
limited liability company or other business entity gains or losses or is or controls the managing director or general partner
of such partnership, limited liability company or other business entity.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Support
Agreements</U>&rdquo; has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Surviving
Company</U>&rdquo; has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Target
Net Working Capital</U>&rdquo; means $11,000,000.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Tax</U>&rdquo;
or &ldquo;<U>Taxes</U>&rdquo; means any federal, state, local or non-U.S. income, gross receipts, capital stock, license, payroll,
employment, excise, severance, stamp, occupation, premium, property, windfall, profits, environmental, customs, duties, franchise,
withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, value
added, alternative or add-on minimum or other tax or other governmental fee, assessment or charge in the nature of a tax, and
including any interest, penalties or additions thereto or additional amounts in respect of the foregoing.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Tax
Matter</U>&rdquo; means any audit, examination, contest, assessment, notice of Tax deficiency, claim for refund, Proceeding or
other adjustment of Taxes of or relating to any Tax of any of the Company Entities with respect to a Pre-Closing Tax Period.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Tax
Return</U>&rdquo; means any declaration, disclosure, estimate, return, report, information statement, claim for refund, schedule
or other filing (including any related or supporting information) with respect to Taxes, including any amendment thereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Taxing
Authority</U>&rdquo; means the United States Internal Revenue Service and any other Governmental Authority (and any subdivision,
agency or authority thereof) responsible for the administration, collection or imposition of any Tax.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Title&nbsp;IV
Plan</U>&rdquo; means any employee pension benefit plan (as such term is defined in Section&nbsp;3(2) of ERISA) that is subject
to Title&nbsp;IV of ERISA, other than a Multiemployer Plan.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Top
Customer</U>&rdquo; has the meaning set forth in <U>Section &lrm;3.21</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Top
Supplier</U>&rdquo; has the meaning set forth in <U>Section &lrm;3.21</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Transaction
Tax Deductions</U>&rdquo; means, without duplication and regardless of by whom or when paid but only to the extent economically
borne by the Seller Parties and relating to a Pre-Closing Tax Period, the aggregate amount of the following income Tax deductions
to the extent &ldquo;more likely than not&rdquo; deductible (or deductible at a higher level of confidence): (a) any and all stay
bonuses, sale bonuses, change in control payments, retention payments, payments to holders of Company Options with respect to
their Company Options and any Tax gross-up payments in connection therewith, or similar payments made or to be made by any Company
Entity in connection with or resulting from the Closing, including the employer portion of any employment Taxes, (b) all fees,
expenses and interest (including amounts treated as interest for U.S. federal income Tax purposes), original issue discount, unamortized
debt financing costs, breakage fees, tender premiums, consent fees, redemption, retirement or make-whole payments, defeasance
in excess of par or similar payments deductible by any Company Entity as a result of the payment of the Final Closing Indebtedness
in connection with the Closing, and (c) all fees, costs and expenses incurred by the Company Entities in connection with or incident
to this Agreement and the transactions contemplated hereby, including, any such legal, accounting and investment banking fees,
costs and expenses. The parties shall apply the seventy percent (70%) safe harbor election set forth in Internal Revenue Service
Revenue Procedure 2011-29 to determine the amount of income Tax deductions relating to any success-based fees for purposes of
clause (c) above to the extent such Revenue Procedure applies.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Unpaid
Sellers&rsquo; Transaction Expenses</U>&rdquo; means the amount of Sellers&rsquo; Transaction Expenses that are unpaid as of the
Adjustment Calculation Time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<U>WARN
Act</U>&rdquo; means the Worker Adjustment and Retraining Notification Act of 1988, 29&nbsp;U.S.C. &sect;&nbsp;2101, et seq.,
as amended, or any similar non-U.S., state or local law, regulation or ordinance.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">*&#9;*&#9;*&#9;*&#9;*</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above-written.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BUYER</U>:</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHARLES RIVER LABORATORIES INTERNATIONAL,
    INC.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; border-bottom: black 2px solid; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Joseph W. LaPlume</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    W. LaPlume</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Executive Vice President</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>MERGER SUB</U>:</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>MEMPHIS
    MERGER SUB, INC.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; border-bottom: black 2px solid; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Joseph W. LaPlume</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    W. LaPlume</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;Signature
Page to Agreement and Plan of Merger</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above-written.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B><U>COMPANY</U>:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COGNATE BIOSERVICES, INC.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; text-align: left; text-indent: 0pt"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1F497D"><FONT STYLE="font-size: 10pt; color: Black">/s/
                                         J. Kelly Ganjei</FONT>&nbsp;</P></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">J. Kelly Ganjei&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">President and Chief
    Executive Officer</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>SELLERS&rsquo; REPRESENTATIVE</U>:</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Mercury Fund 2 Holdco LLC</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 2px solid; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Petri Vainio</FONT> </TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Petri Vainio</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">and Chief Executive officer</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><I>Signature
Page to Agreement and Plan of Merger</I></FONT></P>


<!-- Field: Page; Sequence: 72; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>dp146258_ex1001.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 10.1</B></FONT></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">SUPPORT
AGREEMENT</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">This
Support Agreement (this &ldquo;</FONT><FONT STYLE="font-size: 10pt">Agreement<FONT STYLE="font-weight: normal">&rdquo;) is dated
as of February 17, 2021, by and among Charles River Laboratories International, Inc., a Delaware corporation (&ldquo;</FONT>Buyer<FONT STYLE="font-weight: normal">&rdquo;),
and each of the equityholder(s) of Cognate BioServices, Inc., a Delaware corporation (the &ldquo;</FONT>Company<FONT STYLE="font-weight: normal">&rdquo;)
listed on the signature pages hereto (each, a&nbsp;&ldquo;</FONT>Holder<FONT STYLE="font-weight: normal">&rdquo;). For purposes
of this Agreement, Buyer and each Holder are each a&nbsp;&ldquo;</FONT>Party<FONT STYLE="font-weight: normal">&rdquo; and collectively
the&nbsp;&ldquo;</FONT>Parties<FONT STYLE="font-weight: normal">&rdquo;. Capitalized terms used but not defined herein shall have
the respective meanings ascribed to such terms in the Merger Agreement (as defined below).</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">WHEREAS,
Buyer, Memphis Merger Sub, Inc., a Delaware corporation (&ldquo;</FONT><FONT STYLE="font-size: 10pt">Merger Sub<FONT STYLE="font-weight: normal">&rdquo;),
the Company, and Mercury Fund 2 Holdco LLC, a Delaware limited liability company, solely in its capacity as the initial representative
of the Company Shareholders (the &ldquo;</FONT>Sellers&rsquo; Representative<FONT STYLE="font-weight: normal">&rdquo;), have entered
or will enter into an Agreement and Plan of Merger dated as of February 17, 2021, attached as <U>Annex I</U> hereto (as amended
or modified from time to time, the &ldquo;</FONT>Merger Agreement<FONT STYLE="font-weight: normal">&rdquo;), providing for, among
other things, the merger of Merger Sub with and into the Company (the&nbsp;&ldquo;</FONT>Merger<FONT STYLE="font-weight: normal">&rdquo;);</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">WHEREAS,
as an inducement to Buyer&rsquo;s and Merger Sub&rsquo;s willingness to enter into the Merger Agreement and the other Related
Agreements, each Holder has agreed to execute and deliver this Agreement; and</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">WHEREAS,
as of the date hereof, each Holder is the record and beneficial owner of the Company Shares set forth next to such Holder&rsquo;s
name on the signature pages hereto (such Company Shares, together with all other Company Securities held by such Holder, the &ldquo;</FONT><FONT STYLE="font-size: 10pt">Subject
Shares<FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">NOW,
THEREFORE, in consideration of the foregoing premises and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged and accepted, Buyer and each Holder, intending to be legally bound, hereby agree as follows:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Consent; Appointment of the Sellers&rsquo; Representative; Binding Effect of Merger Agreement; Further Assurances</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Agreement to Consent</I>. Each Holder hereby agrees that, by 11:59 p.m. Eastern Time on February 22, 2021, such Holder
shall execute and deliver to the Company a duly executed counterpart of the Company Shareholder Approval (in the form attached
hereto as <U>Annex II</U>). Each Holder further agrees that, following the delivery of its counterpart of the Company Shareholder
Approval, such Holder will not take any action to withdraw, modify, revoke or otherwise challenge the effectiveness of the Company
Shareholder Approval.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Appointment of the Sellers&rsquo; Representative</I>. Each Holder agrees and consents to the irrevocable appointment
of Mercury Fund 2 Holdco LLC (subject to substitution in accordance with Section 7.2 of the Merger Agreement) as the Sellers&rsquo;
Representative and as the representative, true and lawful agent, proxy and attorney in fact of the Company Shareholders, including
the undersigned, with full power of substitution, with all of the powers and authority contemplated by (w) the Merger Agreement,
including Section 7.2 thereof, (x) the Escrow Agreement, (y) the Paying Agent Agreement and (z) any other Related Agreement, as
applicable. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">Each
Holder acknowledges and agrees that any compromise or settlement of any matter by the Sellers&rsquo; Representative as contemplated
by the Merger Agreement (including Section&nbsp;7.2 thereof) shall be binding upon, and fully enforceable against, such Holder
and each such Holder will not have any right to object, dissent, protest or otherwise contest the same, except in the case of
Fraud or bad faith by the Sellers&rsquo; Representative.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Binding
Effect of Merger Agreement</I>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Holder acknowledges and agrees to be bound by the provisions of the Merger Agreement purporting to bind the Company
Shareholders as if such Holder were an original signatory to the Merger Agreement as a Company Shareholder, including the provisions
regarding the appointment of the Sellers&rsquo; Representative to act on behalf of the Company Shareholders pursuant to the authority
granted therein, all as set forth in Section 7.2 of the Merger Agreement. Without limiting the generality of the foregoing, such
Holder acknowledges and agrees that, as provided in the Merger Agreement, a portion of the consideration otherwise payable to
such Holder pursuant to the Merger Agreement will be withheld by Buyer and deposited into (x) escrow for the purpose of covering
any post-closing downwards purchase price adjustment under Section&nbsp;1.12 of the Merger Agreement and (y) the Sellers&rsquo;
Representative Expense Fund under Section 7.2(e) of the Merger Agreement. Each Holder further acknowledges and agrees that such
Holder shall be entitled to receive distributions only with respect to the Purchase Price Adjustment Escrow Deposit Amount and
the amount in the Sellers&rsquo; Representative Expense Fund if, and to the extent that, any portion of such amounts are required
to be distributed to such Holder pursuant to the terms of the Merger Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Holder hereby (A) expressly acknowledges that the consideration to be paid to the Company Shareholders pursuant to
the Merger Agreement will be allocated as provided in the Estimated Closing Statement and the Distribution Schedule, and agrees
that Buyer, Merger Sub, the Surviving Company and their respective Affiliates shall be entitled to rely on the Estimated Closing
Statement and the Distribution Schedule, and to make payments in accordance therewith, in each case without any obligation to
investigate or verify the accuracy or correctness thereof, and (B) expressly acknowledges and agrees to the provisions of Section
1.12(b) of the Merger Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Holder agrees that it will not bring, commence, institute, maintain, prosecute or voluntarily aid any Proceeding,
in law or in equity, in any court or before any Governmental Authority, which challenges the validity of or seeks to enjoin the
operation of any provision of this Agreement, the Merger Agreement or the other Related Agreements.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Further Assurances</I>. Each Holder agrees to execute and deliver, or cause to be executed and delivered, all further
documents and instruments as Buyer may reasonably request to consummate and make effective the transactions contemplated by the
Merger Agreement and this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Existing Contracts</I>. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Each Holder, on behalf of itself and its Affiliates (to the extent applicable), hereby irrevocably and unconditionally
waives any rights, including rights of first </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">offer,
co-sale rights and related notice rights, granted pursuant to Section 2.4 or Section 2.5 of that certain Second Amended and Restated
Equityholders&rsquo; Agreement, made effective as of January 7, 2020, by and among the Company and the other Persons party thereto
(the &ldquo;</FONT><FONT STYLE="font-size: 10pt">Equityholders&rsquo; Agreement<FONT STYLE="font-weight: normal">&rdquo;), with
respect to the transactions contemplated by this Agreement, the Merger Agreement and the other Related Agreements (including the
Merger).</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Holder covenants and agrees that it will take any required actions to cause the Related Party Agreements to which
it or any of its Affiliates is a party, to be terminated in accordance with and subject to, the provisions of Section 5.3 of the
Merger Agreement, in each case, without any continuing liability or obligation of any of the Company Entities thereunder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Withholding</I>. Each Holder agrees and acknowledges that such Holder is responsible for payment of all taxes legally
imposed upon it in connection with benefits and payments provided under the Merger Agreement. All benefits and payments provided
under the Merger Agreement are subject to applicable tax and other withholdings required by applicable Law, and they will be made
net of such withholding amounts as and to the extent required by applicable Law.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Holder Representations and Warranties</U>. Each Holder represents and warrants to Buyer, Merger Sub and the Sellers&rsquo;
Representative as follows:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each Holder is duly organized, validly existing and in good standing (where applicable) under the laws of the jurisdiction
in which it is incorporated, organized or constituted, and the execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby are within such Holder&rsquo;s corporate or organizational powers and have been duly authorized
by all necessary corporate or organizational action on the part of such Holder. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each Holder is the record and beneficial owner (as defined in Rule 13d-3 under the Exchange Act, as amended) of, and has
good title to, all of such Holder&rsquo;s Subject Shares, free and clear of any Lien (including any restriction on the right to
vote, sell or otherwise dispose of such Subject Shares), except (i) transfer restrictions under applicable securities laws, (ii)
this Agreement, and (iii) the Equityholders&rsquo; Agreement. Each Holder&rsquo;s Subject Shares set forth on the signature pages
hereto are the only Company Securities owned of record or beneficially by such Holder on the date of this Agreement. Each Holder
has the requisite voting power and the requisite power to agree to all of the matters set forth in this Agreement, with respect
to all of its Subject Shares, necessary to perform its obligations under this Agreement, with no limitations, qualifications or
restrictions on such rights.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement has been duly executed and delivered by such Holder and, assuming the due authorization, execution and delivery
hereof by Buyer, this Agreement constitutes a legally valid and binding obligation of such Holder, enforceable against such Holder
in accordance with the terms hereof (subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium
and other laws affecting creditors&rsquo; rights generally and general principles of equity). </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The execution and delivery of this Agreement by such Holder does not, and the performance by such Holder of its obligations
hereunder will not, (i) result in a violation of applicable Law, (ii)&nbsp; conflict with or result in a violation of the Organizational
Documents of such Holder, (iii)&nbsp;other than the Company Shareholder Approval, and subject to the terms of the Equityholders&rsquo;
Agreement, require any consent or approval that has not been given or other action (including notice of payment or any filing
with any Governmental Authority) that has not been taken by any Person (including under any Contract binding upon such Holder
or such Holder&rsquo;s Subject Shares), or (iv) result in the creation or imposition of any Lien on such Holder&rsquo;s Subject
Shares.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>There is no Proceeding pending against, or to the knowledge of the Holder, threatened against the Holder or any of its
Affiliates, by or before (or that would be by or before) any Governmental Authority or arbitrator related to the Subject Shares,
this Agreement, the transactions contemplated by, or the performance by the Company or the Holder of its obligations under, the
Merger Agreement and the Related Agreements.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Other than Morgan Stanley &amp; Co. LLC, no investment banker, broker, finder or other intermediary is entitled to a fee
or commission from the Company Entities in respect of the Merger Agreement, this Agreement or any of the respective transactions
contemplated thereby and hereby based upon any arrangement or agreement made by such Holder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer of Shares</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>During the period commencing on the date hereof and continuing until the earlier of (i) the termination of this Agreement
pursuant to <U>Section 7(e)</U> and (ii) the Effective Time, except as expressly contemplated by the Merger Agreement or this
Agreement, absent the advance written consent of Buyer (which it may withhold in its sole discretion), each Holder agrees not
to take any action to, directly or indirectly, (a)&nbsp;offer to sell, sell, assign, transfer (including by operation of law),
subject to a Lien or otherwise dispose of any of the Subject Shares or any other Company Securities, (b) deposit any of the Subject
Shares or any other Company Securities into a voting trust or enter into a voting agreement or arrangement with respect to any
Subject Shares or any other Company Securities or grant any proxy or power of attorney with respect thereto or (c) enter into
any Contract, option or other arrangement or undertaking with respect to the direct or indirect sale, assignment, transfer (including
by operation of law) or other disposition of or transfer of any interest in or the voting of any of the Subject Shares or any
other Company Securities (any transaction of any type described in clause (a), (b) or (c) above, a &ldquo;</FONT><FONT STYLE="font-size: 10pt">Transfer<FONT STYLE="font-weight: normal">&rdquo;).
</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>During the period commencing on the date hereof and continuing until the earlier of (i) the termination of this Agreement
pursuant to <U>Section 7(e)</U> and (ii) the Effective Time, such Holder shall not, and shall direct its Affiliates and its and
their respective directors, managers, officers, and employees (collectively, &ldquo;</FONT><FONT STYLE="font-size: 10pt">Representatives<FONT STYLE="font-weight: normal">&rdquo;)
not to, directly or indirectly, solicit, encourage or knowingly initiate the submission of proposals or offers from, provide any
confidential information to, participate in discussions or negotiations or enter into any Contract with, any Person (other than
Buyer and its Affiliates) relating to the sale of any Company Entity or any direct or indirect acquisition of any Company Securities
or any material portion of the capital stock or other equity or voting securities of, or interests in, or assets of, any Company
</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">Entity,
whether in an acquisition structured as a merger, consolidation, exchange, sale of assets, sale of stock or otherwise. Each Holder
shall, and shall cause its Affiliates and direct its Representatives to, immediately cease and cause to be terminated any existing
discussions or negotiations with any Person (other than Buyer and Merger Sub) conducted heretofore with respect thereto.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
4.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Holder Covenants and Release.</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Confidentiality</I>. Subject to <U>Section 4(b)</U>, from the date hereof until the date that is three (3) years after
the Closing Date, each Holder agrees not to disclose (and shall direct each of its Representatives), in each case only where such
Representatives have received or subsequently receive Confidential Information (as defined below) not to disclose any Confidential
Information. Each Holder further agrees to take all commercially reasonable steps (and to direct each of its Representatives to
take all commercially reasonable steps) to safeguard such Confidential Information and to protect it against disclosure, misuse,
espionage, loss and theft. In the event such Holder or any of its Affiliates and its and their Representatives is required by
Law (including by oral questions or requests for information or documents in any such Proceeding, discovery request, subpoena
or similar process) to disclose any Confidential Information, such Holder shall, if legally permissible and practicable under
the circumstances, promptly notify Buyer in writing, which notification shall include the nature of the legal requirement and
the extent of the required disclosure, and such Holder shall, at the expense of the Buyer and the Company Entities, cooperate
with Buyer and the Company Entities to preserve the confidentiality of such information consistent with applicable Law. Each of
the Company Entities, each Holder and Buyer acknowledges and agrees that the other Parties would be damaged irreparably in the
event this <U>Section 4(a)</U> is not performed in accordance with its specific terms or is otherwise breached. Accordingly, each
Holder agrees that Buyer and the Company Entities shall be entitled to an injunction or injunctions to prevent breaches of the
provisions of this <U>Section 4(a)</U> and to enforce specifically this <U>Section 4(a)</U> and the terms and provisions hereof
in any action instituted in any court of competent jurisdiction over the Parties and the matter in addition to any other remedy
to which they may be entitled pursuant hereto. Notwithstanding the foregoing, (i) each Holder and its Representatives may disclose
Confidential Information to their respective limited partners and existing and prospective investors on a confidential basis in
connection with their normal fund raising, marketing or reporting activities and to their respective tax, legal, accounting and
other advisors that reasonably need to know such information, (ii) no notice shall be required in the case of any disclosure of
Confidential Information in connection with routine proceedings involving requests by such Holder&rsquo;s or its Representatives&rsquo;
securities, tax, regulatory or similar authorities having competent jurisdiction, provided that the proceedings and requests are
not specifically targeted at Buyer, the Company Entities or the Confidential Information, and (iii) Buyer and the Company Entities
each acknowledge that Holder&rsquo;s and its Representatives&rsquo; respective directors, officers or employees (each such person,
an &quot;</FONT><FONT STYLE="font-size: 10pt">Investment Professional<FONT STYLE="font-weight: normal">&quot;) may serve as employees,
directors or officers of portfolio companies and each agrees that in no event shall any such portfolio company be deemed to have
received Confidential Information solely because any such Investment Professional serves as an employee, officer or member of
the board of directors (or similar governing body) of such portfolio company, provided that such Investment Professional has not
provided such portfolio company or any other director, officer or employee thereof (other than another Investment Professional)
with Confidential Information and such portfolio company </FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">does
not act at the direction of such Investment Professional with respect to such Confidential Information. For purposes of this Agreement,
&ldquo;</FONT><FONT STYLE="font-size: 10pt">Confidential Information<FONT STYLE="font-weight: normal">&rdquo; means all information
(whether or not specifically identified as confidential), in any form or medium, that is disclosed to, or developed or learned
by, such Holder or its Representatives, that relates to the business, products, operations, financial condition, services, research
or development of the Company Entities or its customers, vendors, suppliers, processors, independent contractors or other business
relations, including: (i) internal business information (including information relating to strategic plans and practices, business,
accounting, financial or marketing plans, practices or programs, training practices and programs, salaries, bonuses, incentive
plans and other compensation and benefits information and accounting and business methods); (ii) identities of, individual requirements
of, specific contractual arrangements with, and information about, the Company or its Affiliates, its customers and its confidential
information; (iii) industry research compiled by, or on behalf of Company Entities, including identities of potential target companies,
management teams, and transaction sources identified by, or on behalf of, the Company; (iv) compilations of data and analyses,
processes, methods, track and performance records, data and databases relating thereto; and (vi) information related to Company
Intellectual Property; <I>provided, however,</I> that &ldquo;</FONT>Confidential Information<FONT STYLE="font-weight: normal">&rdquo;
shall not include any information that (A) is or becomes generally available to the public other than as a result of a breach
of this Agreement by any Holder, (B) becomes available to such Holder or its Representatives on a non-confidential basis from
a source other than Company, provided that such source, to the knowledge of such Holder or its Representatives (as applicable),
is not bound by a confidentiality agreement with, or other contractual, legal or fiduciary obligation of confidentiality to, the
Company or any other party with respect to such information, (C) was independently developed by or on behalf of the Holder or
its Representatives without use of or reference to any Confidential Information or (D) Buyer agrees to in writing may be disclosed.
Each Holders&rsquo; ownership in the Company Entities has inevitably resulted in increased knowledge and understanding of the
Company Entities&rsquo; industry and business in a way that cannot be reasonably expected to be separated from its overall knowledge
base. Accordingly, and notwithstanding anything to the contrary in this Agreement, it will not be deemed to be a breach of this
Agreement for such Holder or its Affiliates to remember and use or disclose such increased knowledge base in the conduct of their
businesses, including in evaluating businesses and making investment decisions, in each case, so long as such Holder and its Affiliates
comply with all obligations set forth herein. Each Holder shall be responsible for any action by any of its Representatives that
would constitute a breach of this</FONT> <U>&lrm;<FONT STYLE="font-weight: normal">Section 4(a)</FONT></U><FONT STYLE="font-weight: normal">
if taken by such Holder.</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-size: 10pt; font-weight: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Release</I>. Effective as of the Closing, each Holder, on behalf of such Holder and its Affiliates (other than the Company
Entities), successors and assigns (collectively, the &ldquo;</FONT><FONT STYLE="font-size: 10pt">Releasing Parties<FONT STYLE="font-weight: normal">&rdquo;)
hereby, forever waives, releases, remises and discharges the Company Entities and their respective directors, managers, officers
and employees (collectively, the&nbsp;&ldquo;</FONT>Released Parties<FONT STYLE="font-weight: normal">&rdquo;) from any claim,
liability or obligation that such Releasing Parties may currently have, or may have in the future, arising prior to, on or after
the Closing Date, in each case, solely in such Holder&rsquo;s capacity as an equityholder of the Company (so long as the facts,
circumstances, actions, omissions and/or events giving rise to such claim, liability or obligation occurred at or prior to the
Effective Time) (i) relating to the Company Entities or the Company Securities owned by such Holder (including any rights or interests
therein), (ii) relating to any alleged inaccuracy or miscalculations in the Distributions Schedule, (iii) relating to the approval
or consummation of the transactions contemplated hereby, the Merger Agreement or any </FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">Related
Agreement or any other agreement contemplated herein or therein, including any alleged breach of any duty by any officer, manager,
director, equityholder or other owner of ownership interests of any Company Entity, (iv) arising under any Organizational Documents
of the Company Entities or (v) arising from any actions or omissions by the Sellers&rsquo; Representative (collectively, the&nbsp;&ldquo;</FONT><FONT STYLE="font-size: 10pt">Released
Claims<FONT STYLE="font-weight: normal">&rdquo;); <I>provided, however</I>, that the Released Claims shall not include claims
which may not be released under applicable Law and shall not include any claim, liability or obligation arising from, relating
to or in connection with (A) such Holder&rsquo;s rights to full and complete payment for such Holder&rsquo;s Company Shares in
accordance with the Merger Agreement, the Distribution Schedule and the Escrow Agreement, (B) if such Releasing Party is a Service
Provider, rights to earned but unpaid wages or compensation, any accrued but unpaid or unused vacation and paid time off, any
accrued vested benefits, and unreimbursed business expenses, (C)&nbsp;that arise under or are based upon the terms of the Merger
Agreement and the Related Agreements, (D) the Fraud or willful misconduct of a Released Party, (E) any right to indemnification
as a present or former director, manager, officer or equityholder under any Company Entity&rsquo;s Organizational Documents or
the Law and any applicable policy of directors' and officers' insurance maintained by the Company Entities or (F) any defenses
that are necessary to enable the Holder to defend any claim asserted by a Released Party. Each Holder (on behalf of the Releasing
Parties) (i) represents that it has not assigned or transferred or purported to assign or transfer to any Person all or any part
of, or any interest in, any claim, contention, demand, cause of action (at law or in equity), liability or obligation of any nature,
character or description whatsoever, which is or which purports to be released or discharged by this <U>Section 4(b)</U> and (ii)
acknowledges that the Releasing Parties may hereafter discover facts other than or different from those that it knows or believes
to be true with respect to the subject matter of the Released Claims, but it hereby expressly agrees that, on and as of the Effective
Time, such Holder (on behalf of the Releasing Parties) shall have waived and fully, finally and forever settled and released any
known or unknown, suspected or unsuspected, asserted or unasserted, contingent or noncontingent claim with respect to the Released
Claims, whether or not concealed or hidden, without regard to the subsequent discovery or existence of such different or additional
facts. Each Holder (on behalf of the Releasing Parties) hereby acknowledges and agrees that if such Holder or any other Releasing
Party should hereafter make any claim or demand or commence or threaten to commence any Proceeding against any Released Party
with respect to any Released Claim, this <U>Section 4(b)</U> may be raised as a complete bar to any such Proceeding, and the applicable
Released Party may recover from such Holder all damages incurred in connection with such Proceeding, including its attorneys&rsquo;
fees.</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Non-Solicitation and Non-Disparagement</I>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Holder hereby acknowledges that it is or may be familiar with the Company Entities&rsquo; trade secrets and with other
Confidential Information, and such Holder hereby acknowledges that such Holder is selling all of such Holder&rsquo;s goodwill
in the Company and the business in which it operates to Buyer in the transactions contemplated by the Merger Agreement and the
Related Agreements. Therefore, such Holder agrees that until the two year anniversary of the Closing (the &ldquo;<B>Restricted
Period</B>&rdquo;) in any state or city (or equivalent administrative division) in the United States, the United Kingdom or Sweden
in which any Company Entity conducts business during the Restricted Period (the &ldquo;<B>Restricted Territory</B>&rdquo;), it
shall not (and shall cause its Affiliates (excluding any portfolio company of such Holder) not to) directly, or indirectly through
another Person, (i) induce or attempt to induce any employee of</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">the
Company Entities to leave the employ of the Company Entities, or in any way knowingly interfere with the relationship between
the Company Entities and any employee of the Company Entities or (ii) hire any person who is then an employee of the Company Entities
or who was an employee of the Company Entities on the Closing Date or at any time during the six-month period immediately prior
to the date on which such hiring would take place; <I>provided, however,</I> that a solicitation through a public general advertisement
(including through the use of recruiting firms) and any hiring resulting therefrom, shall not be deemed a breach of this Agreement
so long as such solicitation is not targeted at any such employee.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Holder agrees that during the Restricted Period, it shall not (and shall cause its Affiliates not to), except to the
extent done in good faith in any claim, suit, action or proceeding against Buyer, Merger Sub or the Company Entities, (i) make
any negative statement or communication regarding Buyer, Merger Sub, or the Company Entities or their respective employees with
the intent to harm any such Person or (ii) make any derogatory or disparaging statement or communication regarding Buyer, Merger
Sub, or the Company Entities or their respective employees that is intended to damage the business or reputation of any such Person.
Nothing in this <U>Section 4(c)(ii)</U> shall limit any Holder&rsquo;s or its Affiliate&rsquo;s ability to make true and accurate
statements or communications in connection with any disclosure the Holder or its Affiliates reasonably believe, based upon the
advice of outside counsel, is required pursuant to applicable Law.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of Buyer and Merger Sub agrees that during the Restricted Period, it shall not (and shall cause its Affiliates not
to), except to the extent done in good faith in any claim, suit, action or proceeding against a Holder, (i) make any negative
statement or communication regarding a Holder or any of such Holder&rsquo;s respective Affiliates with the intent to harm any
such Person or (ii) make any derogatory or disparaging statement or communication regarding a Holder or any of its respective
Affiliates that is intended to damage the business or reputation of any such Person. Nothing in this <U>Section 4(c)(iii)</U>
shall limit any Buyer&rsquo;s or Merger Sub&rsquo;s or their Affiliate&rsquo;s ability to make true and accurate statements or
communications in connection with any disclosure Buyer, Merger Sub or their Affiliates reasonably believe, based upon the advice
of outside counsel, is required pursuant to applicable Law.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary contained herein, this <U>Section 4(c)</U> shall not apply to any action taken
independently by any portfolio company of any affiliated investment fund or similar investment vehicle of such Holder (it being
understood, without limitation, that such action shall not be deemed to be taken independently if such Holder or any of its Affiliates
(other than the portfolio company) was involved in any respect in such action or the decision to engage in such action, or otherwise
encouraged, facilitated (including through the provision of information) or consented to such action).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each Holder acknowledges that Buyer and Merger Sub would be unwilling to enter into the Merger Agreement and the Related
Agreements, or consummate the transactions contemplated thereby, in the absence of this Agreement, and that the covenants contained
herein constitute a material inducement to Buyer and Merger Sub to enter into, and consummate the transactions contemplated by
(including payments of the amounts contemplated by), the Merger Agreement and the other Related Agreements. Without limiting the
generality of the foregoing, such Holder (on its own behalf and on behalf of its Affiliates) acknowledges and agrees that the</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">restrictions
contained in this <U>Section 4</U> are reasonable and necessary to protect the legitimate interests of Buyer and Merger Sub, including
(following the Closing) the goodwill, trade secrets and confidential information of the Company Entities. Accordingly, it is the
intention of the Parties that if any of the restrictions or covenants contained in this <U>Section 4</U> are for any reason held
invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions
of this <U>Section 4</U>, and this <U>Section 4</U> shall be construed as if such invalid, illegal or unenforceable provision
had never been contained herein. It is the further intention of the Parties that if any of the restrictions or covenants contained
herein is held to cover a geographic area or to be for a length of time which is not permitted by applicable Law, or in any way
construed to be too broad or to any extent invalid, such provision shall (to the maximum extent permitted by applicable Law) not
be construed to be null, void and of no effect, but instead shall be construed and interpreted or reformed to provide for a covenant
having the maximum enforceable geographic area, time period and other provisions (not greater than those contained herein) as
shall be valid and enforceable under such applicable Law. If such Holder breaches any provision of this <U>Section 4</U>, with
respect to such breached provision, the Restricted Period shall be tolled and shall not run for the length of such breach.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
5.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Entity Release.</U> Effective as of the Closing, each of Buyer and Merger Sub on behalf of itself and the Company
Entities, and its and their successors and assigns (collectively, the &ldquo;</FONT><FONT STYLE="font-size: 10pt">Buyer Releasing
Parties<FONT STYLE="font-weight: normal">&rdquo;) hereby, forever waives, releases, remises and discharges each Holder from any
claim, liability or obligation that such Buyer Releasing Parties may currently have, or may have in the future, arising prior
to, on or after the Closing Date, in each case, to the extent related to such Holder&rsquo;s capacity as an equityholder of the
Company; provided, however, that the foregoing shall not apply with respect to claims which may not be released under applicable
Law and any claim arising from or relating to or in connection with the Merger Agreement or any Related Agreement.</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
6.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law; Consent to Jurisdiction; WAIVER OF JURY TRIAL</U>. Section&nbsp;7.13 and Section 7.14 of the Merger Agreement
are incorporated herein by reference, <I>mutatis mutandis</I>. THE PARTIES EACH HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT
PERMITTED BY LAW, ANY RIGHT IT MAY HAVE TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (I)&nbsp;ARISING UNDER
THIS AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS AGREEMENT
OR ANY OF THE TRANSACTIONS RELATED TO THIS AGREEMENT, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT,
TORT, EQUITY OR OTHERWISE. THE PARTIES EACH HEREBY AGREE AND CONSENT THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION WILL
BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH
ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE IRREVOCABLE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY
(A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT
SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND
THE OTHER PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Section
7.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Miscellaneous</U>. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement may not be amended, altered, modified or waived except by a written instrument executed by Buyer and each
Holder. No course of dealing between or among any Persons having any interest in this Agreement will be deemed effective to modify,
amend or discharge any part of this Agreement or any rights or obligations of any Person under or by reason of this Agreement.
No waiver of any of the provisions of this Agreement will be deemed or will constitute a waiver of any other provisions, whether
or not similar, nor will any waiver constitute a continuing waiver.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under
applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law in any jurisdiction,
such provision will be ineffective only to the extent of such prohibition or invalidity and only in such jurisdiction, without
invalidating the remainder of such provision or the remaining provisions of this Agreement in such jurisdiction or any provision
of this Agreement in any other jurisdiction.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement and all of the provisions hereof will be binding on and inure to the benefit of each of the Parties and
their respective heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, benefits or obligations
set forth in this Agreement may be assigned (including by operation of law) by any of the Parties without the prior written consent
of Buyer and each Holder and any attempted assignment without such prior written consent will be void.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Parties agree that irreparable damage, for which monetary relief, even if available, would not be an adequate remedy,
would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise
breached, including if the Parties fail to take any action required of them hereunder to consummate the transactions contemplated
by this Agreement. It is accordingly agreed that (i) the Parties will be entitled to seek an injunction or injunctions, specific
performance or other equitable relief to prevent or restrain breaches or threatened breaches of this Agreement and to enforce
specifically the terms and provisions of this Agreement to prevent such breaches or threatened breaches of, or to enforce compliance
with, the covenants and obligations of this Agreement in the courts described in <U>Section 6</U> without proof of damages or
otherwise, this being in addition to any other remedy to which they are entitled under this Agreement and (ii) the right of specific
performance and other equitable relief is an integral part of the transactions contemplated by this Agreement and without that
right neither the Buyer nor such Holder would have entered into this Agreement. The Parties agree not to assert that a remedy
of specific performance or other equitable relief is unenforceable, invalid, contrary to law or inequitable for any reason, and
not to assert that a remedy of monetary damages would provide an adequate remedy or that the Parties otherwise have an adequate
remedy at law. The Parties acknowledge and agree that any Party seeking an injunction or injunctions to prevent breaches of this
Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this <U>Section 7(d)</U> will
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">not
be required to provide any bond or other security in connection with any such order or injunction.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement will automatically terminate, without any notice or other action by any person, if the Merger Agreement
is terminated prior to the Effective Time in accordance with the terms of the Merger Agreement. Upon termination of this Agreement,
no Party shall have any obligations or liabilities under this Agreement; <I>provided, however,</I> that nothing set forth in this
</FONT><FONT STYLE="font-size: 10pt">&lrm;<FONT STYLE="font-weight: normal"><U>Section 7(e)</U> shall relieve any Party from liability
for any willful misconduct under this Agreement or Fraud by such Party prior to the termination hereof.</FONT></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement may be executed by electronic transmission (i.e., facsimile or electronically transmitted portable document
format (PDF) or DocuSign or similar electronic signature) and in counterparts any one of which need not contain the signatures
of more than one Party, but all such counterparts taken together will constitute one and the same instrument.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any notice to the Holder hereunder shall be sent to the Sellers&rsquo; Representative in accordance with Section 7.4 of
the Merger Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Whenever the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement
they will be deemed to be followed by the words &ldquo;without limitation.&rdquo; The phrase &ldquo;to the extent&rdquo; means
&ldquo;the degree by which&rdquo; and not &ldquo;if&rdquo; for all purposes of this Agreement. Words denoting any gender will
include all genders (including the neutral gender). Where a word is defined in this Agreement, references to the singular will
include references to the plural and vice versa. Where specific language is used to clarify by example a general statement contained
in this Agreement, such specific language will not be deemed to modify, limit or restrict in any manner the construction of the
general statement to which it relates. A reference to any party to this Agreement or any other agreement or document will include
such party&rsquo;s successors and permitted assigns. All references to a day or days will be deemed to refer to a calendar day
or calendar days, as applicable, unless otherwise specifically provided and whenever action is required on a day that is not a
Business Day such action may be validly taken on the next Business Day. Any reference to an agreement or Contract in this Agreement
will be a reference to such agreement or Contract as amended, restated, modified, supplemented and/or waived. All references to
an Article, Section or Annex will be deemed to refer to such Article, Section or Annex of this Agreement, unless otherwise specified.
The terms &ldquo;hereby,&rdquo; &ldquo;hereof,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereinafter,&rdquo; &ldquo;hereunder&rdquo;
and derivative words refer to this entire Agreement, unless the context otherwise requires. The words &ldquo;either,&rdquo; &ldquo;or,&rdquo;
&ldquo;neither,&rdquo; &ldquo;nor&rdquo; and &ldquo;any&rdquo; are not exclusive. The words &ldquo;shall&rdquo; and &ldquo;will&rdquo;
denote a directive and obligation, and not an option. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-weight: normal">[<I>Remainder
of page intentionally left blank</I>]</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">IN
WITNESS WHEREOF, each Party has duly executed this Agreement, all as of the date first written above.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>BUYER:</B></FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 6%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 29%"></TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>HOLDER:</B></FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 6%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 29%"></TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 11%">Company Shares:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 24%"></TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>[Signature Page to Support Agreement]</I></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>dp146258_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">
<B>&#9;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="vertical-align: middle; width: 50%; text-align: left"><B>NEWS RELEASE</B></TD>
    <TD STYLE="text-align: right; width: 50%">&nbsp;<IMG SRC="image_001.jpg" ALT="charles_river_logo.jpg" STYLE="height: 59px; width: 226px"></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CHARLES
RIVER LABORATORIES TO ACQUIRE<BR>
COGNATE BIOSERVICES <FONT STYLE="text-transform: uppercase">TO CREATE<BR>
A PREMIER SCIENTIFIC PARTNER<BR>
FOR CELL AND GENE THERAPY DEVELOPMENT</FONT></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><FONT STYLE="font-size: 10pt"><B>&ndash;
Significantly Expands Charles River&rsquo;s Scientific Capabilities<BR>
in the High-Growth Cell and Gene Therapy Sector &ndash;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><FONT STYLE="font-size: 10pt"><B>&ndash;
Combines Cognate&rsquo;s Comprehensive Cell and Gene Therapy<BR>
CDMO Capabilities to Establish an Integrated Solution from<BR>
Discovery through CGMP Manufacturing &ndash;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>WILMINGTON, MA, February 17,
2021</B> &ndash; Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement
to acquire Cognate BioServices, Inc., a premier, cell and gene therapy contract development and manufacturing organization (CDMO),
for approximately $875 million in cash, subject to customary closing adjustments. The transaction is expected to close by the
end of the first quarter of 2021, subject to regulatory requirements and customary closing conditions.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">James C. Foster, Chairman, President
and Chief Executive Officer of Charles River Laboratories, commented, &ldquo;Cognate BioServices presents a unique opportunity
to expand into a high-growth, value-added sector of the CDMO market and enhance our ability to meet our clients&rsquo; needs in
emerging areas of scientific innovation. This acquisition will be an exceptional strategic fit, adding to our comprehensive suite
of early-stage research and manufacturing support solutions and enabling us to achieve our goal of establishing a single scientific
partner to provide biopharmaceutical clients with an integrated solution to help accelerate their cell and gene therapy programs
from discovery and non-clinical development through commercialization.&rdquo;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&ldquo;Because of the synergistic
fit with Charles River, the market growth potential, and the emerging role of advanced drug modalities as treatments for oncology
and rare disease, we believe Cognate will meaningfully enhance our long-term revenue and earnings growth potential. We look forward
to welcoming Cognate&rsquo;s dedicated employees to the Charles River family,&rdquo; Mr. Foster concluded.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Cognate is a premier, cell and
gene therapy CDMO offering comprehensive manufacturing solutions for cell therapies, as well as for production of plasmid DNA
and other inputs in the CDMO value chain. The planned acquisition will establish Charles River as a premier scientific partner
for cell and gene therapy development, testing, and manufacturing, providing clients with an integrated solution from basic research
and discovery through CGMP</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">production. Cognate has extensive
experience producing various cell types and technologies used in cellular immunotherapy and immuno-oncology, regenerative medicine,
and advanced cell therapy. Headquartered in Memphis, Tennessee, Cognate has operations in North America and Europe with over 500
employees.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Strategic Rationale</U></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">The acquisition of Cognate will
expand Charles River&rsquo;s scientific capabilities into the emerging, high-growth cell and gene therapy CDMO sector, establishing
a comprehensive solution from discovery and non-clinical development through CGMP manufacturing in advanced drug modalities.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Expands
                                         Scientific Expertise into Major CDMO Platforms for Cell and Gene Therapies &ndash;</I></B>
                                         Cognate offers its clients a broad portfolio of cell and gene therapy solutions across
                                         the major CDMO platforms, enhancing its ability to meet its clients&rsquo; evolving scientific
                                         needs. Its primary area of expertise is in CGMP cell therapy manufacturing, which processes
                                         a variety of cellular products and other starting materials to develop and produce allogeneic
                                         (donor-derived) and autologous (patient-derived) cell therapies. Cognate also produces
                                         plasmid DNA, which is a foundational tool used in the development of gene-modified cell
                                         therapies and gene therapies, as well as other CDMO inputs.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Complements
                                         Charles River&rsquo;s existing portfolio and establishes a premier scientific partner
                                         for the development, testing, and manufacturing of advanced drug modalities &ndash; </I></B>Biopharmaceutical
                                         clients are seeking to drive greater efficiency and leverage scientific benefits by working
                                         with fewer, trusted partners who have broad, integrated capabilities. The addition of
                                         Cognate will be complementary to Charles River&rsquo;s existing, non-clinical capabilities,
                                         establishing a premier scientific partner for cell and gene therapy development, testing,
                                         and manufacturing, and providing clients with an integrated solution from basic research
                                         through CGMP production.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">Cognate will be particularly
synergistic with the Company&rsquo;s Biologics Testing Solutions business. It will enable clients to seamlessly conduct analytical
testing, process development, and manufacturing for advanced modalities with the same scientific partner, enabling them to achieve
their goal of driving greater efficiency. Clients will also have access to the Company&rsquo;s cellular products as the starting
point for their cell therapy programs and will be able to work with Charles River through every step of the research and early-stage
development process before moving into CGMP production with Cognate, accelerating clients&rsquo; speed to market for advanced
drug modalities.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Enhances
                                         Charles River&rsquo;s growth potential with increased exposure to a high-growth market
                                         sector &ndash;</I></B> Cognate will immediately enhance Charles River&rsquo;s growth
                                         potential by expanding its comprehensive platform of high-growth cell and gene therapy
                                         solutions. The addressable market for Cognate&rsquo;s CDMO services &ndash; principally
                                         cell therapy and plasmid production &ndash; is currently estimated at approximately $1.5
                                         billion and expected</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">to grow at least 25%
annually over the next five years. With a significant portion of cell and gene therapy programs in the preclinical phase, demand
for Cognate&rsquo;s services is expected to intensify as more of these programs progress into late-stage development and commercialization.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Expected
                                         to drive profitable growth and shareholder value &ndash; </I></B>The acquisition is expected
                                         to generate attractive financial returns that are consistent with Charles River&rsquo;s
                                         disciplined investment criteria. It is also expected to be meaningfully accretive to
                                         Charles River&rsquo;s long-term revenue and earnings per share growth. Cognate is expected
                                         to generate annual revenue of approximately $140 million in 2021, and is expected to
                                         grow at least 25% annually over the next five years.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Additional Financial and
Transaction Details</U></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Based on the anticipated completion
of the acquisition by the end of the first quarter, Cognate is expected to add approximately $110 million to Charles River&rsquo;s
2021 consolidated revenue for the partial year. The transaction is expected to be neutral to non-GAAP earnings per share in 2021,
and accretive thereafter. Items excluded from non-GAAP earnings per share are expected to include all acquisition-related costs,
which primarily include amortization of intangible assets, advisory fees, certain costs associated with efficiency initiatives,
and certain third-party integration costs.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">The acquisition and associated
fees are expected to be financed through Charles River&rsquo;s existing credit facility and cash. The Company is evaluating further
optimizing its debt structure which could be used to finance the acquisition and for general corporate purposes.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Cognate is expected to be reported
as part of Charles River&rsquo;s Manufacturing Support segment.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Advisors and Cognate Ownership</U></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Gordon Dyal &amp; Co., LLC is
acting as the exclusive financial advisor to Charles River. Davis Polk &amp; Wardwell LLP is acting as Charles River&rsquo;s transactional
legal counsel, and Weil, Gotshal &amp; Manges LLP is acting as antitrust counsel. Dark Horse Consulting Group, Inc. is acting
as Charles River&rsquo;s strategic advisor.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Cognate is supported by its majority
shareholder, EW Healthcare Partners, as well as minority shareholders, Medivate Partners, BlackRock, and a sovereign wealth fund.
Morgan Stanley &amp; Co. LLC is acting as the exclusive financial advisor and Kirkland &amp; Ellis LLP is acting as legal counsel
to Cognate and its shareholders.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Use of Non-GAAP Financial
Measures</U></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">This news release contains non-GAAP
financial measures, such as non-GAAP earnings per diluted share, which exclude the amortization of intangible assets, integration
costs, advisory fees, and other charges related to our acquisitions and expenses associated with evaluating acquisitions. We exclude
these items from the non-GAAP financial measures because they are</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">outside our normal operations.
There are limitations in using non-GAAP financial measures, as they are not prepared in accordance with generally accepted accounting
principles, and may be different than non-GAAP financial measures used by other companies. In particular, we believe that the
inclusion of supplementary non-GAAP financial measures in this news release helps investors to gain a meaningful understanding
of our core operating results and future prospects without the effect of these often-one-time charges, and is consistent with
how management measures and forecasts the Company's performance, especially when comparing such results to prior periods or forecasts.
We believe that the financial impact of our acquisitions (and in certain cases, the evaluation of such acquisitions, whether or
not ultimately consummated) is often large relative to our overall financial performance, which can adversely affect the comparability
of our results on a period-to-period basis. In addition, certain activities, such as business acquisitions, happen irregularly
and the underlying costs associated with such activities do not recur on a consistent basis. Non-GAAP results also allow investors
to compare the Company&rsquo;s operations against the financial results of other companies in the industry who similarly provide
non-GAAP results. The non-GAAP financial measures included in this news release are not meant to be considered superior to or
a substitute for results of operations prepared in accordance with GAAP. The Company intends to continue to periodically assess
the potential value of reporting non-GAAP results consistent with applicable rules and regulations. A reconciliation of the effect
of this transaction on non-GAAP earnings per share for 2021 to the most directly comparable GAAP financial measure has not been
included because it is impracticable to determine the allocation of the purchase price for the proposed acquisition and other
necessary adjustments at this time.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Caution Concerning Forward-Looking
Statements</U></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">This news release includes forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified
by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;outlook,&rdquo; and &ldquo;project&rdquo; and other similar expressions that
predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements include
statements in this news release regarding the acquisition of Cognate BioServices, expectations regarding the timing of the closing
of the acquisition, and Charles River&rsquo;s expectations with respect to the impact of Cognate on the Company, its product and
service offerings, client perception, revenue, revenue growth rates, and earnings per share; Charles River&rsquo;s projected future
performance including revenue and earnings per share; as well as Charles River&rsquo;s future growth in the area of cell and gene
therapy CDMO services. Forward-looking statements are based on Charles River&rsquo;s current expectations and beliefs, and involve
a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from
those stated or implied by the forward-looking statements. Those risks and uncertainties include, but are not limited to, the
ability to successfully complete the acquisition of Cognate, our ability to successfully integrate Cognate, and risks and uncertainties
associated with Cognate&rsquo;s products and services which are in areas in which Charles River does not currently operate. A
further description of these risks, uncertainties, and other matters can be found in the Risk Factors detailed in Charles River's
Annual Report on Form 10-K as filed on February 11, 2020 and the Quarterly Report on Form 10-Q as filed on October 29, 2020, as
well as other</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">filings we make with the Securities
and Exchange Commission. Because forward-looking statements involve risks and uncertainties, actual results and events may differ
materially from results and events currently expected by Charles River, and Charles River assumes no obligation and expressly
disclaims any duty to update information contained in this news release except as required by law.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt"><B>About
Charles River</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Charles
River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading
academic institutions around the globe accelerate their research and drug development efforts.&nbsp; Our dedicated employees are
focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services,
visit <FONT STYLE="color: blue"><U>www.criver.com</U></FONT>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"># # #</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Investor Contact:</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Media Contact:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Todd Spencer</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Amy Cianciaruso</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Corporate Vice President, Investor Relations</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Corporate Vice President, Public Relations</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">781.222.6455</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">781.222.6168</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: blue"><U>todd.spencer@crl.com</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; color: blue"><U>amy.cianciaruso@crl.com</U></FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1"  [ .(# 2(  A$! Q$!_\0
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M32:;-&[&9FR-I/<]<CM5;PU_R67Q7_U[P?\ H*UU?BO_ )%'6/\ KQF_] -
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*LT44 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>crl-20210217_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>crl-20210217_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://criver.com/role/Cover" xlink:href="crl-20210217.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://criver.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>crl-20210217.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a85s7xRiXgen8uCZHRMWaaLuaP9x5V66ZkxtmtyfbmKXy4nj176ciu8MLl2Ye8K -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:CRL="http://criver.com/20210217" elementFormDefault="qualified" targetNamespace="http://criver.com/20210217">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://criver.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="crl-20210217_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="crl-20210217_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>dp146258_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crl-20210217.xsd" xlink:type="simple"/>
    <context id="From2021-02-17to2021-02-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001100682</identifier>
        </entity>
        <period>
            <startDate>2021-02-17</startDate>
            <endDate>2021-02-17</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-02-17to2021-02-17">0001100682</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-02-17to2021-02-17">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-02-17to2021-02-17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-02-17to2021-02-17">2021-02-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-02-17to2021-02-17">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-02-17to2021-02-17">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-02-17to2021-02-17">001-15943</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-02-17to2021-02-17">06-1397316</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-02-17to2021-02-17">251 Ballardvale Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-02-17to2021-02-17">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-02-17to2021-02-17">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-02-17to2021-02-17">01887</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-02-17to2021-02-17">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-02-17to2021-02-17">222-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2021-02-17to2021-02-17">Common     stock, $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-02-17to2021-02-17">CRL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-02-17to2021-02-17">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="From2021-02-17to2021-02-17">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-02-17to2021-02-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-02-17to2021-02-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-02-17to2021-02-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-02-17to2021-02-17">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140055516030856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 17,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHARLES RIVER LABORATORIES INTERNATIONAL,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001100682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1397316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">251 Ballardvale
Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M/UY_ 5!+ 0(4 Q0    ( '. 45('04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ <X!14D6YXDWN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ <X!14IE<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " !S@%%2BQ\=T$8$  !%$   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ <X!14H.II0/4 0  ,@8   T              ( !B0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !S@%%2EXJ[',     3 @  "P
M    @ &(#@  7W)E;',O+G)E;'-02P$"% ,4    " !S@%%2JL0B%C,!   B
M @  #P              @ %Q#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ <X!14B0>FZ*M    ^ $  !H              ( !T1   'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ <X!14F60>9(9 0  SP,
M !,              ( !MA$  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @   !,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp146258_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://criver.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="dp146258_8k.htm">dp146258_8k.htm</File>
    <File>crl-20210217.xsd</File>
    <File>crl-20210217_lab.xml</File>
    <File>crl-20210217_pre.xml</File>
    <File>dp146258_ex0201.htm</File>
    <File>dp146258_ex1001.htm</File>
    <File>dp146258_ex9901.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dp146258_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dp146258_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "crl-20210217_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crl-20210217_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "crl-20210217.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CRL",
   "nsuri": "http://criver.com/20210217",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "dp146258_8k.htm",
      "contextRef": "From2021-02-17to2021-02-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://criver.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "dp146258_8k.htm",
      "contextRef": "From2021-02-17to2021-02-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://criver.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950103-21-002397-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-21-002397-xbrl.zip
M4$L#!!0    ( '. 45)J:_X".@,  (<,   0    8W)L+3(P,C$P,C$W+GAS
M9+5676_:,!1]WJ3]!R_O3@@=%"BTFJBZH4)7P=IU?9F,8ZA7Q\YLI\"_GYT/
M/@/B8XMX<.X]Y_C8OM>D>34-&7@C4E'!6X[OEAQ .!8!Y>.6\S" GP?M3L<!
M5Y<?W@/S-#]""&XH84$#7 L,.WPD+L ="DD#?"&<2*2%O "/B,4V(FXH(Q*T
M11@QHHE)I#,U0,6M#@&$>\@^$AX(^=#OS&5?M(X:GC>93%PNWM!$R%?E8A'N
MIS?02,=J+E::EK)G/WJ/*CPGUU&MHLZG??HT)KP6MY^_]GL_$.K&Z+X^K3Q6
MJ\^O4QWJV6@8WC[-/O'?_GD5T[C6Z[+R3U*[3:=L*OQ"0@3,47#5<I:6-SES
MA1Q[Y5+)]YYZW4&"<U)@8\HH?RV"^_5ZW4NR.70#.1U*EDN?>38]1(K,E4V6
M[L!3KC3B> 4?Z#EA&5SQTN0*E!9"JRF4YM" K.$4P>Y8O'DF8?#E$BSY\,S/
MX;&"8X2B.66$U#"1SA(%%"7U)MP$BZ%0SR*B"@EIJH#6[G?G!"RI:31;J!;H
MF]^Y:39&0L+UC9#A-1FAF!E'?V+$Z(B2P $:R3'1MO)4A##9J947+^)<F!HW
M;99%;"R*J"EB$WC7M*?=D(*1[\8TL /37$7*-N6UA7EU  U:3CJT&D8Q40G(
MB'*:3)4UD0^@;9G8+LH,$TK36P<O2<2*!-_X93*.)%&&EWCOFD!&S"!;2!@Q
M'+/#. LKA90LD._18M?R1NF3$4@:K&$/ON4H:B\X)XN]2#)J.5@RF)_-+[,R
MUU1$CK#*._HKV?CUS<CFS260Q!LJ&_UO1$1$I*:F.)>:/'5.M:7?+TT#[#S*
M =X_6#%#PT-7;"B$_<>E=JW^\AJSYO 6W9&]KW=0TZQ62 WX1B/NNAS3:[TK
M<"*U@V+?8,Z#-@3]LKE%W*D*%DX/,;'8@<-,Y+PC3.R\HHM<J&TD.X +]KX&
M=E[X6[8AF;^0Z!&F51XYT<WFO\/Q=A*M(_RL''B@I6>%/"XXY.:REA3O5RK+
MS+N4:&NE;FO%KYYHYC@C1[M8*3XL8J[E[/"J72;F+Z?4R_KWQUZEDI/2,K%?
M)*<Y.+9D-WULK]>FETJ:X5]02P,$%     @ <X!14M7ZS.O^"@  X(<  !0
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M,8TIY870[K"(>HI8*B81EQW4<S:FQ<DLPA\$WU@/6Y:=6Q+_H*LJOC@Y\A"
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MVF*JJNE:6A@5W3;4JN?\;UQJ_/U1JW5IZ-TC9_"K!VV)J_J&S.DZ-].#J'?
ME%GWN0SE.J_W\]4*&:F]0:^E.>OQ33M5!Z\3@JACTTVK^];I7NKT-Y%D\O@S
MOMEL6?G,R/:F(J!S5=>=-G6]6T5!,-#ES.2AU**FV L<"TZ3*,D2MOY57JR*
M!-O*9A.YP@(VJ)EH*X(  K1ETG 0(JWT@L*=( I((JLCGZ:HEDH2MP\/UE%
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MKFUSC^$;)T!Q:)10W[X$QE 1K(OVB:Y;N\&]_+?8X_ZX%]S:+?\#4$L#!!0
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MU80%6Z9@\H,.AT_&N/#82M"+5MM2'+^/9".MU)3*G^Q'JZWAR4%3?!S>W"_
MD4[.F=G'*HEM*88(U]8?LN3?Q7Q1(ST\$->959%.T*(?U[_7E$20Z?DFIXPM
M)172[JL;ZU>U;7<11<[8A""#VOG;97)I0MV#$P[I>[07K-[XUJZ:P_7G)U^3
M:2>"Q'3&F4030 P;*(Y]L9T'4D>C",]E/$).\RM(3ZV,S=U@?_J 1QT&J\+
MB/8@&^\Y' O237M(FLRT!X2KJ.D$V$BV<F>DQ4T,3+F *-5EEH%[PA!J"=[U
M3)=:S/:$.2*"NERT1K*KW\-N@E:IPIT?B8V#8>+!0 ZAUBAXUK)-F!W[88F
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M(GC3'_%DBK-BA[/? X]SP4-Q7E%P<P6FRFV0WV0PO5)UU+HU7JSU;KM_96T
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ML%!36L0.3=-8$@MG=_'[)"FFO0N&)Y/2;J7[6YS%!?6;,L?I0W0C?X;S7W%
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M$8]"/K0BV:-XF$9XPT0C4"VD9=P1@QW3<<C* AC1$IGYQ_)J4%-D;)#*4&?
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MCQ\>%ZK/0>9P\:<:$8M&DE%''Z*;T)HJA@W(35&#E3 RL]G *)4U90<9.2F
M1#>5Q!K'M1'OA_C;J.*P!"\.;7"(&V1]."(5UOAN1>J8T$!L82)>!P6+DP5Y
M[3J9BT)B.1X)$,0:)#Y=(8QH"YH0HP9&2/WT'17X&*!0<(PJ7/P6WLUAE YG
M?#:BLOYJ_+T=&\+[S'FS!E;XGG(\0AU#WWLK?T<IH$MLEJ4H\+2.-V"3!Z5&
M$S?F=Q!\RNQA]7LXKG 9W,6][D#;7,<)@R1&LS*V\AIJ+;5A,&K+((^)7XHU
MH5ILIZA//;&NELR7Z$9OWG*X;H@)K")JJI;R^]$@UF^3&#C_^XT*@FN'_SP>
M(FT@^_@:DT1_J0.4P+9"J?Q[EA0T5XX!<,3 &\$+NRTV3[L2EA4Z:KQBGE'2
M.LP?)IUO>@K*ICFPDPB127Q61^ NY!BYH'0"O@JV;HF#RV9F37Q;=C6T#S,*
MC7(_G0/L7G+:BME6(V;SK)4GJ[=6>,_$V(X=K^/89\7S>8AU1PA+ERB="D(A
MP#PM5 O/ST&_]R<<E!PNXC29L#CCWRX9@8BP._DV!C\O<[JV'=7)2J'-]QB@
MR5-4L[@V9GS$#;\8SP,&/&QH',)F:W:_  RUWX".%<QI&I.>#1F7!_\7_+3K
M)(TO\;-I?H,7%P5KP,(;7E$PIYYYJY7RTG)>,SC [T%( !.^-HH'^,Y4&N(I
M<KS1C/ZSEI+TO6> Z?*8W;Y.#VL,9G?,5W;,GZ[^F'\J+J,L^1^I! !#1!OX
M;?LY5P=T.$[!HM-$Y0.-X[07[;,-Y%Y#269#^FM8&+1D,Z63DK9826T._1X'
M15CR.[W3[\:3%I)'+?\8@SK ,N"4]5@TQDL_$OB*K4\K*^X[RT9Q89E[X,#%
MT\I =+)HTJ@_@#L\54@>>I)9!G6+^THLJ,A#+G1!+PYXGP:W8+'8T*D-/6=W
MRC"^>*6RP;_@:"63^RKX5Y3.X,]'WRD!N6#Y[IR!M)="+<*KX.)V"G,]QBX*
MPU?!1Q J7JB/.4[_R$D7JE_A7W;YS(ZQ;]1AY)<LK\2"A@XSY[&CMN(?: .P
M^8ME]%*H;)4[J5(V@991:\W1-A1<L*Q^6VC(?"<QV3HSYEDG ^:+GIC)37U9
M2!8@D%V6&.D'/<^6D45;]."#X'V13]BL)EGWG3E](!#+*_ES_"OXZ]B<&)'$
MF$$=S>#PQB*,.14$Y CSY0SMWS-8<N5WUU%#]8 BPI#),F]"E=F*ZJ@OW),_
MJA>;>%(4VL%H*4SI]Y9^-<:@KYUXF_M-4S)%?\RMS;6\EG94U[PIYXLD9>?%
MK.SX/U]3L$)Y%S7$;9T8*Y],X(O\Q_OZ-MU"!2X>V75T:B54M2!P"VK00>Q0
M2+T.T<3G-'_\<^/'^!($]T9)B>PDM"B"_W0+$%NJ%#N?OCVXO05-3SQ>[AX1
MQ!)CB&!:E%AV3<AZ7"KZ"^):J&3<C4F3,L6'Z$)R+1'J&YWM)P:\U(:E5<80
M53)F96R?=AK=,FJ<<%58O0]*,#,KRQF;_:7"_'/**T-/$6@T ULX(DH2JDCG
M!(>O)C18LB24AXD8H GR4I4X6[J'W.R>^K%*L9 P-NK']9JHD'C]B!KP$%UQ
MWM =GZ+:-$Y 3W&Z0D_(Y%QK,X(7#%5>JSF*8$]@PZIR.+K.$[Z**0\Z&\ .
M8-C]&O,+HW@:\PF@V#OM8AIA/F@,CG3CX?LXQ09Z]UU25D4R8(BB9H!QZX3=
MY:ZO"+[@>,3"0^79UH11$C A2BZ!WC\PS,<!APSM$>5S1G1 23?/ON&IX>(%
M$4<;A(U" /=20P<])]@SRW*6!VF>H98$J;;4BB1C4 MA^@>+Z1AHK;*@%N8"
M<Q (F22;GT*N=>VH L+:?_"<#X]H+3HAS:/JF2SR[7QY3<837A1+G:7@#D?I
M(/B85SA_M91T0\%3&/DIVJ8J4(:;:=B<(4#PM+,XE5.EM0_\!?8KOL8OLF+D
M'!-N'?=>X8P03*Y6/-OOG?P]2ZI;!7%U<]CVI/AW26%F%0]G1<(!=<R$T7MM
M!>\^>1 ["73975B#UC?R9GO?V$ 'J!R&$@P44]E3<MF_#2DCW"(^&."SY.=!
M0ZH^JZ/?$\H%%@*R@DK6OS!XVZ)>>-7/M>];J J(&$1!2QBK"JN'"=CK*$69
MRF:3 8,E&H/S6^@!$9T,O<EGG$>,$8EL2*B:&VDN0P8"K@>='>=%1C/2#-RK
M=8#9$#@((TF4R[/IE?KA^DPVBCB;4=YM]R\>)/9Q-__BQ>K]"ZVX/JG.H^ G
M;.B2;#3FO;E?>]'^BO?KF(.6G4U]Q[OA#>:@(MR%ML+C&"0F7F,K5&K4 )D=
M_&<R_,<S5!NEU@*(U?@N0K,A8/C5B<Q@(T2F5AAH1"+^%A?#I)0[L\VH-1'W
M?D^;K@0J#@A9."?0.-_K#)I.IS9VR9NJ4T>(%VT%%YL ;Q-[N[L'$M@.2+]W
M#P]D(P7U3IG$GW=)0RMI^&27-%RYLARN6EGJ(T^Y26^H?OZEFN6@3OSJ,S3Q
MDWN4@C#3CBBS6A6W7>59-^F-XB87Q1,XQD>YL0>%DZ#;WQ]KLYW"851>&06N
M' /T>YA-X8[A+BSS7!# :PUWZ1AQYY#47J0"0!+!('NGY@LWP=NRT<?T&R\7
MWCTNEX<,;\D*27S+2$D32&Z%?'Y]\YJ+%GYZ@TX)G,,'CW1A78<=R_\.D2ZL
M*_3-.UA'S$OV::O,@TUQ&WV>],^K]Z1U<DD(97:N]":[TNW!XV:PN!9.#GUY
M/5+1F%RY2R"1(H;Z"8J%!9_.[/;()HWFA1WQ11;_C/VP*X8E3>,BO97/T4/3
MR4ZE3$R8$::2B3)7Q1K]G@04+07%.AM?#E</6!W\8[PB14^54C"B;H:CYT=N
MB8C-ZZR_4F-1EI(Q%9NT^,-KZ5KG8F7;! VNCF2QLH66MG=]10YW*N7=]#1U
M/2)< PCAX9L $3ST;U6^=\AW(5?<EE4<C4)>?;GNC"]M;::XNCJIBZ1YQ&@0
M>S:O#IVQ5K8UU([OK"^G#,6Q%8FE3N> #7*NYL:[!J,)!+6\HE/^2E_J%#R?
M>ZM[EJ?QYOD+)74$%O530WV[$F;OEC*3:":R8]<Y%7#(O#0]A?HWF&IU#KV6
M4']#,55N!0A;?;Z!.VL>MH*-0EP^LLA!87!-2V$7]]&LJ9Z3K?E1$=U0066:
MES4_P*@81C Z:H#IUF:<K$']$5,9Z5^S(BE'R= *+&FZ2=:B]FEAGPHDHE8L
M6L2@C<8&C#FX=7>W0G-VGD@VXYN#V,GP>I:OWR-MC2J&Y<?\E,"H*N=#"D2X
M\U6.O2['X0)]%+2I(TGSNOI(FZ5:"X7ZC/*;U3E11K<\/1FU'2C^HBZ&;!Z/
MYI9;AWUGJ&YD-/C"YGSD[9(C%# 3)9ZV9&@51$L24:R-,8,ZC5W1M(2,THA2
M<S'P[TNV=$AMDGK$&[*0JIPR+JYKR KG2&/>F=*@(%ZA.D8-H)2I#3V0&?B"
M& RBS8E':I9AJ1U=PGAXDBFZAV+F9*!UJR0R2+//13Z,8U3,33(I:YWHT!-%
M'F*Y?(NGT[,U.])OG)F:5(NIE=4QAE0,V\$<*W-W)#<RYM@=Q:+J#2@WLA <
MUA+A&,53^+@2@!_]V&Y9V>_I\R<EYVY0@N)4K3<J_&!69.:6MLT;JSL-VAL9
M%TE4V Z&R39P\&.L((?_+/?[/2[U1B-1J&/Y&"D HQPJ*0^G[)"H O];(TXJ
M<5FYSC^-F!F(H[=/GC^##VY+_CM;7LU '>6]?/2S+F6'%_>J^7.]ILE^TSD0
MYFQGP^FWG7=\NX_]!H&[7ZX^9/1'C 9C4D[H-O@L^4X4L7<6A:-%3] MIO0?
M"*C9B)C2>Q7PE:)R/),J2VTK!(IT*TYJ]"<;('31%E'P(48"&)2""^1)0@(>
M4!=H), RP,H5Y&%, D23YQFX"HB60^<9O08FZY0>6?-H,C9RQ^Z4='ZY2SI;
M2>>GNZ3S?4L0ZP0R>S83K?=TNG1V+?$X/HVV(B X[$U2""/:F)]K1Y"CZRA)
M^5R/9^A,B95EVV\AI6$9VZQRLSH#VZVJH,5P5)$(57CA[1PPGP[<S9\]9YXS
MXI:B:<P*N W!I_E<H =J,5))[_AW;+KV>YQFA<6]< C*T(P+*?_(!$)DA]WD
M#F5;Z263#-X)QOG6JX9EATH)5'MW/93B1T6KQ)3*DVD:M]"DX^O9_1TJ4C?)
M:?IH&ET;G>1&T.=-:+RZ/%PD^(HV7]; ]\*[;GZC8F>1)/1[(@J2<,?^$93L
M;J]Y*;MGR?>5AZ'RN0KF3=$RU3C#WA"%?NA^@@/G ..JX30L3VAPV[ZQQ&#1
M\D<=K_,;#M*#QR>+SH1,I[O@U]/7*LH:_OK3Z6L^9M2X(V@K'FJ0L0HRH+*0
M(_?P89FNM19YJ3<SV.Z:]DVQD5<>@:S9R+KBA+Q]35R/V4^O[).K/DI&CC!1
MAR0- NHN5K4ZE;K&M".11I')7!UM]A)\"5)HGAN9<S_^.Z/?6]VE47]MESLB
M9%@-(KIQ'=V+DH,D$KWE?7DPZT)#9N?>:$M?,!TTN2P:HLR^AR9W_N9T(EJU
M)@<]_BKP:/)F%2@%(]:GR>LA=,,)KC1Y\#$W>$(8+35ICG'9G0W%\/IP6&!%
MERI4;3-BVBP]/$V4USH(OB#E!5ZTV&QC)#TJO.M=I_=S4&-^=3$0Q%S#D)8I
MZ8[:<M%2HF96@-%#Y8&9,(8N!F3./9X=K3Y?K7>+<O1:>2KFT(9O=%'_WHU6
M2<\MCV9NRJW^ $F,C-5&H]>U(^.>:TJ43Y.'11UMY&0TAU;P4,VD! H[H12$
MF/)675J<C0 ?8S9(DR'3H7#3>LV(R^A-4R,2#4!D<\QCJ(>%05R">Q#1>,MD
M KJ_0)Z:[1;'#0JN'SY>?73]8][OO9\5E)3YI"M7SQB1D_@85 Q)?1?2"!OS
M:R&TF_A?Q]1MEF1[4L"^:T9HWAME >J@.%6[5*%7(Z0?,W*/YS_ESDB29_0Z
MS)AK8Q0,9Z_GX==)/>NA9#D,@!<>5A&=[,CT'A6+2A/K8]O28C2'D2D?UX=&
MJWT3+XVV9 #/MN=/-NG8/D!/F,\6%O(T0V;>>(1>B?2%H4QMLT^$H7UGJ[;.
M:("B;S_-#0:IV(^,ERDM#@_[O;UFK<=93-9F?6@:F*H. 1Y!).>C;VN2&?SW
MK7-NT8'@6=#E"5/$&DD&:8'U%PV1D1@UD?O[4&HIV]L[.C<IDN#K))%T8(['
MN #DO$C76'@V7)!!&G/;@3%R*>B*F#D+H!RMVN^97L#TT])4M[J8!H>?(>8F
M58:KHE\34[[?PTX5LXQ>J6U#-.RKI)I5.I?N[&U+=P1#XHH20A$'M1DJK6X&
MINM_%->6$RJVU_<$<_6)QD$0TDB&*Y72::HOBJA(Z#&,GB.Z)Z)M*(Q[HIT0
M1DNYB"#Z*X.NV:Y&7 ,\_T,29\A7K\&#B[;,1FU@*]]XM&5Z<7XB\/#Q+A-H
M90*?_4"9P$VZ_QZ@F=)">B^3#]FA0388#7(,)@SW2$<H:#VZVO':GN)]7_#5
MI1 CB)^3KC8Y&_[BZ.X;V"X5V_9[)1H.OM99)D2G9.Q<?=6MLH&;'/_*EI(U
M/!V>I :<XPB]E%@>BK=OR)>797*4W+85GZ9Z;;$\CW.A:M+BCH&KA0/&;]EC
M=9_Q$<R[/_/B*X?YHVF"05/P+:;IK(35H:#!_N*76(\):D_I]&[U(TQ98N"A
MNN>[Y2GM[W:N^+97&,W29L7R0[^PV57KJ7-A.K8%)]^F8'?$[:_R/P,<,<]#
M&H7378*48 _.4M4\I8C'2&;<.IA%NM5;NLUGOC5?S &#.0>*3G+89#*MO#][
M2V7T_K_-D48M5TO\MBF4;3]VK6O5X&_^'GOE)*1H/2LUMFU]H8X1#"L3GE!/
MBS$+/(.]=]"+$4+V.J2_B*\3N%4DK\:6?N8.WDB"V3 U0^]^F\H:MY!")1L,
MX1J5-<#XC8K<[GCAIES5*T]*WX-)TC"5ZR[1EK]+SBQUC=9<_BS\D9V'\8H9
MEZB0LTRI[1H_0:6ZHA1<UH+E9J1=4 JIB=&M-[RHF2D5+T4+V66HZX&18%"&
MDA1*@6'DSZ#UX4FJ+B5<'"AL.,Z@=G1AJ&K!=*N1[Q+R-Z_0D%;G638[YKZ0
M+N)^@7Z9%=&0*)0G23DTW0UU$'C[F9@V8W#KR#3]27B%?N_E8R[5\)-L<)#&
MNB=\=K0J4IG7,9!'AK6[MB'=[S7#@EWL9QJ0SW*VI+(>N3+V@'63]WO=S( .
MIF3++]SH7JLQZ#?D[F.\L3G5Q8@R4-1Y2]718+KS2O5[7N/HCB916_)GOD74
M[[UWCL%\D5;R1Z"!:547.-<,TIT_6O[.&1S9Q0Y<37 &829$2Z7+OD?V417.
M"2(#TJU;&Z%6<R&YDT.D0!X*&6"9E-7B]6 H#5AJM2>IVT%LR-95&MP*K$96
MO]^[V^M$M+6_'%%K%4QD6!]6I--I8Z9T?O1?=.$NGXE!GG_E+ZK\FG6!WH"
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M9-U7\WK;SW->U+VC$I56P-YB/K[CTPWF9=X*)MR_0472;3-&L5<KB$ T&L$
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M51".?F]/\6_@_\5>'/C32^9398)5I. 5%9Q&4VYCAZR/I)C!F[VB]N^*E%5
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MU5UY#A+BG\M]+A!3^0-E)UTK7F!%P ":1OUWPQ@A6Y]H3Y-A91(Y\U=R(T_
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MH=O.#$7!HBSC9J1-BBM=&D(AI1'EI# ,@SQA\8"\&\X5CY)*.3H)? !+DD]
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MX4N#L 'C*!':\GI$BQ&ETFVBQ&[HID-0#GH9&^Y0NL7;)<@L;6TMYG6GHFJ
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MZ/?4(7CZ\R%,T&OG>H\#?HLX#Z,;?1YMKW:_T5/5H@;6S)'$C*QX4;DU@S\
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M(I!:3!B;/4W:?YKB$&\/HM H4P47#Y!YFU]O4.$^4V]N>_"BT2 9.W\PW%T
M"D)Q:=H8JAXE\F@QO23MC]8:9IT)O&!#Z18686SH0=K*<_XP!UV?;3Q8A >#
M#53PRJ'6[WBL.9 :7.33X*W< *&R"53"2O.%M)#-DU_+X9J2RH65=4'!7.61
M+W1T818&]=!RO?^S*,FT&1?YQ&TF4NK)$I]7<[;49T?7/=M%SX.X=I@/Z2C#
M_]]06=H^4=<U'@_D3/L$W1@RM1(UYK<DOVII@VG?.C7]'AZ;\QEBCKB\Q3XU
MZD72OH$B.(H$8ZPM8JHOHP<@K5N>(Y^R.CZA-ME#*_)E FQTFZB.4PO.E>6&
MW_5<>94(U;ET/5=/=S&JU1ZKASE5*.%_Y7 @@FMCRZDD0%04"#RP> 9-?(F$
M&,^ 5?5%7"C7,7P"ATW:-(' 7&(A$&>B%1FM92F^M84/#1]]T'7B[S<TJZ@9
M%%)/Z I#ZZB'IO183+XT0G9E>%YH*)+\[@Z7N<YK$N>&F]O.U<Y:6IVL/[13
MI!0W4?V4B=WA2]):$LW7,C#+DDJ5DR@R+B89<G[M-OBIRTJ_9Z(@UCV%"-B2
MF8KP%.;%;;?0ADO[ C_.4W)G;!/?9^J$8#99$'D347!:7)ER?'>9"F?>NM8!
M2QAFDXGTEJN5/3MYRS%W5:HG!;F*>U.E=!L/T<.<HDD=XUI#K*'LS+(AB$\\
M:I1+^)IB)=D8$PG":3Y)2OAID8,3KH%K+*W72<XU)63U^Z.0[B'V4H X 3],
MX;M#+ WS!AR'MBNC0VM1B2]:UI5MO9FJ&_[W$ PXHJ]@5 X#Q'F@G'=,HQNJ
M8MM0 =S*\_'0UXQ)DGDZ8)=6;2%AB.FNL G^&>;D#T)I9:ZP4$.X1+(16E18
M\[WC2]_>:D,_%%V5' H!@:A>22R BD!PGUW/-(C-'_=K?6[F@]TI8V+P[4[=
M*VMBN^<I\<Y2J-?7)K9U2$N-*!F[;Q(&2)>)"M8E- P%IBJCV><5'RF),_#Q
MHWUAYO4R<X.+9+&+4$-8/,]SF[VRZA_LVYA;*D\B&G(AR,+O*")RUSS21(,6
M-SEJE08YN>:T8KX,9AKGA-="RF(]M,XCHUM7AK:1Q_=NJ?NGN]2]G;I_N4O=
MWS<'V7IL6SH#>'1)15V"Q4[&W#@IEE 3';F4L[GMJPVB[&LQFU9#:LA&K&?9
M$(E-QT4T0U7+J/'K^!9?AXK KA4 ^QO)7/(BF4V<6I(/6($:D4HD>T98?W0T
M42([EW&&I>NI<$V5RIJE7#YYE=Q1@TW?7%K4@>WMD&7K)AYNB2=>)=Q=3S)T
MX#;?E1=77ZA$QLS?R.9Q(?,=H9T?18<^#BR"*$_;C-9+2&IM\9VD65OXH53N
M3C*!S;8=JQN138J_\/[PD]);)D W+O?:Z'$E0OOC)8:/V'L['D('2>H'\EEE
M$:FGT;1L,-_O4PL8#Q,SV3+W[P8C"Z@VL'4:V-G>93F>UR=&Y]+M[C#J\J9L
M@X1VM'7@JUL\",X3MN#X8RV0/H[M,)A[3CJ(K"3T,RY.<OGS46EQ1%:%<CWT
MPWK++1X9S) +$2!]BNMSE4P-4;1#Y*]TK\.S)\!*+-+.X,+("T6S"'\"S8OX
M@(H+:I16%+4\7RY=%)-6__G\GQWT>_76L?-?PYT?L.FW,D15,X=H!E<MS'!(
M8Z]/+AJ0&6B.AZ2<5%GAK6%D4ZN6F;:F ANYA.W.3*3=/,S0:'$?"7KJC@G'
M/[B-J \?1R#;M[\L>F&'2OO#QRMPGN\V'*KMMD.$IE,L5>0[[#XXTKWCI=H]
MXTGFS!8%!>$$CF+L_JL37O2Q9'<#_@M&#>'S#)OOPA3@MLHBFH+U"[PR5.:,
M+"AC 1GV7EU=+@WBI3C!7Y+N CGXCD<-<0X*+1DE4:$ZBVF&9@WT&MDC\\=;
MP2I"S0A?4@VUVEM<H6-*F-+YEH5Q0BU#VK-A;Y;>L&E4<?T(DV524QIG@;NO
M([[D)P3%>59RL?<-(U"++6,*VH9$#0?R%"F\=0F*/0[?&. SRNFV_8;'#N+8
M^*%$M3-$QF6\"9%=5*"_05<$?J>+_4W[A9O5B<+@&*^U,/@]!L\%[RPXXE%6
M/KJGGC.^Y/?7L(Z:,BN"*[0YT91U\&_L(1N?UXH4D9>^W0P09W'FDY(3G36S
MJ^M6ZPYM;DM^B,Z#J8,60EWP4*P"KU;$>1BX-(7^=W1DD>,C$;(V0@"%U1\G
MD;Z]H4R.%:NTW)56)/4)J\'Z!S6GB0^V7YV#1Q6GD#A4%ZRNO54"@*)Q$JUP
M)D%JO?(2$K9^U._Y?K6_8%<LOKW17S-0M[A6?(O (V:9W>*1,MQY&JNFW)N9
MB/B/SY)47D^<FC\5[)!'?CO!;CXED'33K<>N=E''QR_(68R)-JI](((_E",A
MSR>V[3%_ .(4"O_B<OU_6KM;;.2.;YLXKIQ"D$B]^:;ZD.=?B6'N'7%/^YI'
M9BX[A&-A+8B.E(S*K)5R4@P#HQ(Z$C ?,A%Z,!.Z+MIZK%_VO:")S=S[;1/,
MT:H%,VMR6QH2^H:X:K&ABCA06*H=2,9$[;'N=&S+%S&?.B*&O\^=3I8L9ORX
MQ.Y?)@^B_#&]4AIUZ'=*LX'%+U5$BZ:GB\@V4K6V&V--L=],:=DV48X?X,HO
M8H*89[E4;;:(<6@,/OSJ9]VB1;= Z=2TM[JBC@P92K-DZ;S Q#UN-Q5?LM4?
M<2ZOI7S..F&U(^.37;D#_'$JG\;.BXV4C[MEWI_M,N]6YOWH\2[S?M_X_1[1
M^P^O\+AFE\I+)T>!@9_*4:#T,RB8(1RUD+S,@I)%5-[-&&S^-Y-^-P^[I+U5
MF0,Y M:W6L@W=E73J[AZQBN_>J0&9&ZVVU;#K29.5XMEKMI7(2JKR<[BL)2%
M!XEU0+9+&]A!K0FLXM=SRLO"A;0.8:-C\6;*T[8)^^6JA3TV -2[B$>P(NFP
M<3?>$ G^P&XS75;Q%,G<2UA@U: E(<8]%8$9$RT'C$)QS*4+@J(:QB_A9(M)
MOCD!JFR01I-D>UI05ON,-Y$B\TXN*YYK-(-,,XHVYI2$^D&B_D /:3;-,[T&
MZJZK+T.E.B:VY:6<^+MJK&C9U\$LB[CB#DM++1X3L4Y5 :E^Z_PEMUO8RWBY
M:DB5=>"'%JUQZ7; ID26 Y&G5@XHPE%*S=O!9IIARY40J1FCI!"@ ZS/+"E=
MUHL6F= @*!ZE+ F!CW$], 1?)#(X!436RQ(RDXX5A51-2^I4$'/R$Z2"ZV'R
M+OF)[U<@\J.IW:L?6NVVI5&P(7RKTTTI]20>6: T@SI%>&BH2YU0I&U,NTY?
M96CI<%*/_P6J-\7H?"F@+8X&@?ET'2& =115$=9C5=*W0\K+#*$+=9TLP!6A
M@V?BGM2WM>16Q1838Y+IKHQ:^9O2K0;JELDA&6FG4F"?K8ZPILS!ZA:\5.C!
M (0] 86V,)Z.1D3-^&X=&Q+:NHS"9!?!L=2F,O6EP"$8?JM0F5D6RWTWI7Q@
MZ1<98G#FU$=C\502!$$1MKTL/Z"P"^-\/:D>NOT-_1G!UN:8 B(B-,@RAG>1
M>X<B=UFHQK=\=<[R66GV59:KWRO!&Y=,IV),[;"+];M2O5IC<?'05L6LM#;(
MK+_J_.,(I;HQU/6'XFW< 6Z?3"].,GV[2+Z6/A[<[K?)S:Z#S(HZR!P>KOAR
M^/7+ZP]8@4->H-(NC%/K#&\G9 &.C<O$*E5^'0J,WZ]*E R+'@NI.:*^5FQ=
MA\UO[QA?G=<A&TD?;O636?[-#[VY*.=QBH77\8!!;:71C=R95#7 K+\<()-^
M<>W,$LSO7@R2BDHA!%F;C#5:F ^D[BD?C> I99S>MI1R!&"]@AY(QF,=-D*T
M8#;2"%W'$.CWUF$)^(%;V+#/+U9A:S/V9A-$*P/:N!84,4*A:)'%L[&J[!PB
M!4R0A@'B.BC928Q7):4]X41/I<L@"/E-5%!:2KI/C^)A8=B@\8ZWZ'3\VWX0
M= %C;7BOIDU2DT>K5Y-OBOQKC/8>:<=^3PDQ C+&J@J"BJS1[IA&M\H)_X.J
MG(+S*LK2^#;X9S0!U^YM?A!\^/ VI-X97*L!9P-#:*93CUW-K8L-\ S\$1>7
MR+2G#0#-&Z"K0_8LYAAD"8";7.[U?4M#XP$:@H:8,,)WH*9(]D]22J7'&'>C
MT J$)DL$;+YF/YY>[\LZUH-(JG0),6J8@ *;A!39($8Q_AK/%G8ZOXK2<7L7
MD<'M7%;X03[+&%S#W^)5[-)L W$ZWFX;/F6X;U<IXQ\T&8.C C;I?'F._Z9I
M**\*>+)Z%6"X=%3CK#?<URKXG()X;V'#O05YTN>[/*F=)SW<Y4DW']F]H/KV
M\,F<UHJJ8E*;@-Z#WE;)6"^:HT=YG^#BGN'_G7*("J]'='[@*_ON!8)7?4LE
M* :_IDR02N09)C86*A<@"T;Y<,9&!157V&1*IL#3E&I*%31U!T+0((5/X/8C
MV(CT"\&VX#\5,8:*@[WW&,%Y]NSQXWV.]]?9EMQE=:8+KF<:99VG"WM%<?M"
M1YR,!X*EARKQL-TQATTYGJMGH:%::_^YTO:LRBU)+5@T L]758.U 9CG$J.8
MRJP$&TDEU#U]HJK&3%"N]>':D+4BSTZ'-Y#%D[/3\V,EQZ/8*HNNA:O!>_AD
MCG^1(Q8Q=@QQ7I52F>H$3?,%1^X:%[&#ORU*3N(45#2,E.1L?_/(ADG$3(&4
M@_/_7FSG%H>WWSMOB_8W@YN1"KC/T"&?FMEC;!)7S>$TG+.>5K1'YL_952=R
MH1V=KVHA?1$E!MVT+!T'>]JG#TX#N1G=0CNUP(JOC-(;S7'2.E*ZH(JW^[UC
M?GYP0C62.VVYD?#_>=I2M3TA0@-Q_B=Q7$F%L*N;-#O5W\C5/,9D&MH%JHD+
MDUQ(CWH>W]/'ATA09?+TH[A60\!] TFKN60&:5Q5[#TGFNR?]"T-!#,F.7:E
MQB]<YRG8)1B"HU1"P=:*ACNHEV$K:O,V,'<RZSU4N*!PV)3:.Q-^]W.N@MX)
M]T:6$'R<2T!C:@,PV<?(:PK&Z.RNY #E6U*WI[YFL5QZN"PNL+:1AWKZ+S9
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MDTUG&I+SC=DOVTC+>K/*YN.'RJ:M;+YXJ&S>MM'O%(G[8,.(!5?BHVZNE9B
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M0.?],:4'JWW$,XS_XBBVC&<P_VUXCM:2S.&%W(W6+SX>.7^C;OT!N=,T@XV
M=,@DH, ]^SGCO*OQF-XQ[@,DT$N3&2T:^-/YU0Q?!@O0QJL8=PG%KHMR0MZD
M+!CQ2+UD@9N?[:UHP5ADXH::S)N5H)\\E*!M"?K[AQ+T;4M#U/6)<4ZXL5O
M)+0%8JH%Z->!?R3_RP,<V21'!AO. '  T?8P2!%5ZLG TV:GH03[O>/&B!^S
M8R/[;B H9*(IZ8-'N;:'Z7GF6ESP'/4V"ROQ:+%:]BHP5YW6JD>R4XWQ4(#*
M'N<M!Y+B??3T=;HX\.Y+%I1 M_4*(L^%4$@&UQ;\,J<.\7U<%-4D"'_;!^F*
M5\0J028#"A,K1QB\; *3TBF%;DU5+SG GCU" M?N<>CEVVGK@C6K.,O'V@#B
MO%&2]091O2@!H&OF21G:;^E^5VXWR.W_"LIZQX*,ELCU<$JZ6',L3&1C;%(5
M**34XV3!2*HC0*JJ^-TUT:IQAC>H;[A*AL^540K?)I#E B9O9S(]P=6H3J*7
M?)QV-!"PO[.H+_BA'5.,I,X"($AS3OR?L \1BBI5!@S<6P5'S-Y1,S#\Y4I,
M-&:]?T(?E^(::2@63 W+0&0)J8ZBM:2K8XDD3\ZH*BQZ.#3=CJ93+.'*4= +
M0&A_-!R3WMS>RGQ9-T\P(3\U$0#?4RE0799M;ILL!S_Q.P-OFC,>(Q16G><.
MIFF[IN/!>E4=5!(!AT0/$B)=ULDJ\+QC>M]1+E&?3:2XOR_K]UQJ\N!-<+K1
M?93C11*.+#A.&>435J$&*XW-!8G0*VN$28D_E"OS_0*]("1K.S'"Q:Y7N^@>
M4BAW9DN_@D[736A8.SCQ8NHPHL1[^:]N-DRE(PQLV]/M+60%A+^]/3SXQ%2"
MKXDH4(=(9'K[;]_VT$N&(TB3D$]1J ?-)W:[2#1AZ;98-,-AILG!_JM?^KC1
ME!GSIGR8VUN=A)C):C[,^[[-[@^SX+-DW<T54NYMX@QL\MMAU8\/_SQX#UM$
M6#<=@^GQ?6<AW)ACY=E78<!3/60' GEIE+MVDTV;EOO6]W?GG?:O%S7YT-0$
MQ&@AAY(9.3<Z"*3!G2XF#![(:E*]B$K@CHA$^KI<Y!-<IDL"MZ<7\/GN'L/#
MYEY&C\I ".Z:8A\NC#M4*!&D* G%! I^0=-@<)=G?)>4Y+KI:S[!$\1FT8-$
M2(O713.$B4 G6F_3#+093CJF!%]4DCP)?M&5(W<DJI(/^B35:4Z"T0Z^BO.%
MDN:ICR9%3@M]_'PTD'ZVS(1;@JXU:9^W#,<-V$U,*T:'KJ#V5?0HLE+GF!-0
M^8T#$!,I.'4:UA%ER707O(U@[NK<]YMS6&\Y>HB/#H)->!/XX067FCGFD3 %
M$V4P6QZ%@P\XNB@:ND5'MA+.FL/7W^W]  %.AN^MT;;P[:W%C-$99LIZ9%?"
MA*#HF.%+I/B+):T)PI.-\_D5+02'KE'A"EH5.IJ4(WR]#RV$G?U!LB =,S=E
MIY@WS!'(QPVI@F"+R+UD1WK]U['ILV\K?X?2(]@3S-HCZXB]TI,U<UZ\\-"S
M# 8XPY552*?XSDM^BNCEVR=)@](- 6+@T_ED[!ZE>^@$4V<6A^2RJK]0+XL$
M\=$^G1=3Z9L%*SO)78)&ZK:*-Y2^?P0X9E>JI>T^(]"EP:TGYJ?D;X=_IR[,
M$8I?'E+/<A;L'8\HI"6.,^@ISPB )ND4RF;F\$R^V]]H,2<'1NTW@&MUDTJ,
M6:)/:LK<!BPEY!Q+P57M\/A"V\ %[MWDLW0I$Z6 3KOK,4*Z"E=9#TUY;+X#
MY7::(2ZZW\(6#Z0OSEMC9X*-6=Y1]<*6,4:"R.M:8Z:_6KE.>&]NI$=RLV+E
MTX=BI2U6_O!0K+QM-:1M$9<:UUNX0LD23VA[ZP]QA9)^3PC,X!_D"B6=GE (
M.OFZKE 2>$+4<DK<',XHSW VY[8 V^/><+>78*FHW6N>?1&&@Z$4CC/L:!W3
M'TJ9_# DP@4S!X]E>^ME-J$)/#[/<_@6-YN=YD&5XY1?Z*02@&+?X100,_0R
MHSQ7O3BA2F0]]IZ/-O31P+]($_0P^"'CGHSHC*:Z4YTC@J>DSG2-O_Z1PXQ.
M9Y/J*L\E[**R]9*1%")R1\4HG!$\M'5ZZGP&%IUWIMSBF!4/L<,/AZU5YOM=
MHMV43,*=,PB]A]U&,9-Z93TK0<)L1F_,62<4ED!(2=,'2!Y2HR?5O>J*ZG*"
MXE7@1;=%4C<8%5*'2YTOYC2>3O-ZR(PV0Z%%Z:0_??V@-GAWZ<BOP?Y)/6R"
M%WC='VZTCI>S6FRPK[=3EY]G'XQ[R\S1S9US+KYA1]27B9-S7'9T33I4S3>%
M_P,W@6)_FBH16E[*&,&XT1;[(J^XN3YZF+F3M*\AC8+D5D-?[YYC^5O6%* T
M886E[D;Z5CPX53=EGT0H608O&QPZ1B:6"MJG<IX8?@V4WH S)U^WF<I'AL'Y
MA[49/O\HPB2LF;0[5H@(H3P'_U9?@_2#>4IQJV\J;IR<9$2&!.:"6KXJ#%GG
M!$?A*1ICV(P-G>!%WJ17-/7PDI(M;D<83&O8,C=%WBL/"^<"&9&ESS.57B-U
M5 2:YOLL\2/+^$A:,(YXCQ3C<*YKO=<"12_8<=IQ31QFOAVPWJ;_<I-?'K +
MX5[*I/B"L"#L=MN/.;W@?DS-EA$'+!\=VUL3Y$Q ,W]1P#^9C8#YT,A97S#_
M8?0&D^J2CR_/!IU2?JL#A]>.-YH QK*/[Z8&BTI_&BC&(J3FZ@E/VJ_8IVKI
MO>Z\"EC?7&]OR"X&BWV!6"4V7(3USVK5$\!?S9!L8;20/@)<VA48<F,CIAG8
M*.8>PBV#V'-$%=9(M4,?XK?,0$9J $+K &OE/*NGGNY5GJ6X <RO9O('WW<)
M:ZHSMQ;S*+72K<INB[BA3!.6 :X*=\2*?.R40@MC$JBGFWL"_.JWW4I.?&18
MU,/%%-_"D).RAD55^P@8IH;:X3;W!5%'QGW5TB3N-S&2/.&!$O:H3F>2Q#(K
ME"&@XA'QBEL@ZX49*<V@8[] 2Q!&2DHP0KQ/T4VST4A(!-S<15N0TZY$/!1]
M5VVJ64 3[&> 0)(6DWW@8>4(<)G5B/9"=@J_'NPF'^;GBE#+&B4VF%R91*.>
M>I@.9D$/S! A$VLWFZ\N0.,KT#XSG/H[T;IBPQE;2_R0;X!E!LAY136D.>Y^
MMKIC<!CJU%$:0\0F09EC,TZ=JG;*,O,%?T%2NO@=A%SC-_#__+/"DSF$]A;"
M^1DL#^XM6Y_WT.DW6_Y*_@!F7&%67:HUNEQK!TO#41"MVDTA42;E!>KJO#B5
MS(!,GA"D3*>+4M#DDCC9V1M8<M^^B@>=W&XN,!7LDA9]&9%KG_-!P#Y>U/@F
MO/7"]1 &YI$A7'E+[4XFJSUB^/S.XP&=F.8A_D^3O#HO\G%RP/RIL+T^\*KC
M_<E_?..ZH^6/KM+#NH42M>$!Q,O&IMO-J>[\VOCD[QT#C+IG"*DI2NBNB-W<
M^! @E@=KSB%B;!-7H!]^ID 'F,ZRA.<;['8;A,ZC9*6O1!R IP6WJFHUW8P^
M<B2M[Q>RL5N/BSE>0J\.5E99-.>P($)2T#""I_ =8C2&<;R1Q95=5(74[V%@
MHVIQRJ<J+,W\PCFB@K3F$A,OZ,26;_QM),8S]PI[]D+.U^[:F.^NX/.0_5BA
MC1W[KE_34F]I!MIVV!15>>XN8$T@*T &:XI;]'$G,',.:\I<%'6E]%4$4D\3
M?SC+R,%Q): M&"'J!*6]+.E"@E1+%NSC.49+AX=@3.QE Q(@EX!38JRJF."C
MG-7(;'C)*.R<Q.CN&5YP16GIV4-IR926GCSZADI+&Y29^@H,?2<^=B7;J11N
M'ZFBY(G<V-X:J2ALXF#(?9C$- H&2+4_RGV_.Y]]S)!PU1$KNM;ICJ8R/L9/
MT2.@E(!U_GM153!C3+O>+U;!7.;2<F@"^51A%DBR/9]/G"^#L1)3;+M^02F\
M[8_P9=/G7F63X4+\4EPJ@S"U1SXA'\7TS^TMWU"WI%:TP[0W.J)P-"0JQW 0
M<!8F'*M15H!P=-W)%Z.0LKW%KUP)O:(/[U0F0-%6P:%\QMWO-)]?YGG9Z7L.
M3#^2$JTS<X\$=0TV;O/W\?B T^BL8]BIIF2P!_R<Y$/4FPC7[AH/$CR$7[A^
M')WYP[ 3=> '1!<^YZ=TIVR0*.E;J<;?>+*[]X.J#01Y2HU5-'HHR@5>OX\1
M944X-'?NR3T[B#=E>%WV^2MP+(+%G4!XAU)Q4CY(EM0/#']GQ[IU_#+RD6F3
M3S3 [V7^E&SZ)+=) &2F,F12U!2'!T)0$N>?5L$$UXM"..>0DB,T+.:T-^"I
MI $:NW9A2E!TJ,1C"(]S)BRI(%3*R 657FJUA:*98ZU!6&(QOCC^*AK0@(%?
M'%&P_I=NNLDD5DM(9O"T)E;H5%=8_34ON1!D"-V6UA,RBO/NY@405L$WNL*)
ME6<-PRCE"E1S<):=+;)3GK; $.27S\\J?'L^WW'-=\(A?_Q2#&TBRS,1G6\<
MB-[-2^,8YYIOK;4I'XSO#8?'_OPGC<TV9%Q=A\)7X(K\6).&*/@[;A/NER6X
M?D/KK)_ >D-7B&S#&:D&4+5A"=RUK)+9 GR((:95Z=JTNOVE#2IJ%9ESNR2B
M&D3";535C@+-DI^91M^6IV?RM=M;[,Y'B=H(;QQ:B%2HO>/;=3C'036QD^4B
M):& T/%+.S+*9H#R6(%;)Q7U_K8*0>X*-Z-B>A6:+/EG>_#K.T?0'5=][-J(
MZMV<8R:'N;N6'*9%Z6:<R3,7)8Z, -+8@C/6^9D&1#OR$@Q3I,WX,<T?'QM9
MF$W$/W%XAI)%AB/$TD:QE!'L[B\Y)P$%.YU)@,4/"Q/CRE)]:YT/TG"^!,K)
M^ IF&YYBQ6"DQ;)ECY[B@5%=FD6C[\H<T"3]S<4P)5]=.DHLHXXN7/*3"VT-
M3N<0"TOOJSG.G9.!CW!U79J90:V=F>R%J)F- RX0#R+TP^$B58<&H<T9A^E<
M,(\<H?OL/#V 6"%3F(P>.VU5%+%J?,7U;DJW.FPMOW !=&'5D])1\]7WV/6Z
M BL,2^+4V0+T#N_RBLO6>;R5L'R8S[#LD27*8\ZO6/ASQ$RV"6=3AW/)10Y'
MNK74PDX7<]8/H TD^!ZM=*SY/-;PA8>)U( L70Y/@#]E>JTF626'['!9%]\:
M1"YCWJN!M[R6!)%[Z]3A_5O4UJ,O2E'4\?9,ZVPX/JD.!!M!C"OI<W,=,ZL+
M4Z!-.(\4^IF%95Q$7G4]&I1 &2X^U\;%ZSUJQ_DJ9W+HR*N.)D(P2I64A4'W
M?Z";\*-@+MXZ*[@=APTL_=-,$TG#$9:+W& TX4Y[/3KXFBJ94(K'D6P-BUG!
M\U0[Q0FN0WS)\UD;0F Q, ^.])TYK%^![#<J$THFX^0\W&)N*[4*@&T?<H%G
MCZA!:"0NE5$J?3G!V6O;"Q<XPUW.2/_%:SS[LTS0*$J?U%T.M1(.!SW*RRQM
MW68>B\4%W.10"R+;AX"/>WGQL,/K#<J6URE$FNQF3YN K9P.K,R8.%-F-_@@
M;F61[?E#D<T6V?;N:Y&-7_FFM$O0?C9:(3T[. T=6<$[UKG"5V!/5&!^ZHSY
M"-N6Z_3*PV1:7;82QC'.D.A_79Z_SI0<V%8E0H^ZPV]8@M*('JKD<+KOBJI:
M3IAJO#P;Q2@NTL@C&/'][I#9H"/Y*W"7'[F(<WOK)>:$#S@GS+FCX]!>]ZV-
MJ,V97,DL%@(!K\^'>]_+"H7+R"^WM^2T>#%(._,8+HN]I$_?9[+Q0]V\AAQ5
M,0]B00EJ(2\T'R#8/;JDL#FGL_GDBO\=QOPH3D<Q):.*HIZ]4=[  A!2P9K@
M1Y@ZG^6CW#5BVXCN)UAZWAB8CKAR6>0N"2H&WN>3AL-!!CPS>6M8<G95 DOD
MH2D;PCMC_8:D4#AU/ZW*_(H;HJ;YB"/I4)<[)*ED)#M15%YY[!-1DDLJ8Z@2
M#EZI")ZA/BWF#L'F)/284IR0\93302I"Q[CNI+=9CSL)JK=Q[?5=+/&*+?"C
M@=2#")N4D=V\HA8$1$&-W.A@3H?28K+C=5=L6^E O3"C*@XW@-]/=5TH7P,?
M"?(AEJ$=#T3VA.^OJ4*72E//]GI*,JH>L'-FII!7CI^_5%^LS2LZ[D8$>)P/
M7"#L-%E,IUL@WG*;@3Z$;C<<WK-KD=NBR:=$9%4C3E.4TMG>;^PC;G OZS59
ML(RB5'>>$"(NVJBVG(J_&Z7^,-HY7;C65 :VPEZ%XVCB^6W?Y*?U O%8>]^G
MR>-'C_<&OAEB>ZN;2HL!RMCT-W8H=-G0V, 4=Y#3J$S#W2_'1\3F'<ILF42X
MZRB25HZNBNRU]! _1Q? :!5U5UMC2F7IJ&,1)&G39/G[[451@W.3?R'6L:LV
MN5B.-I>;E)C'+!@4[+RA3RS;=HVNA<&$!2[2%X%!QH%G([;969@GT)(:'XIP
MZE+Y#T5B$%*.A7/'NT"=G\O1 >S<^'<J[\<WP= [=U?<41F9"AD0\-3)BHF_
M#I^Q-,R>*PP"2$(TDPU?GX$%<VRR<?HGU7C@NT1DN7+.M3W[:ZQ3;HK#<3ND
M&EP=O*."M8G-?HNZ1*F.X#/@KL\$;X>^);5+F*_CISXLYD@\P5IR.XX<W \Q
M]&=#B9]P>7;HL-&,4K8=.:41VP81G_>"J]IENXQK' Q_8%'C.U$J9VD=P0V'
M7 YY&;TL$4*O1PV"4@ ,2B:$XPR?'E7\$B/B%T<DA>C>B#\W@@"\E*X9;O(R
MJLT#-H,(V*A][>NZ27@CM9.U^RXC2YAR5E$B:18&P"<9\;*_I8 @3PPN29Z.
M\*U*M8@CGN6+DLL_3CFHTUJH]()+<=+5M?6!?Y5;%5PA,V/E:1;8S=FIKP,4
M,7*U5!.4*0*_F3"C\+41)B+)PL#>I1=/V0?/@$Z')F*!I-FD"X5CFC7@,W\E
MD)C/S_Z5R<0MZDVSKLXJTDU#TY@U;;8;#"S9S2=$D#X;95T-/  72+?B^ T.
MR8Z&(EMM\TI)MFY/G^@9 DVC%,NH1MWSI*MMH%MME/5J+[>T51N20Z,PH;U6
M-:F6/B2N>E<T=#?MZ81R/7FBL&EZ]&+NGK!N2,U0+)_BM/SH<);?P11.\_I,
MXG-\M9A3YI;E2[)@C'V8+>KA>=:(:D O8@S/'(6=Z5=]$Q(S K#1LJ1M!DKG
MCD3_]_HL*XO?-<(%C[#@KFX]1].0-6G9TZJU9 1C#)!KMS6[KFN/-*$5B!;/
M:1U/9]KR[Q!UG#+1!DC:2-R_E#*&B#\VH1QLG2O.0^6IR1W1+Z7< @V!#T%!
M4RY\8/<8YPO,>9!@"+UD2[)C$;D,-Y+<[:I"B?M-+H=+1T2^9M3('SI+U[#9
M+:'LP'0'#K/L:>V2%8?48)MHD4BB(,Z,[;2.;SFU![ +U)AL:*QWDZ:P%P_U
M*ENO>GQ?ZU6;4[APYH4RMET^1?)570I_+J?2,G7CD_E>EX:^6?(TJ?LX I3>
MBDXOJ=H+QO,M 1D'TE'M1!@>,ATXICC26Y/P!"ZJR2$27I-L.Y<T<9<TWB7@
M1@RAR\B$8SC*??$%,"E7T.Y*#9;,^+ZY45]2374$\[F>0>>LP4C"ANJ/Y((J
M)98X"+[X@.F!6KK[VLC ^TT"MRG;:O@UU0VZMP,M_XSITA'61.O]1VKY7+'.
M'59;,0D^+^A6?AW5^D[S2'V\EU60X5"6?=INF%0"IHZ=$]PTVCR*W>^Z'W5H
M=1Y9P@C?)4:6,QV'<-1"O(",6E?]\ @NM5VW4!7K/OAZ2A*44[SZ W6[3H-L
M@;P3"3PQC^S^U'6]5;5H9O->(XN;1K4%6 ?(*9MV9'=I#JOX"_"K,K<?I]IS
M$Y'ZAIQS2R(@>@5+D_PGYG30;L-JU:-V4!IU-5/C9="V]UUGX"=]60[>)-[Q
M(""-=L;,470XIR8#Q_%3" RX0:[<N41]>?]B=P(H7<((7=N@:P$]G AW<2*,
M[OI$$$V"[:U E. ,_():"/VZ*9 [$*28TNKIB@]B]\YNI<DDQ<Z5B9#B$$%5
M7P^/K%?SA^[0PN=)S[MX-8T)(TX#9A0C4,2PF$FC!-H23#$(&"47J'DEW..Y
M5D%=D@CV XRED;WHVH5Z@A\A R?"N/%-.ME\EY>(30CP ZWQ&?JKT9^LS>+#
M3SA6\?;<F )O5YY3?$;S/(%H U=^\4WSI8O;OKKM+3\S9'3\RY BC'L="JN)
MAVL9X=W?PV?P('ZAJP<3533MS@ENW16N_*![AC9$,1'R(FWGF:,J+LSX-)]6
M-3)%INBPS'%V9MBGIT<N:F+48LTY(M7LJ*2S\$@*F-@@U)AHLE&*1U)9BG-U
MIE?P>ARJ.,_4'4:I8#I?G WG8\,Q4X*=6^C]Y#$DT>;.)** ^#67F]M2\+*D
MOO:D;6_9!1O0CU4S3%+#U 2DK=JCUKCJ D\U-F>=3@O'S1M,J_<US8?(E;G
MKGIF 6MM']K0PVHF\L?L,_EW[UZQOV;[?2NGMGG#Y"ZXA4-*RK2B.<Z=G^=Z
MEV'N"\V*PQ48/@5K(5M *WJ-(/3=YIH70,^;PDQW/CW-ZV9I7L>0C,.PQ^,>
MLQ_C+^RJ]""5U1 SBUP\KR[!,M4I(A@3D8IGX^P*1>ZS],J3BHL^WR%K39.#
M7XG\8\1T1PGA7F[07AK0*NZ_U.K?2LI/L&Y57>97WPTGA9;F9/U9)MZ8=I<
M@G79["9ON"FN1R$[I/YAJ,V57>3J;6KF#.WA,"]F>#[]2%2(C >W&\F161#[
M)B$3EV;\.KQ&_+185+(6VL\A":"0N1I9%'W'7Z4:XHSM]%4+5-MFBF+[%ZE+
MV?(*'4R4TFV-VIY(MT0+\1[G>:<C*#8M[,0+43!?'K;.?-$X/BIN$/1#=X^I
M@MVO!C8V<&6Z]5Z+JE9E\)>13B,1I,IVE,BCZSUU\VW&3;PV# \X=A&.2S"(
M #+3(:VR8KYS&[<M[3@.<,MMPG"9?][@]95D1\ N,V-6#X=G3-:9>*6:,U:E
M1ZEV[EUP_;>!W MW537)19&+S0@*5; 2 CS-.FCT-8M_75X!;G<FTM4^,VR^
M )N(.2)1P/OFU+F^?ZB6V6K9DX=JV6UK.=) (IMX>\OLSK.,(D#G:@\G>499
M];X#*;GI>22IP^!@#9!@Z*98@!TU$[ FI$=!I9Q04IO:2BG1<M3&,QJ@LJO(
M[7H.5U%Q@(.=BO54\LFS$;L*SM<0](J?L,;:)3Y0+S!Q@5B-BWQ2S?3,QS_-
MJL:#%Y$C"O..WLDT;T$G<%YI=PH857HJ>P#2Z>@B!S[(KN'RK$A$*AMU.>KS
MEPK+>.N#2$[_73$FS?W9>CFIGLV6_HH5A]/^1PB7&P?'][MZND&-=3]\E5YW
M*I-(D_M'6^DX<)2A^+AKP&G:H<,JUV,GBCC$=TK68!A-.IG@>FXT,*A&:55M
M- 9C19-0563AVK<<W^> ,5BBX$$)!4F*$<[.,,+EOSGKV+--!AQQ%C;2TZ8D
M5QUBH[.D/$1@Z.M;]Q;4+:18TKHY$48Y<EKI>ORAU0LL3](V/A[ZYH(2:BC[
MCN,8!_O0%T!\7C'%KH*];4S0U:IF2%%H38745ATR";)B6[?D=3O@PXR.OQ6W
M2WU+7A)TY'%\/R0*XB!@,FJW34B#^D"P=W>V<N_1W1O+UR(7PCM3)1O>.DY;
M_"UJ0T]+UYK$#<J;-F'WK:!UG=:U&Q:T:(MZ,(*T@#"YB;?MF!G$QI3$'Q!2
MC?;QL"^$6J2 B(YRPJ;XC;RSD@X> LA9*=Q*6>!:%V&=M33L6>#UQJN/>@]0
M%(I*9&3D)96+K3I$F.)I45UN6_K,I'^&+D1)IKI+*<?IXWC)G'$Q6@P++:J?
MF0Q:+[MO< 1QGY6F6%"6?98-"]8(SMRMA1>7]MP*ON@(^O#Z_\VFLY\^^+TI
MM-OP48N <#BR!FQU0#DX$[HM1(DP1'!. &Y_N7;)*CI7; ZL@^G;YVX^&,P[
M+,37U7 AB2X, QOFVAE.LF(*TSBIN'U$>;5I;D?9%%X"_./7Q>A, C)7[L>W
M5>8*V'+.TCC/J01!7+$&N-8$P9ZDG5W2'K\E'2[-*1+JN[O1+/4&)28[F=5$
MT879=6XBP%PREY@((5&PK,Z8E-NT2Z/OA5)UD3R*AC+VNEIJLXC&+5GJL(G@
M9HNQZY*"IT'.M,:3"^,7"6?*740QU;\G>. &.]LAMIISC5*):^7M!E8RVBQR
MOQ"=?,O-YS*YS51*P],5%DAS-K+4[";LHK@#D'U+YBYM::E%'(2\M<>+R83B
M B'(5$+,I(L/$P*BPZ"(W9E@3TD=CJQ9_[I41Q:+,?.)Z-4P$:9F'\QNU,V'
M%)5^)]$!P3V!'16*JHYB?3J''/U!B%[%C':"+O%+;;5YG5TU/ HNY"C8;GO+
MG6?]3T>O3>-!BOK'>%2T2?/X$\@7-&0E@T*9+RT&B:O$X&_3UZ@)F#&D,4JC
MC\.5M?/*O*!ETXY.T?'O%^"T/73XWKC0BO@/'#/,1M%H>:TQ90#X)X=I>%TU
MO9H-ZJK'Y @^-W_8P4.1ATR<@\H&BZL@<"I1O835TAF<Y9KA^M^0XS@9)(*?
MH2]XM9"^A]LY'.SL#V@A8H--PZ_*13 9LRSAMO*<K^-5H^%:('S%ZT%$YT"\
MQ[:W,.TWJH1='U9Z-;G()=%6ZKQF(U?''X?MK((L"3Y 6Z&&!3K26D^K U9X
M;R/+*,XA(P_=B$0VB\IQOKAE;SC.%A.<Z,5D9F0PL.N<<-C8JS;7"CA&R>K?
M=$RD"J!H0<^-PS4\+]VPCCOW5WB7DCB9H!R<2Q!2@QSM)V9>X1/M\'# &4U<
ME4OL@3L / QWYTJ<^.4C\]V-J\FIJ>Z-?SY>U!=<.G,;_ _9LK J>_9L$F_9
M DF)B3%XY9;=R*CL9F6R'Q[*9+9,]O2A3'879;(K9GZ2\XQ,X.^#I1:/ I^.
M++4/2#N!4*:96H@%!=_G!&XC?XR!AN3RW^^JQZ9D?NZ\9^Q]5>8NW7+-Y>)*
M8NMXC<M/()=KN+77Z)2VM%5<&_.]1^PB+6HJ4PG8HI3>+*UGU'$I8-%QCAEH
M";517N0F.I&4RQP\&F78,'<A-222#V#-3IJ#9=UY>X]V1H.U*+\VZ4C<C,']
M$8UB;V!9<[:H'74OS7=&[;42HINL9JC*U<EUT<&+0H4X++,@7> L9_)#H5W$
M'24D%!AXYW63ZW(_A2U%V+?Z2F&S7/#!;4&^NRSOEIMI$%<V&1R?+IHNZTWM
M.11<M-? TRZFQ22K+<6,38_Q;J6 @DN&E 6(KC*.LKF-2^(V/K';^(1NXS.Z
MTA]$.=U>62BO9P]&I2.];%]UBCAD=H3QMT6I?+SXDW*HNCS?C08L*W+YD'L$
MUD/87C!N;8L5O(=-Y)"A#%X# S+"]W"C#)3=%)@0R2C.;B6*;):V-ERYW1E;
M@3NK_@@GF 0&NB2U"F\989I#G1HT_F46:IJVU:G!($9&_<&B;VRCUR&UE4A6
M(,"JZC:PNZF?(D7XDP@"@)NW* 5ZP:DB*J9S3R*LO8N*UWO;>PB<%'4?R.=0
MRCD50KD\KY)+Y")7DV$3U:X)H5]LLC86QIL5;&7O,H1W4B$(41C]HK^,N8(+
M<-%'B1KQFG/$OX$M@0,VV7D^2*[RK&YZ"I""OS<.V3"KX;EJ_Y*I[D4 ,-)Y
M&=9([;:]5?-QDS6=DZ>61>IB?=<W(!7W6O2KQBUUOW.90;L&: FAV.Y""B#-
M$ (R/P\PQ'%V4=7<)+%\O*X@XQ96/$XIW:!@5U?M9HE,\P.YP5U9N/QK6#A?
MT:&34,F@RN6Z>F&X!V<^(K<JMC19@S3J#6UC@<3FRX$ / J[<5<[R%@,]31M
MNF*IUZH^(S],159,VCITHT]SU[+ DLSD,C;.L559"'$_<YZ'HG0MDLH1QW^?
M<D^O%CN51J11K5'7]<;Z7I.):K9@XWU>LQX>SU_.6&</MF"YAU3!K9)EY7&0
MR32N$8&T^)K&;6\J[TJ:]R44B_C"J*$UJ)'U5?!52YL-?I.+_X3*AB2'1H0'
MS6(JJ$4C%[C,.6H%O(+#C+M2EC2AX%N:-/DE*7&T.E(X>2X3TBEJUS4" =[Q
MLG KID5!H:L3-_@8)8[!ZW\P>W=A]L9W;?9.J&'6K,J@YP]WY#%LU6(DKDY$
M3!OOA($C*EZ]EISM(?9$([FLL7G!^2,FZ'(A>B,5<@S4<6]1?+DB0FE7C"+D
MI]><Y.OA-\G6B.+54EP)>!ZRUQ,CGQ!D#];<7O=[C_R)"@)[>]>2$#B0Z!CB
MB!,EN#K)?LM%-H9>>0C/$(TV[L-N"D)&H9,GT%\)(QSL2</O((JN(N6R@OMS
M(Z6R-7H]5K6*!DB;?C!$*-F"F&VA-T5WPCU.5?NGZ189CIXQZ@9@IUX.!W>B
MLO<$+GSX\,X=,?S3$37WB9^(1-^C=V6P.SLK1@ZE\A/['YY C1]*ATSEFGZ
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M^?4.L!^3G?W!30XQJIITGF+K'DPX-TW7DJ#..%D1WE10'L7S1^,+\0*./IO
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MI6/%$0P,:L.#^-E.%J062/*(2+5")?4E$T77Z;@&]4_'SV@N@W:;3_.B%AH
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M D>3R\[ $P1>,XQJ0#A8F;>BKO.+"A<@@DLD7VEL!1T_#Z?,1C:4GF"JSTF
M\/M<(AM"_A^:$F11G-*AHX+:WI[LZ$IF6^O$O="] 4O7+;"PO76&88%X)["3
M%DSGA52#N,@9,6V/BK.R^)TQ6N=Y51-=.XZP)IV53L8R;O-I9 OC-@E. T%&
M!5O5(]I;A#)RIJTT*V:WDWW+)CEKX35>8:K,SRK1=$T1X8U &"6/MT=;RQH.
M-%XB/FV*P"1N$D/.)#2<8G?4^D)%=WE>:1><^X0;+--5S+)FGJK& !FU!9'#
ML;9Q2A%'B?^PZF:ID1&O8@)@3^S&P$?63T"NWJ9BMC7,%:/K4:6^.N"^LF)
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M)V,V$O)S?(]!E[&E7;83=@+'8PMC\;F"2 ;N1J;1G'A,5V0J5BJ\MPN4ZT;
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M;#SF!$$\[1/2%$D2<@>E/]2B5"%;1JX.V=%;&$#%:3)-16UT3@.=(*"[BW.
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M&J=3L'#139Q<7MDX"SV&)JF(9B-,D_:E8;:T=@5 1-9?SD[W2&HF+_ (=JD
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M7J0C3C^0KMO#W*%5H]ES3RO@S^[ -;E"0]H9"1<+P?[VP*YYW'>"8QG_TDU
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M&M,Q)[@"1[D2<V ^+++?K[^&P=XS&0)A<PF$S$6^VMM]M!L&0NBR$PJY@X
MA@9?V^@5)J(7-F3+0X&Y-&N!LXI&4C7R5UX3(F/O:LG_\]/_>?:\_L]#:-AG
MG(%/'[5GH'\&/FG/P'MLU <F&OHDA=_WSX]Z9V?!^]>]T][Q2T.R)"H]9Y(*
MLA'C15>M#XML,V+PH:0@TY,5XVT%C/EV(M$M@6_ZWO/NB\->L-\[/#SI'AST
MCU[]W[\]^AM_/COI[IO/VK:;9#2]PM0\^I_G@384;^^"^#T,7L?I-1C+(FHB
MG93;W,Z__0MO.36/N 9E%1U4IJ6T??YFEO_Y0<-J$!JAWVX?C 4!28]:^:'2
MQ=O$\-=_2[!_C(DY^K]_>]RT=3[WC?]\@9+^%V]_[YU"X?GMG_^@+[YZ+^F?
MTT]9+;5E^<O_K'-(;IN$ZGL?/_I&+_[U6W7X&[WWR;?J[[<:Z-TOO;(^=<?]
M2*+T>Q?8^Z^[IX>]L^"T_ZYW&AQV7QR?=L^/3_OT5?_HO'=ZU#WO'Q]U#T-I
M2_]H?^?[$.L_TO2W;_D+OJ5=\.U;_E)O:1?\UU(,?2,_C2^F=4Q U@W6UJ 7
M\]_N4&KV_K:\937/X8 ]AWN3C^(Y_+(M_T?Y#VGMO_,RGEP%[W>"P^@DG8WC
M3QK>5OMNW_)0-R<[N!]0>V2G22/:[?; ENB/])9OL[PY*_TA[;=]A8R)I1T]
M87>XCH-W*-LX*>*2L[+:#?@@%FW[EA_K+;>M[W]P4.U?/WC<MHU<MI'+!^$(
M_^?;?[WIG;[JT4R]?=&&+]OP91N^;,.7K4+Y<*6V'NZ"K9(7X]^"V00E&%$9
MLT!_TWMS\KI_)HUPHCUL8Y@_\$IKW_*@WM(N^/8M?ZFWM O^Q_3;MC',=MNT
M;WF@F[.-8;;;[2_YEC:&R4_ZRE'*;[FCOEH4JGWH=_+0OU:X<&'<OGP%./_[
M.,D:&[F>)CVZ;Y-NK6C^G(KP?_:UB6=T$V-%=S:X9GB:U_!W (Z(.M@W<7$)
M-+G^OQYPKVHMNZV^??>K5+7?IV[[ 5>*?]&I?"#2X\<M$O_NI&:],9^4I''/
MO(SG@9?-\?TF:7S]AZXCF'?G N!\C/WC-_2>WS49XROI45\_[^)KI5E\I:R*
MKY1$\95R)KY6BL37RHAHC=>'(@!?D'Q[==0][P4O^L=GO=-W_?W>F<E.>&#"
M[ON9G/:A#_NA[<IK']JNO._@H2NY\N_C,OBTH/J]0NAW-7-UBWN8IWGQ6_!_
M=E_^_.SIP>UFC+V:_4)>)/Y>__?OG> _<9K.@U=1]D><Z$#YCIPVR/$7?.A7
MV);?-)S^MW_5%OYGC$6[Z'^PAWZ%1?]M@]I>#)N#+?M727Q1K\@]OKA(A@B]
MM%NA?>A?ZZ'K#W)_A:CN7Z!);8#F 3YT;?Y),,'1%/9.SPRUQ&GOY+1WUCLZ
M[Y[WW_6^3)5L&YQI@S-M<*95NKZQ\'L3%\-9,0]>SD@?WPM>Y^EHF >'A_L/
M4N!]/Q/4/O1A/[1=>>U#VY7W'3ST1PS0?-XPW5;U>!)/BR1X!T*U7/L2M*ZS
MO^1#?_S02<-B;]?Z7_*A/WS$Y+8R0&V'MNQS1]?&8;P03-Z&8-J'_C4?^O5#
M,%\[B/'9[_ER57GW*;-KF_G#-'/U(LP[BAWWG@?'$S ZE[\%AU$Y_4:,OK>'
M_3Z;T/<3JQS-_W]^M>,G%.(]6KD0S[[RQWC./UX<'_S.!\KK\S>'__K_ 5!+
M P04    " !S@%%2M:FHTU,Y   .- $ $P   &1P,30V,C4X7V5X,3 P,2YH
M=&WM?5ES$UF:Z+LB]!]R*J)KK(C$8&J;!H8(80M0M[&YMBB&F)B'(REE9U<J
M4YV+C?K7WV\[6R[R I1EVO5 65+F6;]]??%V\N[P9;_WXNUH> #_#_"_%Y/Q
MY'#T\L5C_C_\^EA^?O'J^.!3<#KY=#CZ[Q\665H^"_:>K,I@$B^C(CB*+H.3
M;*G2D+\(@],HCQ<_P(OPZGO]7AE]+A^I)#Y+GP5Y?'9>/@^6*C^+X>.3'UZ^
M>'U\-'&G>%3$_XIX'OCUU<O1Y_-X&I?PQ>[>B\>O8)GX!OSO?6T>,^CSP)TR
MB18PT(_IM%@]O^%+-WU\XU;T"CI6SZ<[S9)YL/?TJB-V3A >K2UF%J5EE%^U
MG-,/[]\?GTSZO>&;D]'HW>AHLC5+^]-.ZA]54<:+M7P9I_,(1WZR^TN<;E[C
M\X"^N(P0G)\%:98O5?+#R\EY7/1[I]5JE>5E,#S+HV@)0P8[)?P0_)C,_UEE
M9E\;C\"\VWRL/NF/.0T["&"*N2JC>;^GBB!;!*^C:5ZI?!WL_18&3Y\\W0N#
MZ3I0Z3Q0RRP]"_;/59[ R9W$%U$>'*IIEJLRRV/X:HS7E*HRSE*5A/!QMAL&
M*CB($G6I\BB89?D*GX;?@QU_7Z^J=91??]4AK!96%*G9.:ZY/(^"Z)]57*[/
MX7ZC?*<8X-?[V1FL)@I>Q1G<ZD4\P_O=O"H<R5_9?K9<J71]_;7U>TE<P($&
M,!X.5\2XB@IF6JDS.*7S*(_*+-C!Q<-"&&S].=_2+JX_Y6[P.LN#504;*2*
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MWL&#;AU>WN]=9.CP+2*<V(THG\>%#GRCU?C3#TR ^4X\8$1?$-,T,Q5R%HX
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M+;) J$7)A PDXH>=5B#+PO40,T"G ,H%.D*GH&!E4/'PQ$Q=U)!85DPV IQ
MY:B^V=6YC8;:!"-JQPL@F"W)=0^L>$[B2%&A=DS?B04DXQZ=\PCS'"3+E=S0
M6@*@4]=;0.:<Z'4;0\XS4D3(<XL J!_VU'3'[.-^[?JL"TQ7B,Y M5TE*M4Z
M')E1*#="'R/(2D:>=T\/;]>H"S1$:-^GT*X\.\O5LJ# J9CXM_U=5!EYH%#
MYTDJGF8IR!B\700JE%#L^OAX2!9."\L>33&MN,8W?4W$'M42H#N;%X/GK%TP
M_!J_.'KG02*H?+,.NN'A1V,0T#>'CSG19H4)*)C[RYF"8N'+U@(Y;D:*!TE&
M!IYYAE5GU.<B<<.*X24RPS'TTAG%B<T?\>H+-^TR#KBX9P$R1RGDA?4$*XP"
M7'#8"G?UCN@>2>9W8LX*4/#QMAV2T;(>[U2><SH9KU]';RS0\*[X2@'FUP7-
M+SB%ZY<+)5 #+E\OGL,U(^!G,PS^@1'^A8,3; 9XSIK,!1UK#758;C9!$6/
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MI58Z6CB;< ]I'.^\@^:_>-$FP*VY+\TI.U_ZO?=\FU@PTVR.74*@L9=P$=2
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MO]DL;04]+T")FCO2Y=$0-.SN!/ZXGX3/2]C]45]49KXQ3")M?Q)XNLLKY%O
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M\2PX5$7YW5@!QR__]U2')=&VT7-R6JTP9,H:F_X/K=9;:';3 /3XU?'!)T*
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M2\26I%4;MH@B"7\OI%!IJK(<O^0S%GK)S@^R10H@IN3()NS(.N+&BPK9]8(
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M9SX <A@YMXE,EG$")":G-RXRDE&H;XIH.OS#91\".<KI8$1!J5IIB\:^*J*
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M^=1H0!;0KY0%,D5IR6 ABZE,=C21U#_)YYCF5R4)MHU$%9CW1Q4('GBF]_L
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MWO9\_D,E/7#7I&-8G#^X_?GLM&SS*^__(?"_SV$A]QW^J1[V:1X&JA^JH3-
M99/^ [#9RC\*=/]?]UGRMWRJ?UEG_8Z/;=F!\HHY5.I%]8S"GQB76I"\I8.Z
MO\+ST#W=E_M302 N4P*7V=*UW_-^/P9T"3D1GA5:?<25'I0=N6\ISU+>+T_=
M<Y8)0VG+ ^^SD]7C7Q3 6_[RT3_P)K__8:>WN[O;^^[;9\_>9Q/E^SO?_?#1
MEKDGFN8ZAQ3UM)&B?_M9U##:&VQA<6POGO7\N82M&G[M7Z>JA6Z+0=KJOT)U
M[XOE*VM"VF>52X9/Z+C3(XYKGST\KKT_UMR4K4_ICQ2RD/ ?-_Q_4$L! A0#
M%     @ <X!14FIK_@(Z P  APP  !               ( !     &-R;"TR
M,#(Q,#(Q-RYX<V102P$"% ,4    " !S@%%2U?K,Z_X*  #@AP  %
M        @ %H P  8W)L+3(P,C$P,C$W7VQA8BYX;6Q02P$"% ,4    " !S
M@%%2.14&-58'   P60  %               @ &8#@  8W)L+3(P,C$P,C$W
M7W!R92YX;6Q02P$"% ,4    " !S@%%2_:TH2IX:  #MD@  #P
M    @ $@%@  9' Q-#8R-3A?.&LN:'1M4$L! A0#%     @ <X!14@_K:S#F
M4 $ 9*4( !,              ( !ZS   &1P,30V,C4X7V5X,#(P,2YH=&U0
M2P$"% ,4    " !S@%%2M:FHTU,Y   .- $ $P              @ $"@@$
M9' Q-#8R-3A?97@Q,# Q+FAT;5!+ 0(4 Q0    ( '. 45)')S8:/QD  .-P
M   3              "  8:[ 0!D<#$T-C(U.%]E>#DY,#$N:'1M4$L%!@
0   '  < P@$  /;4 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
